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This chapter is divided in five parts. 
 
In the first part, a general introduction on the importance of vector-borne diseases worldwide is 
provided and factors that contributed to their expansion and increasing interest are explained. This 
chapter focusses on tick-borne diseases and more specifically on Anaplasma phagocytophilum and 
granulocytic anaplasmosis.    
 
The second, third and fourth parts describe the main characteristics of A. phagocytophilum and 
Anaplasma platys including their classification, morphology and structure. An overview of the most 
important epidemiological features of both bacteria including the transmission modes, the reservoir 
host range, the life cycle, their zoonotic potential and an emphasis on the epidemiological roles of 
dogs in both infections are also exposed.   
 
The fifth part summarizes the main studies about the distribution and prevalence of both                    
A. phagocytophilum and A. platys worldwide and discusses the limitations of prevalence studies.  
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1. Vector-borne diseases gain interest 
 
Vector-borne diseases (VBDs) are caused by various infectious agents including parasites, 
bacteria and viruses that are transmitted to a host through the bite of hematophagous arthropods. A wide 
variety of VBDs are zoonoses,1 i.e., infections or infectious diseases transmissible under natural 
conditions from vertebrate animals to humans. Zoonoses comprise almost 60% of all known infectious 
diseases and 75% of emerging infectious agents are zoonotic.2 VBDs impact human and animal health 
and the global economy, representing approximately 17% of the burden of all infectious diseases, 
causing one billion cases, over one million deaths and millions of dollars in losses to the livestock 
industry annually.3,4 In addition, many people who survive infection are left permanently debilitated, 
disfigured, maimed, or blind. One sixth of the illness and disability suffered worldwide is due to VBDs, 
with more than half of the world‘s population currently estimated to be at risk of these diseases.3 Their 
distribution is determined by a complex dynamic of environmental and social factors.4 Although many 
VBDs affect mostly the least-developed countries such as malaria, dengue, schistosomiasis, 
leishmaniasis, Chagas disease, yellow fever, lymphatic filariasis and onchocerciasis, others are more 
prevalent in Europe and the USA such as Lyme disease and tick-borne encephalitis virus.5 Among 
VBDs, canine VBDs have been of increasing interest the past decades due to the close relationship 
between dogs and humans. Indeed, dogs share the same environment as humans; hence they are exposed 
to similar vectors. In addition, dogs may play important epidemiological roles as competent reservoirs 
host of vecor-borne pathogens (VBPs), source of infection for vectors, mechanical transporters of 
infected vectors, or effective sentinels of regional infection risk for humans.6-13  
 
Ticks display a worldwide distribution and are considered to transmit the widest number of 
pathogens when compared to other arthropod vectors, producing the highest number of human disease 
cases in some regions of the world.13,14 Indeed, in North America and parts of Europe, Lyme disease 
transmitted by Ixodes spp ticks is the most important VBD and a main cause of human morbidity, 
surpassing any mosquito-borne disease. Lyme disease is responsible for more than 90% of all VBD 
cases in the USA and it may be responsible for disease in 255,000 persons annually worldwide, mostly 
in Europe and North America.13,15,16 According to the USA Morbidity and Mortality Weekly Report 
(MMWR), a total of 484,352 cases were reported between 1992 and 2015, with a steady increase of 
287% in the number of reported cases during this period.17,18 In Europe and China there is an estimated 
average of 85,000 and 30,000 cases per year, respectively.19,20 Tick-borne diseases (TBDs) are also 
responsible for several diseases in domestic animals causing serious illness, mortality and major 
depression in livestock production worldwide.21-24 Unlike other human flying arthropod-borne diseases 
where infection can be independent of association with animals and humans are the main host, TBDs 
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are overwhelmingly zoonotic and humans are usually incidental hosts. Therefore, integration of 
veterinary and human reporting systems, surveillance in wildlife and tick populations, and combined 
teams of experts from several scientific disciplines such as entomology, epidemiology, medicine, public 
health and veterinary medicine are needed for the formulation of regulations and guidelines for the 
prevention of TBDs.13 
 
Within the past decades, several VBDs have been considered to be emerging or re-emerging 
because they are newly recognized within an area or because of an increase in their incidence or 
expansion of their geographical distribution or host or vector range.2,5,7 Many VBDs have been reported 
in previously not affected areas such as babesiosis in northern Germany, Belgium, Poland and the 
Netherlands. Anaplasma platys seems to be more frequently diagnosed in Europe, Candidatus 
Neoehrlichia mikurensis seems to extend its distribution worldwide. Canine monocytic ehrlichiosis, 
granulocytic anaplasmosis, tick-borne encephalitis virus and D. immitis are reported to extend to 
northern Europe. Similarly, leishmaniasis is spreading to Northern Europe and Northern America.25-31 
Multiple factors are supposed to play a crucial role in arthropod-vectors expansion mainly increased 
animal travelling and migration, climatic changes with a global warming, landscape rehabilitation and 
management with increased urbanization, development of large suburban areas with private gardens, 
creation of artificial lakes, forests modification, increased popularity of open-air activities, changes in 
wildlife fauna, loss of biodiversity, decreased host population densities, and residential growth 
expanding into rural geographic areas. All these conditions affect the ecology and epidemiology of 
infectious diseases, enable the circulation, multiplication and spread of both vectors and pathogens into 
formerly unaffected areas, promote the creation of niches for vectors and their capacity to newly acquire 
pathogens, impact wildlife populations that serve as reservoirs and the dynamic of transmission amongst 
natural reservoirs, increase the risk for the host to enter in contact with vectors and impact the likelihood 
of animal–human transmission.1,5,30,32-34 Therefore, although traditionally regarded as a problem for 
countries in tropical settings, VBDs pose an increasingly wider threat to global public health, both in 
terms of the number of people affected and their geographical spread.5 Beside these environmental 
changes leading to increased hazard exposure to VBPs, increased clinician awareness, new diagnostic 
tools, improved surveillance and increased reporting and communication of these diseases in several 
countries can also explain the increased incidence.1,21,30,34 Advances in molecular biology also allow the 
discovery of new species, strains or genetic variants and extend the list of VBPs able to infect either 
animals or humans or both.13,35,36 Finally, VBP spectrum seems to expand, and some pathogens 
traditionally associated with domestic animal infections may also potentially emerge as human 
pathogens13 such as Ehrlichia canis37,38 and Anaplasma platys.39-41 
Chapter I General introduction 
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Anaplasma phagocytophilum, the agent of granulocytic anaplasmosis, is considered as an 
emerging zoonotic tick-borne pathogen.42 Indeed, the environment suitability of its main vector seems to 
increase in Canada43 where human granulocytic anaplasmosis (HGA) is of growing concern for public 
health due to the recent establishment of Ixodes scapularis in southeastern and south central regions.44 
In the USA, human and canine infections with A. phagocytophilum have been reported in the Pacific 
northwest, the upper Midwest, and the northeastern and mid-Atlantic USA, and most cases occur in 
Minnesota, Wisconsin, New York state, New Jersey, and Connecticut, suggesting that expansion from 
the USA may further drive the emergence of this tick-borne disease in Canada.32 Possible implication of 
migratory birds in the expansion of I. scapularis ticks in Canada (especially in northern provinces) has 
also been suggested.45 In the USA, HGA is a nationally notifiable disease and both canine and human 
exposure to A. phagocytophilum has progressively increased from 2008 to 2010.46-49 Data from the USA 
Center for Disease Control and Prevention (CDC) and MMWR reported 10,670 human cases between 
2010 and 2013, and an 8-fold increase in reported cases between 2000 and 2013.18,50,51 In Europe, high 
prevalence rates of A. phagocytophilum were observed in both Ixodid ticks and wild animals.52-55   
Ixodes ricinus, the main vector of this bacterium in Europe,23 has expanded its territories over the past 
few years in European countries due to several factors including climatic and ecological modifications 
and also probably because of a low host specificity and tolerance to various environments.56-59 
Serological evidence of A. phagocytophilum infection and granulocytic anaplasmosis have been 
reported in several European countries in both dogs60-66 and humans.67-75 Currently, HGA is considered 
the third most important VBD in both the USA and Europe, and is also increasingly diagnosed in some 
Asian countries.77,76 In China, A. phagocyophilum exposure among high-risk populations seems to have 
rapidly increased and reported cases showed a higher severity and mortality than in the USA and 
Europe.78 Despite the increased reporting of this infection, it is still unrecognized and underdiagnosed.79 
Moreover, its occurrence is unknown in large parts of the world including Africa, Oceania, South 
America and many Asian countries.80,81 In North Africa, ticks are abundant and might represent 
potential hazard for animal and human public health. Evidence of Anaplasmataceae species infection in 
various tick species have already been reported.82,83 However, only a few epidemiological data are 
available on A. phagocytophilum in this continent mostly on ticks84,85 and domestic animals (ruminants, 
horses and dogs)86-88 but studies on human exposure are still missing.  
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2. Classification and morphology of Anaplasma phagocytophilum and Anaplasma platys 
 
2.1 Classification of Anaplasma phagocytophilum and Anaplasma platys 
 
Anaplasma phagocytophilum and A. platys are α-proteobacteria belonging to the family of 
Anaplasmataceae in the order of Rickettsiales. The order Rickettsiales is divided in two families: 
Anaplasmataceae and Rickettsiaceae (Figure 1). The family Anaplasmataceae includes agents of 
Ehrlichia, Anaplasma, Wolbachia, Neorickettsia, Cowdria genera and provisionally the genus 
Aegyptianella. Except for Wolbachia, the family of Anaplasmataceae includes obligate intracellular 
arthropod-borne bacteria that infect mature and immature hematopoietic cells and develop within 
intracytoplasmic vacuoles.89 They are responsible of endemic and emerging diseases of major relevance 
in both veterinary and human medicine with important economic and public health outcomes (Table 
1).90 Seven Anaplasmataceae organisms are able to infect humans namely, Ehrlichia chaffeensis,              
E. ewingii, E. canis, E. ruminatum, A. phagocytophilum, A. platys, Neorickettsia sennetsu and 
‗‗Candidatus Neoehrlichia mikurensis‘‘ (Table 1) but only the former three species are sufficiently 
investigated because they are responsible of the majority for human ehrlichiosis and anaplasmosis 
cases.37,91-93 
 
 
Figure 1. Phylogenetic tree of the order Rickettsiales on the basis of the 16S rRNA gene 
sequencing, showing relationship between the belonging agents (species and family name on the right 
in parentheses). Bootstrap percentages are noted at the nodes of the tree. Bar, 10 substitutions per 100 
nucleotides.10  
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Table 1. Rickettsial agents belonging to the family Anaplasmataceae infecting companion animals 
and human.Adapted from 90,94  
Agents 
 
Primary vector Distribution Host cells Susceptible species and disease 
Anaplasma 
phagocytophilum 
Ixodes persulcatus 
complex 
 
Worldwide Neutrophils 
Eosinophils 
Granulocytic anaplasmosis, tick-
borne fever, tick-borne pasture 
Humans, dogs, cats, horses, 
ruminants  
Anaplasma platys Rhipicephalus 
sanguineus? 
Dermacentor auratus? 
Worldwide Platelets Dogs: Infectious canine cyclic 
thrombocytopenia 
Cats: questionable 
 
Ehrlichia canis 
Rhipicephalus sanguineus 
Dermacentor variabilis 
Worldwide Monocytes 
Macrophage 
Lymphocytes 
Dogs: canine monocytic ehrlichiosis 
Cats: fever, lethargy, anorexia 
Human : infection identified in 
Venezuela 
Ehrlichia  chaffeensis Amblyomma americanum Southern USA 
Eastern USA 
California 
Monocytes 
Macrophages 
Lymphocytes 
Human : human monocytic 
ehrlichiosis 
Dogs: mild/subclinical unless present 
in co-infection 
 
Ehrlichia ewingii 
Amblyomma americanum Southern USA 
 Eastern USA 
Neutrophils 
Eosinophils 
Human : human granulocytic 
ehrlichiosis, uncommon 
Dogs: granulocytic ehrlichiosis 
Ehrlichia ruminantium Amblyomma spp. Africa 
Caribbean 
Endothelium 
Monocytes 
Nacrophages 
Neutrophils 
Ruminants : heartwater 
Dogs: subclinical/rare 
 
Neorickettsia risticii Acanthatrium oregonense, 
caddisflies, aquatic insects 
North 
America 
Monocytes 
macrophages 
Enterocytes 
Dogs: lethargy, fever, vomiting, 
arthritis, 
thrombocytopenia 
Cats: experimental infection 
Neorickettsia 
helminthoeca 
Trematodes: Nanophyetus 
salmincola 
Northwest 
USA 
British 
Columbia 
Brazil 
Monocytes 
Macrophages 
Enterocytes 
Dogs: fever, anorexia, diarrhea, 
vomiting, 
lymphadenopathy 
 
Anaplasma phagocytophilum is known as a veterinary pathogen since the discovery of tick-borne 
fever (TBF) in Scotland in 1932.95 The taxonomic position and the name of the bacterium changed 
several times being successively named Rickettsia phagocytophila,96 Cytoecetes phagocytophila97 and  
Ehrlichia phagocytophila.98 A. platys, the agent of Infectious canine cyclic thrombocytopenia, was first 
reported in the USA in 1978 and was first named as Ehrlichia platys.99 Phylogenetic molecular analysis 
based on the 16S rRNA, groESL and surface protein genes sequencing in addition to morphologic and 
phenotypic characteristics have led to the reorganization of the Anaplasmataceae family and the 
reclassification of some agents. Consequently, E. platys was renamed as Anaplasma platys. Similarly, 
the name A. phagocytophilum was given in 2001 to three previously distinct agents, i.e., the agent that 
causes equine granulocytic anaplasmosis (Ehrlichia equi), the agent that causes tick-borne fever or 
Chapter I General introduction 
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pasture fever in sheep and cattle, respectively (Ehrlichia phagocytophila) and the agent that causes 
HGA.89,100 The renaming of these three agents as A. phagcytophilum has been controversial because of 
differences in their host tropism and cell target from other Anaplasma species such as             
Anaplasma marginale.101 Additionally, although these three agents share genetic, antigenic and 
biological characteristics,89 they are considered phenotypic variants due to differences in their 
distribution, prevalence, virulence and target host species.102,103 
 
2.2 Morphology and structure of Anaplasma phagocytophilum and Anaplasma platys 
 
Anaplasma phagocytophilum and A. platys are gram-negative, non-motile pleomorphic bacteria 
that mostly display a coccoid to ellipsoid shape. Their sizes vary from 0.2 to 2.0 μm and 0.3 to 1.2 μm in 
diameter, respectively. Like the other members of the Anaplasma genus, these bacteria are obligate 
aerobe that lack glycolytic pathway. Their membrane is rippled, thin and lacks the peptidoglycan layer 
and lipopolysacharrides of the cell wall. These two features make them sensitive to mechanical stress 
including freezing, thawing, sonication and osmolarity changes.99,104-107 Both bacteria infect peripheral 
blood cells derived from bone marrow precursor with A. phagocytophilum infecting preferentially 
neutrophils but also occasionally eosinophils whereas A. platys parasitizes circulating platelets.99,106,108  
A. platys is also able to infect megakaryocytes and promegacaryocytes of the bone marrow in naturally 
infected dogs.109 These organisms develop within intracytoplasmic inclusions of varying size (from 1.5 
to 6 mm in diameter) derived from the host cell membrane. These vacuoles are endosomes where the 
bacteria find nutrient and multiply by binary fission.79,81,110-112 The vacuoles can contain two distinct 
ultrastructural forms characterized by their DNA organization, i.e., a small dense core with condensed 
protoplasm also called ‗elementary body‘ (0.2 to 0.4 μm) or a large reticulated form named ‗reticulate 
body‘ (0.8 to 2.0 μm).79,81,90,110,111 Both forms can replicate by binary fission producing 1 to 20 
organisms forming a ―morula‖ (from Latin morum: ―mulberry‖) (Figure 2).  
 
Figure 2. Intracellular development of Anaplasmataceae pathogens.90 
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Morulae appear as basophilic intracellular inclusions of varying size from 1.5 to 2.5 μm; but can 
be as large as 6 μm.81,99, 106,108,110 Other authors consider that only the reticulated forms (vegetative form) 
multiply by binary fission until forming morulae, and then turns into the dense cored cells (infectious 
form), which are released and bind to host‘s cells target.10,90,113 Morulae of A. platys (Figure 3A) and       
A. phagocytophilum (Figure 3B) are detectable in peripheral blood smear 9 to 17 days and 4 to 14 day 
after experimental inoculation, respectively.99,114-117 
 
        
  
 
 
 
 
 
 
  
 
Figure 3. Anaplasma platys (A) and Anaplasma phagocytophilum (B) intracytoplasmic inclusions 
(morulae) within a canine peripheral blood platelet after experimental infection and a canine neutrophil, 
respectively. Morulae appear as purple stained bodies within the platelet cytoplasm (arrow).10,117 
 
The only bacteria, other than A. phagocytophilum, known to survive and multiply in neutrophils 
are E. ruminantium, E. ewingii, and Chlamydophila pneumonia.79 By light microscopy, morulae of 
Ehrlichia ewingii are identical to those of A. phagocytophilum. This can lead to misdiagnosis in the 
regions where both pathogens are present if only blood smear examination are performed.10,81 
 
 
 
 
 
 
 
 
 
 
 
A B 
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3. Anaplasma phagocytophilum  
 
3.1 Genome 
 
The A. phagocytophilum genome is composed by a single circular double-stranded chromosome. 
The complete genomic sequence is estimated at 1.47 megabases (Mb) that contains 41.63% of G+C 
content, 1,369 open reading frames and 458 hypothetical proteins but lackes any associated plasmids.118 
The complete genomic sequence of the bacterium has been submitted to GenBank in 2006 (NC007797) 
and comprises between 1,140 and 1,411 genes including protein coding sequences, rRNA, tRNA, and 
pseudogenes.118,119 This genome also contains many repeated sequences that are associated with 
important functions such as the expansion of outer membrane protein of the msp2/p44 family, type IV 
secretion system, vitamin/cofactor biosynthesis and many variable number tandem repeat (VNTR) 
sequences.118-121 The genome contains 113 ―functional pseudogenes‖ msp2/p44 that encodes for the 
major surface antigen. These hypervariable pseudogene are recombined into a single expression site 
which enables the bacterium to serially express variable antigens and to escape from host 
immunity.118,122,123 Outer membrane proteins play several essential roles in the adaptation of the 
bacterium to variable environments and host niches, the transport of nutrients and molecules acting in 
the host-interaction, antimicrobial resistance, response to osmotic stress.124,125 and inducing neutralizing 
antibodies against homologous strains of A. phagocytophilum.126,127 Type IV secretion system has a 
crucial role in the pathogenesis of the disease.128 Some genes may also contribute to the resistance of the 
bacterium in diverse environments.118  
 
Despite the apparently genome simplicity of A. phagocytophilum, this bacterium exhibits an 
extensive genomic diversity.120,129,130 More than 500 partial pseudogene sequences derived from human, 
tick and animal strains from several USA, European and Asian regions are available in GenBank.120 
Moreover, twenty complete A. phagocytophilum genomes have been sequenced including sixteen 
American strains and four European strains. However, only a few genomes per host species are 
available, except for humans, which might underestimate the true strain diversity.56,118-120 
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3.2 Genetic variability 
 
The genetic variability has been suggested as an explanation to the ecological complexity, host 
tropism diversity and the observed differences in incidence, clinical severity, and disease manifestation 
between geographic regions.118,131-133 Clinical cases of granulocytic anaplasmosis in ruminants have 
exclusively been reported in Europe while only a few human cases have been described in this 
continent. In contrast, USA strains do not cause disease in domestic ruminants but a higher human 
incidence rate and severity of the disease were reported.56,120 In western states of the USA, the 
discordance between the distribution of clinical cases in humans, dogs and horses and the infection in 
the reservoir hosts suggests that multiple strains are circulating.134 Genetic variants from Rhode Island 
and Connecticut could interfere with the transmission and maintenance of strains causing disease in 
humans. This presumed host competition between different variants could explain the lower incidence 
of human cases in some areas.130,135,136 Variants causing the disease in sheep and cattle failed to induce 
the disease in horses. Conversely, isolates from horses induced seroconversion but not clinical signs in 
lambs and cattle when inoculated.137-139  
 
Genetic variability has been demonstrated first by the sequencing of the 16S rRNA gene.140-142 The 
TBF variant differs from the human variant in three positions of the 16S rRNA gene.143 The sequencing 
of the 5‘ region of this gene enabled the identification fifteen A. phagocytohilum variants, 
respectively.113 In the USA, several variants have been identified based on the sequencing of the        
16S rRNA and the only pathogenic variant to humans (Ap-ha) is also able to induce the disease in dogs, 
horses and mice but not in cattle. Another strain (Ap-variant 1) circulating in deer (Odocoileus spp), is 
genetically distant from the Ap-ha strain and infects only deer, goats (Capra aegagrus hircus), and tick-
origin cell lines, while experimental infection of mice was not successful.129-131,135,144 In Europe, other 
variants have been identified in humans and the Ap-ha variant has also been detected in wild 
ruminants.56,118,141 Strains infecting domestic ruminants in Europe and white-tailed deer in the USA (Ap-
variant 1) seem to genetically differ from those infecting humans, horses and dogs.132,145 The Ap-ha and 
Ap-variant 1 can coexist in the same geographic area, could be transmitted by the same vectors, and 
seem to segregate only according to their host tropism.146 Similarly, multiple 16S rRNA variants can 
coexist in a single infection and several phenotypically untyped variants have been reported in Europe 
and the USA.147,148 In Washington, five different 16S rRNA variants (named WA1 to 5) that differed at 
four nucleotide positions were identified from dogs displaying clinical signs consistent with 
granulocytic anaplasmosis. All WA variants were distinct from those identified in sheep in Norway and 
llama-associated ticks but one was identical to equine and human variants.136 In another European study, 
seven different 16S rRNA variants were identified from dogs, with the two most common variants 
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showing statistically significant differences in the frequency of clinical signs and hematological 
abnormalities, suggesting possible differences in strain pathogenicity.133 
 
The 16S rRNA gene was considered too conserved for use in phylogenetic analysis between 
different strains of A. phagocytophilum. It had poor resolution and failed to discriminate between 
ecotypes circulating in wild ruminants compared to other animals. Furthermore, the 16S rRNA sequence 
analysis could not categorize human-infective isolates in order to detect virulent strains and was unable 
to distinguish variants according to their geographic origin.52,131,140,141 Consequently, other genes have 
been proposed to study the genetic variability of A. phagocytophilum including msp4, ankA, groEL 
operon, msp2/p44 genes.52,122,142,149,150 The genes encoding outer membrane proteins of the OMP-
1/msp2/p44 protein superfamily are involved in the interactions with the hosts and vectors. The high 
variability of msp2/p44 is associated with multiple antigenic variations that arise during the                  
A. phagocytophilum reproduction in mammals and ticks and facilitate bacterial survival in diverse hosts 
and persistence in vertebrate reservoir hosts.107,113,118,151 A comparison of the msp2/p44 sequences of 
ruminant and tick isolates from Europe and the USA have demonstrated that most of the sequences 
displayed only moderate identity to one another, and any distinct clustering of sequences from 
individual isolates, from different countries, or different host species was absent. Therefore, it has been 
hypothesized that the sequences of msp2/p44 gene in similarity groups may provide an index of 
adaptation of A. phagocytophilum strains to specific vectors or reservoir hosts in different geographical 
locations.122,152-154 In contrast, the msp4 gene sequences are genetically stable during the multiplication 
in hosts‘ cells; thus, it is preferable for phylogenetic analysis. The analyzed strains of                             
A. phagocytophilum showed a high degree of identity in the msp4 locus.141,155 The ankA gene encodes an 
ankyrin repeat protein involved in host cell transcription regulation named the ankyrin repeat-containing 
protein (ankA) (153-160 kDa).56,113 This gene is suspected to play a fundamental role in the pathogenesis 
by interfering in the transcription of some genes.79,156 The ankA gene enables the discrimination between 
animal host tropism only52 and some authors consider that it could not display the required level of 
discrimination for epidemiological studies.56 The gene sequences seem to vary according to the 
geographic location and show a relative conservation among North American strains as opposed to 
European isolates79 except for human European strains that seem identical.150 European variants and 
American human variants were segregated in separate subgroups. Sequences of this gene were found to 
divide in distinct variant clusters associated with animal host tropism. Isolates from humans, horses, 
dogs and cats were found exclusively in the same cluster, which also included several variants from 
domestic and wild ruminants. Another cluster was composed of variants from wild ruminants (roe deer 
and red deer) while the third one included variants isolated from both wild (red and roe deer) and 
domestic ruminants (cattle and sheep). Two other clusters included exclusively variants isolated from 
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roe deer and rodents, respectively.52,56,157 Another study found four distinct animal hosts tropism 
ecotypes with different enzootic cycles based on the sequencing of the groEL heat-shock protein 
gene.142 The groESL heat shock operon has an intermediate genetic variability and is expected to act as 
a marker for demographic analysis. Hence, it could more clearly discriminate between                           
A. phagocytophilum isolates from different origin and further between isolates of different pathogenicity 
than the 16S rRNA gene.56,142,158 The first groEL cluster contained all human isolates and variants from 
wild (hedgehogs, mouflons, red deer) and domestic animals (cattle, dogs, horses and sheep). The second 
cluster included wild and domestic ruminant isolates (roe deer, red deer and sheep) and rodent variants. 
The third and the fourth clusters grouped exclusively isolates from rodents and birds, respectively.142 
Different gene sequencing revealed similarities between human and canine isolates, suggesting that 
dogs and humans may be infected by the same strains in Europe and the USA.120,150,159-163  
 
All previous single gene based sequencing methods enabled the identification of geographic 
and/or host tropism clusters but failed to categorize human-infective isolates in order to detect virulent 
strains and had some contradictory results depending on the loci used. More recently, other methods 
such as multilocus strategy, whole genome sequencing or other locus targets56,113,162,163 were proposed to 
help solve these problems. A gene named drhm (for ‗distantly related to human marker‘) was suggested 
to be a potential valuable marker of human strain virulence because it was identified in several strains 
including the USA Ap-variant 1 (ruminant), MRK (horse) and the European sheep variant but deleted in 
strains infecting humans and dogs in the USA.162 Despite the worldwide genomic diversity, human-
infective strains seem to represent a conserved subset. Indeed, the homology between human-origin 
strains in the USA, Europe and Asia suggests that humans may not be susceptible to many of the 
circulating wildlife strains and that their susceptibility may be conditioned by selection pressures in 
small mammal reservoir hosts that cause evolution of novel strains able to invade and survive in 
humans.120 
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3.3 Vector 
 
Anaplasma phagocytophilum is commonly described as a TBD because most contaminations of 
people and animals occur after tick bites28 especially when they come in contact with the vector in 
reservoir hosts habitat.164 Anaplasma phagocytophilum is transmitted mostly by hard ticks of           
Ixodes persulcatus or I. ricinus complex. The genus Ixodes includes approximately 245 species among 
them 14 belong to the I. ricinus complex. This complex contains four tick species that are involved in 
the transmission of the majority of Ixodes-vectored human diseases, i.e., I. scapularis, I. pacificus,        
I. ricinus and I. persulcatus.23,80,89 Species of this complex are widely distributed throughout the world 
and are commonly found in the northern hemisphere (Figure 4). Their occurrence within a territory 
depends on climatic conditions (between 10 and 30°c, and >80% relative humidity) and the availability 
of feeding hosts.8,23 
 
 
Figure 4. Worldwide geographic distribution of Ixodes spp. ticks, vectors of                     
Anaplasma phagocytophilum.Adapted from 80 
 
In the USA, several ixodid ticks are competent vectors of A. phagocytophilum, depending on the 
geographic location (Figure 4). The main vector in the humid forests of the upper Midwestern, north 
central and northeastern regions is Ixodes scapularis (Figure 5) whereas Ixodes pacificus (Figure 5) is 
located in shrub forests and deserts of the western USA.165-168 Surveys from Canada suggest that            
I. scapularis ticks are also the most important vectors of A. phagocytophilum in this country.169,170 The 
activity of I. scapularis varies during the year according to the life stage and the geographic localization. 
In the North of the USA, adult ticks are active from early spring to summer and in winter, nymphs are 
active during spring and summer whereas larvae activity extends from summer to fall. In the South, all 
stages are active from the end of fall until the end of spring.1,165 The prevalence of A. phagocytophilum 
DNA among I. scapularis and I. pacificus ticks range from less than 1% up to 50% and 10%, 
I. ricinus and 
I. persulcatus 
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respectively.171-174 Other tick species have been reported to be infected by A. phagocytophilum such as 
Ampbyomma americanum and Dermacentor spp., and D. albipictus, I. spinipalpis and I. dentatus are 
recognized as competent vectors.175-179 In central and southern America, very few studies are published 
on the prevalence of A. phagocytophilum among ticks. However, among the three available studies, 
none have detected the DNA of this bacterium in Ixodes spp. ticks. In contrast, its DNA has been 
amplified from Rhipicephalus sanguineus, Amblyomma cajennense, A. dissimile, A. maculatum, 
Dermacentor variabilis.180,181,182 Amblyomma spp. and D. variabilis were positively correlated with      
A. phagocytophilum infection in Brazil and Mexico.180,182 
  
 
 
 
Ixodes scapularis 
Blacklegged tick 
Deer tick 
 
 
 
 
Ixodes pacificus 
Western-blacklegged tick 
 
Figure 5. Ixodes scapularis and Ixodes pacificus ticks stages (TickEncounter Resource Center of the 
University of Rhode Island). 
 
In Europe, the most common vector is I. ricinus (Figure 6),23 which is widely distributed from 
Western Europe to central Asia (Figure 4). This tick lives mostly in humid wooded habitats and pastures 
and is rarely encountered in the Mediterranean region or in mixed or deciduous forests except at high 
altitudes.28 It is active mostly in spring, from April to June.42 The prevalence of A. phagocytophilum 
DNA among I. ricinus ticks in Europe range from less than 1% to 76.7%,53,183 and variation according to 
the stage of development and between countries are reported to occur.23,54 Other Ixodes spp. ticks seem 
to be involved in epidemiological cycles distinct from those involving I. ricinus including                      
I. trianguliceps, I. hexagonus and I. ventalloi.26,141,184-186 In addition, the DNA of this bacterium has been 
detected in several other tick species in Europe including Dermacentor reticulatus and            
Hyalomma concinna.149,187,188 Rhipicephalus species were also infected with A. phagocytophilum and 
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could act as competent vectors in the Mediterranean area.121,189-193 Ixodes persulcatus (Figure 7) is 
another competent vector of A. phagocytophilum in Eastern Europe and Asia (Figure 4), with prevalence 
rates reported to be up to 16.7% and 21.6%, respectively.194,195  
 
 
Figure 6. Ixodes ricinus tick developmental stages (sheep or castor bean tick).196 
 
Although I. persulcatus is considered the primary vector in Asia, A. phagocytophilum DNA has 
been detected in several other tick species including Ixodes nipponensis, I. ovatus,              
Rhipicephalus turanicus, R. microplus, R. sanguineus, Hyalomma marginatum, Boophilus kohlsi, 
Dermacentor silvarum and several Haemaphysalis species.190,197-201 Molecular investigations indicated 
that I. ovatus, D. silvarum, H. concinna, H. longicornis, R. microplus, R. sanguineus and D. nuttalli 
might be involved in the transmission A. phagocytophilum in China.201-204 
 
                  
Figure 7. Ixodes persulcatus tick (Online photographic guide to ticks, Bristol University tick ID). 
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In North Africa, only a few studies have investigated the prevalence of A. phagocytophilum DNA 
among ticks. A survey from Morocco and Tunisia detected A. phagocytophilum DNA in 1% and 3% of 
I. ricinus and Hyalomma detritum, respectively.82 Although I. ricinus has been suggested to be the main 
vector of A. phagocytophilum in this part of the world as well, some reports detected its DNA in several 
other tick species.85 Indeed, two studies showed a prevalence of 13.7% and 2.3% in R. sanguineus 
(Figure 8) collected from free-roaming dogs in Egypt and H. marginatum collected from horses in 
Tunisia, respectively.84,85 Additionally, Hyalomma dromedarii, H. excavatum and H. impeltatum ticks 
have been collected from dromedaries with positive antibody titers to A. phagocytophilum in Tunisia.87 
Therefore, A. phagocytophilum is likely to circulate in a wide variety of ticks feeding on a wide range of 
hosts; however whether all these ticks are involved in the transmission to hosts or not is still 
unestablished.85  
 
 
 
Figure 8.  Rhipicephalus sanguineus ticks or brown dog ticks (TickEncounter Resource Center of the 
University of Rhode Island). 
 
 
 
 
 
 
 
 
 
 
 
Chapter I General introduction 
 25 
3.4 Reservoir hosts 
 
A reservoir host is defined as a biotic or abiotic environment that enables a pathogen to persist in 
a sustainable manner. As A. phagocytophilum is an obligate intracellular bacterium and not 
transovarialy transmission in Ixodes spp. ticks, its reservoirs should be animal hosts permitting its 
survival, particularly outside the activity period of its vectors. Although a wide range of domestic and 
wild animal species can be infected by the bacterium, hosts might fulfill several characteristics to be 
considered as reservoir hosts. Indeed, a host reservoir most be fed on by an infected vector tick at least 
occasionally, take up a critical number of the infectious agent during the bite by an infected tick, allow 
the pathogen to multiply and survive for a period in at least some parts of his body, and might allow the 
pathogen to find its way into other feeding ticks. Therefore, the detection of pathogens or their DNA in 
vertebrate hosts is not enough to consider them as reservoir hosts. If these hosts display also 
physiological and behavioral characteristics enabling the multiplication and transmission to the vector, 
they can be considered as candidate reservoir hosts. Otherwise, these animals can act as simple carrier 
or dead end hosts.33,205,206  
 
Wild mammals are considered to be the main reservoir host of A. phagocytophilum. Wild cervids 
are the most common reservoir hosts because they develop a persistent subclinical infection54 with 
white-tailed deer (Odocoileus virginianus) and roe deer (Capreolus capreolus) the main feeding hosts 
for ticks in Eastern USA and Europe, respectively.54,57 Small mammals are also major feeding hosts for 
ticks.207 The host reservoir range of A. phagocytophilum seems to differ according to the geographic 
localization.23 In Europe, prevalence rates of A. phagocytophilum in wild ruminants range from 10% to 
more than 90%, with highest prevalence rates recorded for roe deer.52,55,208,209                             
Anaplasma phagocytophilum is highly prevalent in other wild ruminant species that may act as efficient 
reservoir hosts in Europe including red deer (Cervus elaphus), feral goats (Capra hircus), fallow deer 
(Dama dama), sika deer (Cervus nippon), moose (Alces alces), elks (Alces alces), alpine ibex            
(Capra ibex) and chamois (Rupicapra rupicapra).24,56,210,211 Similarly, several small mammal species 
were found to be infected with A. phagocytophilum including bank vole (Clethrionomys glareolus), 
wood mouse (Apodemus sylvaticus), yellow-necked mouse (Apodemus flavicollis), common shrew 
(Sorex araneus) and European hedgehog (Erinaceus europaeus) with prevalence rates up to 85%.186,212-
215 However, even though A. phagocytophilum has been detected in a wide variety of wild animal 
species in Europe, reservoir hosts for the human pathogenic strain are still unknown.150,216 Indeed, the 
reservoir competence of rodents is not established and cervids were reported to mainly disseminate 
variants that have not been isolated in humans, dogs, horses or domestic ruminants.52,121,158,216-218 In 
addition, the phylogenetic analysis based on several loci (groEL, msp4 and ankA) revealed that rodent 
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strains are clustered in different groups than A. phagocytophilum isolates from other animal species, 
making these rodent strains unlikely to circulate in A. phagocytophilum epidemiological cycles 
involving other mammals. Furthermore, according to recent studies, rodents could be reservoir hosts in 
an independent epidemiological cycle, involving only rodents as mammalian hosts.142,157, 219 
 
The main reservoir hosts in the USA, with variations according to the region, are white-footed 
mouse (Peromyscus leucopus), white-tailed deer (Odocoileus virginianus), grey squirrels               
(Sciurus carolinensis), Eastern chipmunks (Tamias striatus), dusky-footed wood rats                   
(Neotoma fuscipes) and southern red-backed voles (Myodes gapperi).23,35,54,136 In the eastern USA, the 
white-tailed deer is the principal reservoir host of the A. phagocytophilum AP-variant 1 with reported 
prevalence rates up to 46.6%.132,220 In contrast, rodents are considered the most important reservoir hosts 
of the bacterium in the northeastern, the upper Midwestern and the western coast of the USA. Both 
white-footed mouse (Peromyscus leucopus) and eastern chipmunks (Tamias striatus) were found to be 
the main reservoir hosts for the Ap-ha in Northeastern USA.221 Other rodents such as southern red-
backed vole (Clethrionomys gapperi) are considered competent reservoir hosts for                                  
A. phagocytophilum.130,222,223 In the western states of the USA, among the most frequently infected small 
mammals species are dusky-footed woodrat (Neotoma fuscipes), western gray squirrel (Sciurus griseus), 
Douglas squirrel (Tamiasciuris douglasii), gray squirrel (Sciurus carolinensis), deer mouse  
(Peromyscus maniculatus) and red wood chipmunk (Tamias ochrogenys). DNA of the bacterium has 
been detected in several rodent species with prevalences ranging from 1.8% to 88.4%.54,175,220,224-226 
However, there is an important spatial discrepancy between human, canine and equine clinical disease 
in the western USA and infection in the supposed reservoir hosts, suggesting that multiple distinct        
A. phagocytophilum strains could circulate in the western USA ecosystems.134 
 
In Asia, no information is available on the reservoir host‘s competence of wild animals for                      
A. phagocytophilum.199 Only a few studies have been carried on wild ruminants and A. phagocytophilum 
has been detected in sika deer and Korean water deer (Hydropotes inermis) with prevalence rates up to 
46% and 63.6%, respectively.227-230 Small mammals such as wood mouse (Apodemus sylvaticus), 
Korean field mouse (Apodemus peninsulae) and black striped field mouse (Apodemus agrarius) also 
showed relatively high prevalence rates up to 10%, 25% and 20.8%, respectively in China.199,231,232 In 
Korea, prevalence rates in black striped field mouse were up to 23.6%, hence this rodent species was 
suggested to be among the most important reservoir hosts in Asia.233   
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Anaplasma phagocytophilum has been detected in several other wild vertebrates including boars, 
foxes, bears, European bisons, donkeys, mooses, hares, Eurasian lynx, Coyotes, mountain lions, birds 
and reptiles. However, their role in the epidemiological cycle of the bacterium has not been 
assessed.54,234,235 In the western USA, lizards and snakes were both seropositive and PCR-positive to     
A. phagocytophilum, but I. pacificus larvae fed on lizards did not acquire or transmit the bacterium, 
suggesting that reptiles can be naturally infected but unlikely to be competent reservoir hosts.236 
Raccoons (Procyon lotor), have been reported to be competent reservoir hosts for                                  
A. phagocytophilum.224,237 In northwestern California, gray foxes (Urocyon cinereoargenteus) hosted all 
three life stages of Ixodes spp. ticks, displayed a high seroprevalence of 51% and PCR-positivity of 9% 
and urban foxes had the same seroreactivity rate than dogs. Therefore, gray foxes were considered as 
good sentinels for the bacterium transmission in this part of the USA.238 Similarly, 25% of wild foxes 
(Vulpes vulpes) were PCR-positive for A. phagocytophilum in Austria.239 Wild boars (Sus scrofa) are 
strongly suspected to be reservoir hosts for A. phagocytophilum human strains in Europe as some 
studies demonstrated that A. phagocytophilum isolates from these animals and humans harbored the 
same groEL, ankA and msp4 gene sequences.54,150,216 Furthermore, all three-life stages of I. ricinus can 
feed on wild boars.216 However, other studies suggested that wild boars are capable to control               
A. phagocytophilum infection through activation of innate immune responses, phagocytosis and 
autophagy explaining the low prevalence in some European regions and making them less likely to be a 
competent reservoir hosts.150,240,241 In some geographic areas, several bird species are thought either to 
be competent reservoir hosts or to contribute to the circulation and spread of infected ticks.45,242-247  
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3.5 Life cycle of Anaplasma phagocytophilum transmission by Ixodes tick species  
 
All Ixodes-transmitted pathogens of humans need a vertebrate reservoir host for their perpetuation 
in nature.54 More specifically, A. phagocytophilum is considered to be naturally maintained in complex 
and not fully assessed enzootic tick-wild animals cycles (Figure 9).56 In the case of bacterial tick-borne 
infections that often lead to immune system stimulation in the reservoir host or to its death limiting the 
bacteriaemic phase, ticks represent a critical feature for the maintenance of the enzootic cycle in nature. 
The perpetuation of cycles can be ensured either by the transmission of the pathogens between different 
tick developmental stages (transstadial transmission), or between generation (transovarian transmission) 
or between ticks during cofeeding.80,248,249   
 
The life cycle of Ixodes ticks lasts for almost two years80 and its duration depends on climatic 
conditions varying from less than a year in tropical regions to three years or more in temperate 
regions.250 This life cycle comprises four distinct developmental stages, i.e., egg, larva, nymph and 
adult. Ixodes ticks activity varies according to the life stage and they mostly quest on vegetation in 
prime suburban real estate.80 Some authors consider only three life stages including larvae, nymphs and 
adults.21,56 The feeding behavior at each life stage has a directly effect on the risk of tick-borne 
pathogens transmission.80 All Ixodes species of public health relevance need to feed on a new host at 
each life stage after hatching except for males that do not feed, and the blood meal is completed in three 
to five days.56,80 Ticks belonging to I. persulcatus complex are nonspecific feeding ticks that can have 
their blood meal either on various host reservoirs or on humans.80   
 
Anaplasma phagocytophilum is transmitted to the host during the bite of a nymphal or adult tick 
infected during previous stages (larval or nymphal) (Figure 9).35 Transmission of A. phagocytophilum to 
the host during tick feeding occurs usually within 24 to 48h.251,252 As nymphs have very small size 
(approximately 1mm), they are often able to feed much longer on humans and are at increased risk to 
transmit tick-borne pathogens such as A. phagocytophilum.80 In a recent study, 41% of retrieved ticks 
from humans in Italy were from nymphal stage.253 Moreover, ticks have the capacity to modulate host 
immune and inflammatory responses that may also decrease the chance of detection.254 Considering that 
A. phagocytophilum is transmitted transtadially in ticks, nymphs and adults contaminated in a previous 
stage last infected after molting and are able to contaminate susceptible hosts during the following blood 
meals.80 Adult female ticks require an addition blood meal and are thus twice likely to acquire the 
infection.21,54,80 As no transovarial transmission of A. phagocytophilum among Ixodes ticks occurs,118 
larvae are mostly considered free from infection until hatching and having their first blood meal.54,80 
Another consequence of the absence of transovarial transmission is the interruption of                           
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A. phagocytophilum cycle when adult female tick lay their eggs.255 However, transovarial transmission 
has been documented in moose ticks Dermacentor albipictus and seems to be due to an atypical feeding 
system as compared to normal Ixodes infection cycle.179  
 
 
 
Figure 9. Transmission cycles of Anaplasma phagocytophilum in Ixodes spp. tick populations and 
infection of people and dogs. The pathogen is acquired from reservoir hosts during feeding by larval or 
nymphal ticks and then transmitted in subsequent feedings of nymphal or adult ticks.255 
 
Ixodes tick species involved in the transmission of A. phagocytophilum in the USA, Europe and 
Asia are exophilic, telotropic and anthropophilic ticks. They have an open questing behavior, a wide 
host range and a ubiquitous distribution. Some of them such as I. scapularis are reported to have a high 
affinity for biting humans, hence are also able to transmit the bacterium from host reservoirs to 
people.1,54 Therefore, the trophic preferences of these ticks are difficult to determine although it has 
been suggested that larvae parasitize small mammals while nymphs and adult stages are more likely to 
feed on medium (such as rabbits) and large mammals (such as ruminants), respectively.56 Other more 
nidicolous and host-specific endophilic ticks are thought to play a role in niche cycles which may 
contribute to the persistence of the bacterium in nature.54 Some recent studies showed that rodents could 
be reservoir hosts for A. phagocytohilum in an independent epidemiological cycle, involving only 
rodents as mammalian hosts. In the USA, two potential alternative A. phagocytophilum epidemiological 
cycles have been described, one involving N. mexicana, P. maniculatus and I. spinipalpis ticks.176,177 
and another involving cotton tail rabbit (Sylvilagus spp.) with I. dentatus and I. scapularis.178 Similarly, 
red wood chipmunk hosts both antropophilic (I. pacificus) and nidicolous (I. angustus) ticks and is 
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suggested to maintain niche cycles.257 In the UK and Central Europe, at least three independent 
epidemiological cycles have been described involving rodents with I. trianguliceps,141,185,213,258,259 and 
hedgehogs with I. hexagonus.215 These mammilian hosts can harbor two to three different stages of both 
endophilic and exophilic ticks simultaneously and thus promote the transmission to human through the 
anthropophilic ticks.260 
 
3.6 Other transmission ways 
 
Although A. phagocytophilum is primarily a tick-borne pathogen, other ways of transmission have 
been described including percutaneous and blood sub inoculation, blood transfusion, vertical and 
nosocomial transmissions.164,261-263 Currently, eight human cases of transfusion-acquired granulocytic 
anaplasmosis have been reported, seven in the USA164,264-268 and one in Slovenia.269 Another probable 
transfusion-transmitted A. phagocytophilum infection has been described from the USA.270 The 
seroprevalence of A. phagocytophilum among human blood donors in the USA ranges from 0.5% to 
11.3% (Table 2).271,272 In Europe, a very high prevalence rate has been reported in Greece with almost 
21% of blood donors being seropositive for A. phagocytophilum (Table 2).273 Because the risk of 
developing complications seems to be increased in some transfused people such as 
immunocompromised patients and because A. phagocytophilum can persist up to 18 days in refrigerated 
(4°C) human blood products, this infection is among the TBDs considered to represent a potential risk 
for transmission by blood transfusion in the USA.274,265 Therefore, A. phagocytophilum should be 
suspected and researched in every transfused person who develops acute thrombocytopenia especially if 
associated with febrile illness and leucopenia. In addition, because sharing blood products between 
different areas is growing, such acute illness after blood transfusion might be included in the differential 
diagnosis even in nonendemic areas.164,265,266,269,275  
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Table 2. Seroprevalence of Anaplasma phagocytophilum in blood donors form the USA and several 
European countries.  
Country Number of blood donors Prevalence (%) Method References 
AMERICA 
USA 
Connecticut 
Wisconsin 
Westchester County (NY) 
 
992 
 
159 
 
3.5 
0.5 
11.3 
 
IFA 
 
IFA 
 
271 
 
272 
EUROPE 
Poland 
Eastern 
Lublin 
50 
32 
56 
2.0 
9.4 
5.4 
IFA 
 
276 
277 
278 
Bulgaria 70 2.9 IFA 279 
Norway 301 16.2 IFA 280 
Germany 103 1.9 IFA 281 
Austria 357 9.0 IFA 70 
Switzerland 530 1.1 IFA 282 
Belgium 402 15.9 IFA 283 
France 50 0.0 IFA 284 
Greece 496 21.4 IFA 273 
Portugal 96 4.2 IFA WB 285 
             IFA: immunofluorescence assay; WB: western blot. 
 
In canine species, no cases of transfusion-transmitted granulocytic anaplasmosis have been 
recorded. A recent study carried in the UK screened 262 healthy canine blood donors without travel 
history outside of the country for several vector-borne pathogens by PCR, and none was positive for 
Anaplasma spp. Even though the UK is not an endemic region for A. phagocytophilum and its vectors, 
this bacterium is considered among the organisms of potential significance in transfusion medicine in 
this country.286 Another study from the USA failed to detect positive individuals to A. phagocytophilum 
among 118 feline blood donors.287 However, it has been strongly recommended to screen canine blood 
donors for A. phagocytophilum infection in endemic areas because some PCR-positive dogs can be 
clinically healthy and also because of possible chronic carrier status.62,287,288 Finally the consensus 
statement on canine and feline blood donor screening for infectious disease of the American College of 
Veterinary Internal Medicine (ACVIM) recommends to test for diseases that meet at least three of the 
following criteria: (1) the infectious agent is known to induce clinical infections in recipients via blood 
transmission, (2) the infectious agent can cause subclinical infections making asymptomatic carriers 
possible accidental blood donors, (3) the infectious agent can be cultured from the blood of an infected 
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animal and (4) the  disease induced in the recipient is severe or difficult to clear. The consensus 
statement also recommends considering testing in the case of documented experimental transmission 
without described clinical transmission via transfusion or if the disease does not represent a threat to the 
recipient or is easily cleared.289 
 
Perinatal and transplacental transmissions have also been reported in people and cattle, 
respectively.262,290 In dogs, no report described such transmission and a study on naturally infected bitch 
did not shown any perinatal transmission.291 A study described the first nosocomial infection in people 
in China after direct contact with blood and respiratory secretions.263 However, a recent report 
contradicts the nosocomial transmission of A. phagocytophilum in those patients based on discrepancies 
in clinical and laboratory features when compared to HGA cases from the USA and suggests that those 
Chinese patients could have been infected with a newly discovered bunyavirus, called ‗severe fever with 
thrombocytopenia syndrome virus‘ (SFTSV).292 Human cases of granulocytic anaplasmosis have been 
also described after percutaneous exposure or inhalation of contaminated blood of deer in the USA.261 
According to these previous reports, respiratory secretions could also be a source of infection. In a case 
of canine granulocytic anaplasmosis with respiratory signs, inclusions of A. phagocytophilum have been 
identified in neutrophils from tracheal wash smear.291 Consequently, precautions might be taken when 
necropsies are performed on animals suspected of granulocytic anaplasmosis.81 
 
3.7 Anaplasma phagocytophilum infection in humans 
 
Several wild and domestic animals are receptive to A. phagocytophilum. However, the disease has 
been reported only in a few species including domestic ruminants, horses, cats, dogs and 
humans.62,95,172,293-297 The first human granulocytic anaplasmosis (HGA) case has been reported in the 
USA in the mid-1990s.143 In the USA, HGA is a nationally notifiable disease since 2000298 and the 
number of cases has critically and rapidly increased between 2000 and 2012 from 348 to 2389 cases.18,49 
Data from the USA CDC and MMWR reported 10,670 human cases between 2010 and 2013, and a 8-
fold increased number of reported cases between 2000 and 2013.50 The disease incidence has increased 
from 1.4 to 6.3 cases per million persons per year between 2000 and 2010293,298,299 and a 12-fold 
increased incidence was recorded between 2001 and 2011.300 Figure 10 shows the evolution of annual 
cases of human granulocytic anaplasmosis in the USA from 1994 to 2010.  
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Figure 10. Number of annual human granulocytic anaplasmosis cases in the USA from 1994 to 
2010 (http://www.cdc.gov/anaplasmosis/stats/). 
 
HGA is currently considered the third most important VBD in both the USA and Europe and is 
also increasingly diagnosed in Asia.76,204,301 Endemic regions include the Upper Midwest, New England, 
parts of the midAtlantic states and northern California in the USA and also several parts of Europe 
(central, northern and western countries) and some Asian countries.73,78,92,302 Serological surveys carried 
in endemic areas of the USA found prevalence rates ranging from 15 to 36%.271,303 Serological evidence 
of human exposure to A. phagocytophilum has been reported in almost all European countries with 
prevalence rates ranging from less than 1% to 32% and the disease has already been reported in several 
of them.21,71,73,304,305 Similarly, exposure to A. phagocytophilum in China has continuously increased in 
high-risk populations according to the Tianjin CDC from 8.8% to 59.2% between 2006 and 2009.77,306 
Despite a moderate to high seroprevalence in several countries, HGA is still unrecognized and rarely 
diagnosed due to several factors including limited epidemiological, ecological, clinical and 
microbiological information, difficulties in the diagnosis, possible asymptomatic or subclinical 
infections and the lack of awareness by physicians and the public.21,78 Seroprevalence studies conducted 
worldwide are summarized in Table 3. 
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Table 3. Seroprevalence of Anaplasma phagocytophilum in healthy, high-risk or sick populations 
worldwide.  
Country Number  Study population Prevalence 
(%) 
Method References 
AMERICA 
USA 
 
 
Wisconsin 
New Jersey 
Great Smoky Mountains and 
ROMO National Parks 
 
9,987  
 
475 
202 
141 
 
 
Healthy military personnel  
 
Healthy permanent residents 
People evaluated for Lyme 
disease  
Healthy permanent employees  
 
2.6 
0.11 
14.9 
16.3 
8.1 
 
ELISA 
WB 
IFA 
ELISA 
ELISA 
 
299 
 
303 
307 
308 
Peru 
Lima 
Northern coast, southern 
Peruvian Andes and Peruvian 
jungle region 
 
160 
 
Healthy urban residents 
Healthy rural residents 
 
0.0 
 
IFA 
 
309 
EUROPE 
Poland 
 
 
Eastern and southern 
Eastern 
 
Northern and northeastern 
Eastern  
 
Southeastern 
Northeastern 
 
 
180 
 
216 
400 
 
478 
39 
119 
113 
130 
 
Patients suspected for 
rickettsiosis 
 
Employees of National Forest 
Healthy client-owned dogs 
 
Raworkers from forest areas 
Farmers 
Forestry workers 
Forestry workers  
People living in Białowieża 
Primeval Forest 
 
4.9 
 
29.6 
8.0 
2.8 
9.6 
5.1 
11.8 
17.7 
6.2 
 
IFA 
 
IFA 
ELISA 
PCR 
IFA 
IFA 
 
IFA 
IFA 
 
310 
 
302 
311 
 
312 
277 
 
278 
276 
Bulgaria 200 Patients with a history of tick 
bites 
7.4 IFA 279 
Slovenia 
Koster Islands 
53 
185 
90 
Children with fever and tick 
bite 
Permanent residents 
People bitten by ticks 
1.9 
11.4 
17.0 
IFA 
IFA 
IFA 
313 
314 
315 
Czech Republic 809 Patients suspected of tick-borne 
encephalitis 
9.9 IFA 208 
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Norway 47 Patients with clinical signs and 
history of tick bite 
29.8 IFA 316 
UK 
 
518 Farmworkers and family 
members 
1.5 IFA 254 
The Netherlands 108 
 
174 
 
154 
54 
626 
Febrile patients with 
unresolved etiology  
Patients suspected of Lyme 
disease  
Forestry workers 
Healthy controls  
Patient with a tick bite or 
erythema migrans 
4.0 
 
4.0 
 
1.0 
0.0 
0.8 
IFA 
 
 
 
 
 
PCR 
304 
 
 
 
 
 
317 
Belgium 
 
 
1,350 
 
148 
Patient with clinical signs 
compatible with a TBD 
Workers professionally 
exposed 
31.0 
 
8.1 
PCR 
IFA 
IFA 
73 
 
283 
Germany 
 
Bavaria region  
150 
105 
107 
Forestry workers  
Patients with Lyme disease 
Patients with history of tick 
bite  
14.0 
11.4 
7.5 
IFA 
 
IFA 
281 
 
318 
Switzerland 
 
Northern 
Eastern 
181 
 
70 
258 
149 
 
205 
patients with suspected tick-
borne encephalitis and healthy 
controls 
 
People bitten by Ixodes ticks 
Hunters  
Persons previously diagnosed 
with Lyme disease  
Patients previously diagnosed 
with tick-borne encephalitis 
virus 
17.7 
 
17.1 
9.0 
12.7 
 
19.5 
IFA 
 
IFA 
IFA 
319 
 
284 
320 
Cyprus 227 Farmers, or workers in farms, 
people in contact with animals 
of veterinary importance and/or 
ticks 
32.0 IFA 71 
Italy 181 Forestry rangers  8.8 
0.6 
IFA 
WB 
305 
Portugal 147 Patients with Lyme disease, 
forestry workers, and persons 
with history of tick bite 
1.4 IFA 321 
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 367 
792 
Potentially exposed patients 
Clinically ill patients   
5.8 
3.9 
IFA 
IFA 
285 
322 
Turkey 637  7.8 IFA 323 
ASIA 
China 
Eight provinces 
Nine provinces 
Two provinces 
Beijing  
Yiyuan County 
Near Tianjin 
Central and Southeastern 
 
3,669 
7,322 
819 
562  
46 
365 
323 
 
 
Healthy people living in forest 
areas 
Healthy agrarian individuals 
Healthy urban residents 
Healthy farmers from rural 
areas 
Healthy farmers 
Healthy Farmers 
People at high risk exposure to 
ticks and animals 
 
7.11 
15.4 
1.5 
14.1 
26.7 
8.8 
20.0 
 
IFA 
IFA 
 
IFA 
IFA 
IFA 
IFA 
 
324 
78 
 
201 
204 
77 
325 
IFA: immunofluorescence assay; ELISA: enzyme-linked immunosorbent assay; PCR: polymerase chain reaction; WB: 
western blot. 
 
High-risk populations (i.e., people living in forest areas and forestry workers, people living in 
rural areas and farmers, hunters, national parks rangers, military personnel, people in close contact with 
domestic animals, and people at high risk of exposure or previously exposed to ticks) have significantly 
higher prevalence rates of A. phagocytophilum exposure.78,278,299 The disease is typically seasonal with 
most cases recorded during spring and summer. Major risk factors for acquing A. phagocytophilum 
infection include outdoor activities especially related to wooded areas, meadow habitats and grasslands, 
immunodepression and blood transfusion.35,253 HGA is an unspecific flu-like illness mostly 
characterized by fever, headache, chills, myalgia and malaise.79,92,255 Symptoms usually appear five days 
to three weeks after a tick bite.265 Less frequently, human patients can display arthralgia, rash, liver 
injury, digestive (nausea, vomiting, diarrhea), respiratory (cough, pulmonary infiltrates, acute 
respiratory distress syndrome) or nervous signs (stiff neck, confusion).79,92 Clinical signs are frequently 
accompanied by nonspecific hematological and serum biochemistry profile modifications including 
thrombocytopenia, leukopenia, lymphopenia, anemia and increased liver enzymes activity.79,92,255 
Leukopenia and lymphopenia can lead to severe opportunistic infections such as herpes simplex 
esophagitis, Candida albicans pneumonitis/esophagitis and invasive pulmonary aspergillosis.326-329 The 
severity of the disease and mortality are strongly correlated with advanced age of patients, 
immunosuppression, the presence of co-morbidities and delayed onset of treatment.316,330 The 
differential diagnosis should include other acute viral and bacterial infections, some inflammatory 
disorders, other vector-borne diseases and malignancies (Table 4).300  
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Table 4. Differential diagnosis of human granulocytic anaplasmosis.255,300 
Viral infections Enterovirus infection, Epstein-Barr virus, Hantann virus, human herpes virus-6, 
human parvovirus B19 infections, viral hepatitis A, B, C 
 
Bacterial infections 
Acute bacterial endocarditis, group A streptococcal infection, leptospirosis, 
meningococcemia, Mycoplasma pneuminiae, Neisseria gonorrhea sepsis, Neisseria 
menongitidis sepsis, post-group A streptococcal infection, Q fever, rat-bite fever, 
secondary syphilis, septic shock syndromes, typhoid fevers 
 
 
 
Other VBDs 
African tick-bite fever, babesiosis, bartonellosis, chikungunya virus disease, Colorado 
tick fever, Ehrlichia muris-like agent infection, human granulocytic ehrlichiosis (E. 
ewingii), human monocytic ehrlichiosis (E. chaffeensis), heartland virus fever, Lyme 
disease, malaria, murine typhus, Rocky Mountain spotted fever, severe fever with 
thrombocytopenia virus infection, scrub typhus, tularemia, dengue virus fever, 
malaria, Powassan virus disease/tick-borne encephalitis, West Nile fever 
 
Inflammatory disorders 
Allergic-drug reactions, idiopathic thrombocytopenia purpura, immune complex-
mediated illnesses, Kawazaki syndrome, thrombotic thrombocytopenic purpura, toxic 
hemophagocytosis, macrophage activation syndromes 
Malignancies Lymphoma, acute leukemia 
 
In most cases of HGA, clinical signs are mild and self-limited, with favorable evolution even 
without treatment. People usually recover completely after antibiotic therapy however some patients 
could display persistent clinical signs from one to three years after treatment.79,92,331 Life-threatening 
complications have been reported to occur in 3% of patients (Table 5).293 Two reports from China, 
described complications by systemic inflammatory response syndrome (SIRS) and multiple organs 
deficiency syndrome (MODS) in 45.8% and up to 41.2% of cases.78,301 Consequently, half of the HGA 
cases are hospitalized and up to 17% require intensive care unit admission especially when diagnosis 
and treatment were delayed.79,293,327,332-334 Due to the potential serious outcome associated with the 
disease, the Infectious diseases Society of America recommends to give antimicrobial therapy to every 
person suspected to have HGA on the basis of the clinical presentation although mild or self-limiting 
pending the laboratory results and to not delay treatment.255,292 Even though relatively high 
hospitalization rates are recorded in some studies, the fatality rate is usually lower than 1%.300 However, 
mortality rates up to 8.1 and 10% were recorded in China and the USA, respectively.21,78 Two reports 
from China, described 3.2% and 26.5% of fatality.263,301  
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Table 5. Complications and associated risk factors in human granulocytic anaplasmosis.78,92,300,301 
Clinical complications 
Hemodynamic 
Toxic or septic shock-like syndrome, coagulopathy, hemorrhage, myocarditis, pancarditis, renal failure, systemic 
inflammatory response syndrome (SIRS), multiple organ deficiency syndrome (MODS) 
Respiratory 
Pneumonia, acute respiratory distress syndrome (ARDS) 
Nervous system 
Meningoencephalitis, cranial nerve palsies, demyelinating polyneuropathy, brachial plexopathy, seizure 
Others 
Rhabdomyolysis, opportunistic infections, acute abdominal syndrome 
Risk factors 
Preexisting disease 
Immunosuppressive conditions 
 
3.8 Epidemiological role of dogs 
 
Although dogs are susceptible to A. phagocytophilum, they are mostly recognized as incidental 
hosts and their role as potential reservoirs is still controversial.136,335 Dogs are considered unlikely 
reservoir hosts due to the potential short duration of bacteremia (< 28 days) and uncertainty regarding 
their ability to host enough nymphal tick stages to contribute to the spread of the bacterium.10,54 In 
Austria, no significant difference in the seroprevalence of A. phagocytophilum among owners of 
seropositive pets and owners without pets was observed, suggesting that pets are not a source of 
infection for humans.336 However, according to some authors, almost all studies investigating the role of 
dogs in the transmission of TBDs focused on companion dogs. These animals are usually treated against 
ectoparasites, have limited free access to the outdoors and reservoir host‘s habitats, and are less exposed 
to ticks when compared to hunting, stray or shelter dogs. Therefore, these studies may not accurately 
reflect the public health risk associated with dogs in endemic areas.337 Others suggested that domestic 
animals including dogs could be considered as potential reservoir hosts of A. phagocytophilum in 
Europe especially in urban areas.337-340 In a study from Hungary, the prevalence of A. phagocytophilum 
DNA in stray dogs was higher than in several studies from other European countries.337 In addition, two 
studies reported high prevalence rates of A. phagocytophilum DNA in dogs suspected to have Lyme 
disease and rural dogs from Poland and China, respectively.201,341 Anaplasma phagocytophilum was also 
the most frequently detected bacterium by PCR in stray dogs that lived in close contact with domestic 
animals and humans in rural and peri-urban areas of the Mediterranean zone of Jordan.342 In addition, 
high prevalence rates of A. phagocytophilum DNA was found in I. ricinus collected from dogs in 
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Belgium and Poland, and Rhipicephalus sanguineus (adult and nymphs) from free-roaming dogs in 
Egypt.84,343,344 Moreover, A. phagocytophilum DNA was detected in experimentally infected dogs during 
60 days without immunosuppressive drug, and the canine immune response seems to have evolved to 
only partially control infection, suggesting a longer bacteremia that possibly allow timely transmission 
to the vector.117,161 Based on these results, dogs could act as potential reservoir hosts for the bacterium in 
some regions, but further studies are needed to confirm this hypothesis.  
 
The geographical distribution of canine infection seems to parallel the distribution of HGA in the 
USA with a positive association of human and canine cases in many states.46,345 Indeed, several studies 
found the highest prevalence rates of A. phagocytophilum antibodies in dogs from the upper Midwest, 
Northeast and Mid-Atlantic, which correlate with areas where the highest incidence rates of human 
anaplasmosis were reported.46,50,293,345-347 In addition, the estimated regression coefficient for the 
endemic risk factor in the contiguous USA model was positive and significant. This implies higher 
prevalence among dogs living in areas where HGA is endemic.347 Furthermore, human and canine 
strains of A. phagocytophilum were similar according to several gene sequencing, and human isolates 
have been reported to induce clinical disease in dogs in both Europe and the USA.120,150,159-163 Therefore, 
in addition to the possible role of dogs as potential reservoir hosts, the prevalence data of                      
A. phagocytophilum infection in dogs provides important information on the incidence, risk factors, 
sources of exposure, and real-time risk of exposure for human infection.46 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter I General introduction 
 40 
4. Anaplasma platys 
 
4.1 Transmission  
 
The natural mode of transmission of A. platys has not been demonstrated conclusively, but it 
likely involves a tick vector. This bacterium is most likely transmitted through R. sanguineus tick bites 
although the tick vector competency has not been proven.89,90 Indeed, although one experimental study 
failed to demonstrate the ability of R. sanguineus to transmit  A. platys,348 its DNA has been frequently 
detected in this tick species. In addition, the 16S rRNA gene fragments amplified from ticks were 
identical to A. platys sequences obtained from dogs infested by these ticks and canine infection with this 
bacterium is common in areas with high R. sanguineus pressure.349-361 Moreover, A. platys has been 
repeatedly reported from areas where other R. sanguineus-transmitted pathogens such as           
Ehrlichia canis, Babesia canis or Rickettsia conorii are commonly present362-364 and coinfection 
between A. platys and these agents have been reported.365-371 A recent study detected A. platys DNA in 
adult and nymph R. sanguineus ticks collected from negative dogs and did not found any difference 
between A. platys detection in ticks collected from positive and negatives dogs. These findings suggest 
that these tick stages may acquire the bacterium in the previous life stage and may maintain a constant 
load after moulting. Therefore, as R. sanguineus ticks display a three-host life cycle (i.e., each life stage 
requires a new host to feed on), a transstadial transmission of A. platys may occur, possibly playing an 
important role in the pathogen spreading throughout canine populations.358 
 
Anaplasma platys DNA has been detected in several other Rhipicephalus spp. ticks such as         
R. camicasi, R. turanicus, R. evertsi and R. bursa.360,372-375 In addition, the DNA of this bacterium has 
been detected in several other tick species including Haemaphysalis longicornis, H. leachi,                    
I. persulcatus, Hyalomma spp., Ampblyomma spp.233,360 and in the dog chewing louse           
Heterodoxus spiniger.376 However, further studies are needed in order to confirm their role as competent 
vectors of  A. platys.360 Dermacentor auratus could be a competent vector of A. platys in some Asian 
countries.90,352 
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Similarly to other Anaplasma species, A. platys can be transmitted through direct blood 
subinoculation.117,364,377-379 Therefore, because transmission of these pathogens via infected blood can 
occur and asymptomatic infections are frequent, screening canine blood products for bacterial DNA 
with a PCR assay is recommended in highly endemic areas to ensure the safety of blood products.99,380 
A recent study detected A. platys DNA in uterine, ovarian and fetal tissue samples from both pregnant 
and non-pregnant naturally infected bitches, suggesting possible vertical transmission of this infection in 
canine species.381 
 
4.2 Reservoir hosts and epidemiological role of dogs 
 
Dogs are considered the main reservoir host of A. platys and are also a strongly preferred host for 
R. sanguineus.112,378,382 Anaplasma platys has been detected in all stages of Haemaphysalis longicornis 
and I. persulcatus ticks collected from small wild-caught mammals and striped field mouse    
(Apodemus agrarius) was found infected by this bacterium with a prevalence of 16% in Korea.233 
Similarly, 14.5% of wild foxes were infected by A. platys in Portugal.383 These two studies suggest that 
some wild animals may play a role in the epidemiology of this infection and could act as candidate 
reservoir hosts.  
 
4.3 Zoonotic potential of Anaplasma platys  
 
For decades, A. platys was thought to infect dogs exclusively.40 However, recent reports described 
this infection in domestic ruminants,384,385 cats386,387 and even in humans.39-41 Camelids              
(Camelus dromedarius) infection by Anaplasma species closely related to A. platys in both Tunisia and 
Saudi Arabia were also recently reported.388,389 Another study detected A. platys DNA in Camelids in 
Nigeria.390 Previous reports have described intraplatelets inclusions resembling those of A. platys in a 
stained blood film from a cat in Brazil391 and organisms within platelets of an impala in South Africa 
identified by  transmission electron microscopy on blood.392 In addition, organisms with 99.5% and 
100% gene sequences homology with A. platys were identified from blood samples from sheep in South 
Africa393 and goats in Cyprus,394 respectively.  
 
Infection with A. platys was suspected in people from Venezuela based on the appearance of 
inclusions in platelets in stained blood films. Indeed, between 1993 and 2012, 5,954 people had intra-
platelet inclusions in buffy coat smear and most of these patients displayed moderate to severe clinical 
signs, some were hospitalized, and some patients responded well to tetracyclines, especially to 
doxycycline. When platelet-rich plasma from buffy coat smear-positive cases was prepared for 
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ultrastructural examination by transmission electron microscopy, and organisms compared with 
ultrastructural studies described in the United States111 and in Venezuela, it was concluded that 
organisms infecting dogs and people appeared different. In canine organisms, a well-defined double 
membrane, characteristic of the Anaplasmataceae family, was evident and the intra-vacuolar space was 
clear, whereas in organisms from human cases, organism membranes were thickened and the intra-
vacuolar space appeared electron-dense. To date, the etiology of these intra-platelet organisms has not 
been identified.40,395 Similarly, intra-platelets morulae were identified on blood smears from HIV-
seropositive patients in Venezuela and showed morphological characteristics similar to those observed 
in infected dogs confirmed by PCR. However, the Ehrlichia or Anaplasma species involved was not 
identified.396 
 
4.4 Genetic diversity 
 
Comparison between experimental and natural A. platys infections in dogs revealed 
morphological and ultrastructural variations that have been associated with different developmental 
stages of A. platys but may also suggest differences between strains.106,108 Molecular analysis and 
variations in clinical severity also supports the possibility of multiple A. platys strains associated with 
geographic variation.108,397-399 Indeed, Infectious canine cyclic thrombocytopenia caused by A. platys 
infection is usually mild and self-limited especially in the USA and Australia.400,401 In the USA, 
although some clinical signs have been described, most reports of experimental and natural infections 
have indicated that A. platys causes no or few clinical signs in dogs.99,108,400,402,403 In contrast, 
experimental infection using an A. platys Greek strain seems to be more virulent than the inoculation 
with American strains.404 Similarly, A. platys natural infections were more frequently associated with 
severe and life threatening clinical signs, absence of response to treatment and mortality in 
Mediterranean and South American countries including France, Greece, Spain, Italy, Croatia, Portugal, 
Israel, Chile, Turkey and Tunisia.86,371,382,397,401,404-408 Although variations in pathogenicity could be 
caused by A. platys strains diversity, other factors can explain the variability in clinical signs including 
concurrent diseases and more specifically co-infections with other VBPs or intrinsic factor such as 
genetic factors, immune status of the animal and stress conditions.365,366,368,379,397,401 Some authors 
suggested that the genetic diversity of A. platys might be lower than the reported diversity of                
A. phagocytophilum possibly due to restricted movement of infected hosts and/or the limited host range 
of A. platys.398 Therefore, although a variety of polymorphisms has been reported among A. platys 
strains of different geographic origin, there is little genetic diversity among this species100,409 and this 
variability may also be associated with the range of hosts within a specific country.399 
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5. Distribution and prevalence of Anaplasma phagocytophilum and Anaplasma platys in dogs 
 
Both A. phagocytophilum and A. platys have worldwide distributions. Endemic areas of               
A. phagocytophilum include some regions of the USA (northeastern and mid-Atlantic, Upper Midwest, 
and Pacific Northwest states), Europe and Asia (China, Siberian Russia, and Korea). These regions 
correspond to occurrence areas of I. persulcatus group ticks.9,92,136,410,411 Anaplasma platys has been 
reported in all continents but is mainly present in tropical and subtropical regions such as southern USA, 
South America, the Mediterranean area including southern Europe and North Africa.86,106,112,354,369,382, 
404,406,412-418 It is also prevalent in other African and Asian countries233,350,355,366,367,405,409,419-422 and has 
been reported in Australia.370,423 Several prevalence studies on both bacteria have been conducted in 
dogs in various American, European, Asian and African countries and are summarized in Tables 7 to 
10. However, data are lacking in large parts of Asia, Africa, South America and Australia especially for 
A. phagocytophilum. The geographic variation in tick exposure, the differences in inclusion criteria to 
select canine populations, and the use of different serologic test (i.e., immunofluorescent antibody test, 
enzyme-linked immunosorbent assay or Western blot) make comparison between studies 
difficult.81,288,357 
 
The first canine granulocytic anaplasmosis (CGA) cases in the USA were detected in California; 
therefore, the exposure of dogs to this organism has been recorded in more than 39 USA states and 
highest rates were noted in the upper Midwestern, northeastern and western states. Serological surveys 
revealed prevalence rates ranging from 0% to 40%.46,49,307,345-347,411,424-432 Infectious canine cyclic 
thrombocytopenia (ICCT) caused by A. platys has been first documented in the USA in 1978.99 Five 
countrywide serologic studies showed an overall prevalence of Anaplasma spp. of 1.9% to 4.8% with 
the highest rates recorded in northeastern regions.46,432,345-347 One of these studies used species-specific 
peptides to detect canine antibodies to A. phagocytophilum and A. platys with prevalence rates of 3.5% 
and 1.5% in the USA, 1.1% and 1.8% in Canada and 3.4% and 10.3% in the Caribbean, respectively.46  
In addition, cases confirmed of CGA9,136,410,411,433-436 and of ICCT99,400,402 were confirmed in several 
USA states. In Canada, three serologic surveys on Anaplasma spp. are available (Table 7),43,46,437 and 
four cases of CGA from Vancouver Island438 and Saskatoon439 were confirmed by DNA detection. In 
addition, a case report described a coinfection with B. canis, E. canis and A. platys in a dog imported 
from the Bahamas to Canada.440 In Latin America and the Caribbean, the seroprevalence of    
Anaplasma spp. ranges from 1.0% to 53.2%.441,442 In these regions, A. platys seems to be the most 
prevalent Anaplasma species with DNA detection rates among canine populations up to 48.8% in 
Brazil.443 However, some studies and a case report have also detected the DNA of A. phagocytophilum 
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(Table 7).180,340,444 Recently, a report from Colombia detected A. platys and Anaplasma spp. closely 
related to A. phagocytophilum in canine blood samples.445 
 
Table 7. Prevalence of antibodies to Anaplasma spp., DNA detection of Anaplasma phagocytophilum 
and Anaplasma platys in blood samples from dogs in American countries. 
 
American  
countries 
 
Number       
of dogs 
Serology  
Anaplasma spp  
 
PCR                                 
A. phagocytophilum (%) 
 
PCR                    
A. platys (%) 
 
References 
% Method 
Canada 
7 provinces 
South Ontario, Quebec 
86,251 
285 
53 
0.19  
1.1  
0.0  
ELISA 
ELISA 
ELISA 
  43 
46 
437 
USA 
 
 
 
 
Oregon, California 
North Carolina, Virginia 
Maine 
California 
 
Minnesota 
 
Oklahoma 
Northern Arizona 
New Jersey 
North Carolina 
 
Connecticut, New York 
3,950,852 
3,588,477 
479,640 
14,496 
6,268 
2,431 
1,845 
1,087 
1,082 
182 
731 
273 
259 
233 
202 
118 
27 
106 
3.8  
4.4  
4.8  
1.9  
1.5 - 3.5  
2.4  
1.1  
7.1  
8.7  
40.0  
55.4 
 
33.0  
11.6  
9.4  
0.0  
 
9.4  
ELISA 
ELISA 
ELISA 
ELISA 
ELISA 
ELISA 
IFA 
ELISA 
IFA 
IFA 
IFA 
 
IFA 
ELISA 
ELISA 
ELISA 
 
IFA, WB 
 
 
 
 
 
 
 
 
 
7.2 
 
9.5 
 
0.0 
 
 
11.1 
 
 
 
 
 
 
 
 
 
 
 
0.0 
 
6.9 
 
 
33.3 
347 
345 
346 
432 
46 
429 
426 
430 
6 
9 
411 
411 
424 
428 
307 
431 
365 
425 
Brazil  
 
 
 
 
Rio de Janeiro 
 
Southeastern 
Southern 
Central-northern Parana 
320 
60 
256 
230 
221 
398 
253 
198 
196 
138 
 
  
 
 
 
 
 
 
9.7 
13.8 
 
 
 
 
 
 
 
 
ELISA 
ELISA 
 
 
 
 
 
6.0 
7.1 
0.0 
 
7.2 
1.6 
16.4 
15.6 
14.9 
 
 
 
14.1 
 
446 
447 
448 
449 
450 
180 
340 
451 
452 
453 
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Northeastern 205 48.8 443 
Puerto Rico 629 1.0  ELISA   441 
Colombia 
Northern 
498 
218 
33.0  
53.2 
ELISA 
ELISA 
 
 
16.1 
454 
442 
Uruguay 191    4.2 455 
Nicaragua 39    13.0 456 
Argentina 
Bueno Aires 
86 
52 
   
20.9 
13.5 
457 
357 
Mexico 1,706 
100 
9.9 ELISA   
31.0 
458 
459 
Panama 201    21.4 460 
Venezuela 43   0.0 16.3 461 
Chile 30    20.0 382 
French Guiana 65    15.4 417 
Haiti 210 
207 
17.6  ELISA  
0.0 
 
6.3 
462 
 
West Indies 157 
110 
10.8  ICG  2.5 
4.0 
463 
464 
Costa Rica 300 
146 
   6.3 
10 
465 
466 
Cuba 100    16.0 361 
Caribbean region 29 10.0  ELISA   46 
IFA: immunofluorescence assay; ELISA: enzyme-linked immunosorbent assay; PCR: polymerase chain reaction, WB: 
western blot; ICG: immunochromatography. 
 
In Europe, seroprevalence to Anaplasma spp. has been reported in almost all countries with rates 
ranging from 1.1% to 56.5%.322,338,467-470 The detection of A. phagocytophilum DNA has also been 
reported mostly from central and northern countries (Table 8) with prevalence rates up to 14.2%.341 
Additionally, several cases of CGA have been described.60-66,471-474 In contrast, information is limited 
regarding the prevalence of A. platys infection in dogs from Europe, based on molecular analysis288 but 
this infection seems to be emerging in this continent.475 Most studies available are from southern 
countries with prevalence rates of A. platys DNA detection ranging from 0.4% to 57.7%.476,477 In 
addition, several cases of ICCT have been reported from Croatia, Romania, Italy, Spain, Portugal and 
France397,401,407,408,478 and a case of coinfection with A. platys and B. canis imported from Spain to 
Belgium.479  
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Table 8. Prevalence of antibodies to Anaplasma spp., DNA detection of Anaplasma phagocytophilum 
and Anaplasma platys in blood samples from dogs in European countries. 
 
European  
Countries  
 
Number       
of dogs 
Serology  
Anaplasma spp  
 
PCR                                 
A. phagocytophilum 
(%) 
 
PCR                    
A. platys (%) 
 
References 
% Method 
Germany 
 
 
 
 
 
Northeast 
 
Southern 
 
Brandenburg 
5,881 
1,124 
 
522 
 
111 
1,862 
448 
171 
57 
1,023 
21.5  
50.1  
 
43.0  
 
43.2  
17.8  
19.4  
50.3  
24.6  
 
ELISA 
IFA 
 
IFA 
 
IFA 
IFA 
ELISA 
IFA 
IFA 
 
 
 
5.7 
 
6.3 
 
 
 
 
1.5 
 480 
467 
 
481 
 
61 
482 
483 
470 
  
484 
Russia 
European part 
Voronezh Reserve 
 
440 
82 
 
1.1  
34.1  
 
ELISA 
ELISA 
 
 
 
  
469 
469 
Hungary 
 
1,305 
199 
7.9 
 10.6 
ELISA 
IFA 
 
1.9 
 485 
486 
Slovakia 87 
180 
 
11.7  
 
ELISA 
8.0 
 
 487  
488 
Bulgaria 
Central-southern 
 
167 
 
19.2  
 
IFA 
 
 
  
489 
Austria 1,470 56.5  IFA   490 
United Kingdom 120   0.8  491 
Sweden 611 
100 
17.7  
17.0  
IFA 
IFA 
 
 
 492 
493 
Finland 390 5.3  ELISA 0.5  494 
Albania 
Tirana 
30 
602 
40.0  
24.1  
IFA 
IFA 
0.0 
1.0 
 
3.3 
495 
496 
Latvia 470 0.85 ELISA   497 
Romania 
 
 
 
Southeastern 
1,146 
121 
109 
357 
257 
5.5  
7.4 
 
 
6.2  
ELISA 
IFA 
 
 
ELISA 
 
 
2.7 
5.3 
 498 
486 
486 
499 
500 
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Serbia 84 15.5 IFA   501 
Poland 
Eastern 
Northwetern 
 
 
 
Central 
3,094 
400 
192 
100 
92 
50 
79 
12.3  
8.0  
 
 
14.0 
0.0 
ELISA 
ELISA 
 
2.8 
1.0 
14.0 
 
 
1.3 
 502 
311 
503 
341 
 
 
504 
Czech Republic 296 26.0  IFA 3.4  505 
Italy 
Stretto di Messina 
 
 
Central Italy 
 
 
Sicily 
 
 
 
 
Southern 
 
 
 
Northeastern 
 
249 
5,881 
200 
1,965 
1,232 
215 
344 
87 
344 
87 
2 
165 
170 
23-29 
34 
338 
150 
 
38.0  
32.8 
 
4.7  
8.8  
14.8  
 
45.0  
 
44.8 
 
37.6 
 
 
 
4.7  
3.3  
 
IFA 
IFA 
 
IFA 
IFA 
IFA 
 
IFA 
 
IFA 
 
IFA 
 
 
 
IFA 
IFA 
 
 
 
0.0 
 
 
0.9 
0.0 
 
0.0 
 
0.0 
 
 
 
 
0.0 
0.0 
 
 
 
3.5 
 
 
4.0 
 
4.0 
 
 
 
2.3 
30.4-57.7 
52.9 
 
506 
507 
508 
509 
510 
511 
398 
512 
 
338 
 
477 
 
514 
358 
515 
Portugal 
 
 
Southern 
1,185 
49 
55 
100 
1,010 
4.5 
 
55.0  
16.0 
ELISA 
 
IFA 
IFA 
 
0.0 
0.0 
 
 
14.3 
9.1 
 
0.4 
516 
508 
322,468 
517 
476 
France 919 2.7  ELISA   518 
Spain 
Nothwestern 
 
Grenada 
466 
1,100 
479 
73 
11.5  
3.1 
5.0  
 
IFA 
ELISA 
IFA 
 
  
 
 
19.2 
8 
519 
520 
521 
Turkey 
Thrace region 
757 
400 
   
4.0 
0.5 
6.0 
359 
375 
IFA: immunofluorescence assay; ELISA: enzyme-linked immunosorbent assay; PCR: polymerase chain reaction. 
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In Asia, Anaplasma spp. seroprevalence is available from China, Korea, Malaysia, Taiwan and 
Israel and range from 1.2% to 24.7% (Table 9).522,523 Anaplasma phagocytophilum and A. platys DNA 
have also been detected in dogs with prevalence rates up to 39.5%and 32%, respectively (Table 9).342,350 
Case reports of ICCT have also been also described in Japan.421,524 
 
Table 9. Prevalence of antibodies to Anaplasma spp., DNA detection of Anaplasma phagocytophilum 
and Anaplasma platys in blood samples from dogs in Asian countries. 
 
Asian  
Countries  
 
Number       
of dogs 
Serology  
Anaplasma spp  
 
PCR                                 
A. phagocytophilum 
(%) 
 
PCR                    
A. platys (%) 
 
References 
% Method 
Japan 154 
200 
  0.0  
32.0 
420 
350 
China 600 
243 
219   
162           
26                 
0.5 
 
10.0  
 
7.7  
ELISA 
 
IFA 
 
ELISA 
 
0.4 
10.9 
 
0.0 
 
0.0 
 
525 
201 
526 
527 
Korea 1,058 
418 
229 
182 
 
63 
 
1.2  
18.8  
4.4  
24.7 
 
ELISA 
ELISA 
ELISA 
IFA 
0.1 
 
 
0.0 
 
0.0 
 
 
 
0.0 
528 
523 
529 
522 
Malaysia 48 
30 
9.3  ELISA 4.3  
13.3 
530 
371 
Cambodia 101    0.0 531 
Thailand 181    4.4 532 
Philippines 70    0.0 533 
Taiwan 344 5.2 ELISA   534 
India 
 
191 
525 
4.7  ELISA   
 
6.5 
535 
 
536 
Israël 195 9.0  IFA   537 
Jordan 38   39.5  342 
IFA: immunofluorescence assay; ELISA: enzyme-linked immunosorbent assay; PCR: polymerase chain reaction. 
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In Africa, only a few prevalence studies have been published on Anaplasma spp. in dogs (Table 
10). Seroprevalence rates recorded in African countries range from 11.8% to 47.7% (Table 10).88,538 
Considering that A. platys seems to be the most prevalent species in African countries81 most molecular 
studies focused on this bacterium. Its prevalence among canine populations in Africa ranges from 1.2% 
to 20.4% (Table 10).539,540 In contrast, very limited studies have investigated A. phagocytophilum 
infection in dogs in this continent. The DNA of this bacterium has been detected in Tunisia, Nigeria, 
Cape Verde and South Africa (Table 10).86,541-543 In addition, an Anaplasma species closely related to   
A. phagcytophilum was detected in blood samples from South African dogs based on the 16S rRNA gene 
sequencing544 whereas all dogs from Algeria, Ghana and Maio Island tested by PCR were found 
negative (Table 10).88,538,545  
 
In Australia, very few studies are available including one combining Anaplasma spp. 
seroprevalence and A. platys DNA detection546 and three other A. platys-molecular based studies (Table 
10).370,546,547 Currently, no report on the occurrence of A. phagocytophilum is available from this 
continent.  
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Table 10. Prevalence of antibodies to Anaplasma spp., DNA detection of Anaplasma phagocytophilum 
and Anaplasma platys in blood samples from dogs in Africa and Australia. 
 
Africa and Australia 
 
Number       
of dogs 
Serology  
Anaplasma spp  
 
PCR                                 
A. phagocytophilum 
(%) 
 
PCR                    
A. platys (%) 
 
References 
% Method 
AFRICA 
Tunisia 286 
228 
25.2  IFA  
0.9 
 
4.4 
86 
Algeria 
 Algiers 
Tizi Ouzou, Bejaïa 
 
213 
110 
 
47.7  
 
IFA 
 
0.0 
 
14.1 
5.5 
 
88 
418 
Nigeria 245 
181 
  0.8  
6.6 
542 
549 
Senegal 34    2.9 550 
South Africa 141   2.1  543 
Ghana 17 11.8  ELISA 0.0 5.9 538 
Côte d’Ivoire 140 
137 
   8.5 
1.5 
360 
539 
Cape Verde 
Priai 
 
Maio Island 
 
57 
130 
153 
   
1.8 
 
0.0 
 
 
7.7 
3.3 
 
541 
551 
545 
Kenya 86    18.6 360 
Gabon 255    1.2 539 
Angola 103    20.4 540 
AUSTRALIA 
 
 
 
39 
215 
230 
238 
 
 
 
3.5 
 
 
 
ELISA 
 51.0 
10.0 
21.3 
3.8 
547 
370 
548 
546 
IFA: immunofluorescence assay; ELISA: enzyme-linked immunosorbent assay; PCR: polymerase chain reaction. 
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Cross-reactivity between Anaplasma spp. pathogens is reported to occur for both IFA and 
ELISA.112,291,346,365,426,429,522 Therefore, in regions were both pathogens could be present (southern USA 
states, southern Europe, South America, Asia, and Africa), seropositivity may not necessary reflect 
exposure to A. phagocytophilum or A. platys and potential overestimation of their true prevalence and 
distribution can occur.81,112,346,365,375,428,450,496 As a result, PCR-based assay is required to determine 
which of the two agents is responsible for positive serologic test results in regions where both bacteria 
are present.112 In areas where the Ixodes tick vector is less prevalent or absent, a positive          
Anaplasma spp. serologic result could be the result of A. platys exposure.498 Less frequent and minor 
serological cross-reactions were described at low titers between A. phagocytophilm and Ehrlichia 
species (i.e., E. canis, E. chaffeensis, E. ewingii and E. sennetsu), especially with hyper immune sera, 
when using IFA and immunoblot assay.101,111,410,425,426,553,554 However, it is not clear whether the cross-
reactivity with E. canis was attributable, in part, to antibodies against A. platys because dogs are 
sometimes exposed to both E. canis and A. platys.498,552 In contrast, no cross-reactivity has been 
documented between Anaplasma spp. and Ehrlichia spp. when using the point-of-care dot ELISA.81,552  
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6. Conclusion 
 
Vector-borne diseases are of growing concern worldwide because of their extending distribution 
and impact on human and animal health. These diseases are not prevalent in tropical regions only since 
some of them are widely distributed or mainly found in Europe and the USA. 
 
 Anaplama phagocytophilum and Anaplasma platys are two tick-borne bacteria currently known 
to infect both humans and dogs and displaying wide geographic distributions that overlap in some 
regions of the world. These two bacteria are responsible of canine granulocytic anaplasmosis and 
Infectious canine cyclic thrombocytopenia in dogs, respectively. Human granulocytic anaplasmosis, 
caused by A. phagocytophilum, is increasingly recognized worldwide with possible transmission via 
blood transfusion and frequent clinical complications requiring hospitalization. Although A. platys has 
been reported to infect people its ability in causing disease in humans has not been described.  
 
Several epidemiological data are published worldwide on both bacteria. However, information is 
lacking on their respective prevalence in several countries, the competent vector of A. platys, the ability 
of tick species other than Ixodes spp. to transmit A. phagocytophilum and the reservoir host range of 
both bacteria especially in some regions such as Africa, Latin America, Australia and large parts of 
Asia. It is obvious that the transmission cycle of A. phagocytophilum is complex and not fully 
elucidated, and variations of the tick species and the reservoir host range exist according to the 
geographic location. Geographic variability in pathogenicity and severity of clinical signs also occur for 
both A. phagocytophilum and A. platys and could be explained by genetic variability. Due to these 
geographic variations, epidemiological data within a specific region are necessary to assess the risk of 
infection for dogs and humans and to sensitize local physicians on the presence of these pathogens. 
Finally, dogs play a crucial role in both infections as competent reservoir hosts for A. platys, carriers of 
infected ticks to close contact to humans and effective sentinels to assess the risk of A. phagocytophilum 
human infection.     
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The Anaplasmataceae family includes some of the most important pathogens to both dogs and humans 
and some of them have been identified from ticks and dogs in North Africa. Moreover, both I. ricinus 
and R. sanguineus that transmit A. phagocytophilum and probably A. platys, respectively are present in 
Morocco. Anaplasma phagocytophilum has an extended distribution through the Northern Hemispher. 
The disease caused by this bacterium, i.e., granulocytic anaplasmosis, is zoonotic and both the 
prevalence and incidence have dramatically increased in dogs and humans in the USA the past decades. 
Human cases have also been described in Europe and China, with high mortality rates in the latest 
country. In addition, life-threatening complications associated with high hospitalization rates and 
transmission by blood transfusion have been reported to occur in human patients. Clinical signs and 
laboratory modifications are unspecific resembling other tick-borne diseases and diagnosis can be very 
challenging for both canine and human patients. Anaplasma platys is another widespread tick-borne 
pathogen, causing infectious cyclic thrombocytopenia in dogs, with non-specific clinical signs 
resembling those induced by A. phagocytophilum infection. Although considered as a pathogen specific 
of canine species for decades, this bacterium has been shown to infect other animal species and human, 
highlighting its zoonotic potential.  
 
In Morocco, canine ownership has increased in the past years. In addition, stray dogs are still a 
major problem in the transmission of some zoonotic diseases such as rabies and leishmaniasis. Despite 
heavy tick infestation is very frequent even in Moroccan pet dogs and especially in rural areas, 
ectoparasites prevention is not regularly administered with only a few molecules commercialized, and 
very limited diagnostic tools of vector-borne diseases (VBDs) available. Although ticks are abundant in 
Morocco, no data are currently published on tick-borne infections in dogs such as A. phagocytophilum 
and A. platys. Therefore, epidemiological studies are crucial to determine if both bacteria are present in 
both canine and human populations Morocco. 
 
The scientific aims of this study are: 
1. To assess canine exposure to selected vector-borne pathogens in Morocco and to determine 
whether dogs are exposed more specifically to Anaplama spp. 
2. To evaluate the occurrence of A. phagocytophilum and A. platys in dogs in Morocco. 
3. To evaluate human exposure to A. phagocytophilum in Morocco.  
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Summary 
 
In Morocco no data has been published on canine exposure to Anaplasma spp.,                     
Borrrelia burgdorferi, and Ehrlichia spp., and only one report is available on the occurrence of 
Dirofilaria immitis in dogs. Therefore, the aim of this study was to collect current data on the canine 
exposure to these vector-borne pathogens (VBPs) in Morocco.  
 
A total of 217 urban (n = 57), rural (n = 110) and military (n = 50) dogs from seven Moroccan 
locations were screened for Anaplasma spp., B. burgdorferi and Ehrlichia spp. antibodies and for            
D. immitis antigens using a commercial in-clinic ELISA test. Of these dogs, 182 (83.9%) tested 
positive for at least one pathogen and positivity to two or three pathogens was found in 14.3% and 
2.3% of the dogs, respectively.  
 
Ehrlichia spp. antibodies (34.6%) were the most frequently detected followed by Anaplasma 
spp. antibodies (16.6%) and D. immitis antigens (16.1%). None of the dogs was tested seropositive to             
B. burgdorferi. Statistically significant differences in seropositivity rates were found for Ehrlichia spp. 
and D. immitis in rural dogs especially those from the north central region (p < 0.001) but not for 
Anaplasma spp. No significant difference was found according to the health status of the dog.  
 
This study demonstrates that Moroccan dogs are at high risk of acquiring a vectorborne 
infection. 
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Introduction 
 
Canine vector-borne pathogens (VBPs) have been of increasing interest during the past decades 
because of their increased frequency and their threat to both canine and human health.                
Anaplasma phagocytophilum, Borrelia burgdorferi, Ehrlichia canis and Dirofilaria immitis are among 
the most important canine VBPs.1 Anaplasma phagocytophilum, B. burgdorferi and D. immitis are 
recognized as zoonotic pathogens1 while E. canis could have a zoonotic potential as human infection 
has been reported.2 Dogs can play an important epidemiological role in some zoonotic VBPs as 
competent reservoir hosts, carriers of infected vectors in close contact to humans or effective sentinels 
to assess the risk for human infection.1 Therefore, prevalence data in canine species can provide 
important information concerning the incidence, risk factors, source of exposure, and real-time risk of 
exposure for human infection. This information, gathered from a particular region is crucial for clinical 
diagnosis and for effective animal and public health interventions.3 Due to the complexity of vector-
borne diseases (VBDs) diagnosis and control, as well as the possibility of subclinical infection in dogs 
that increases the risk of disease transmission,1 epidemiological data aimed to improve knowledge 
within a region is fundamental.  
 
In North Africa, only a few studies on A. phagocytophilum, B. burgdorferi, E. canis and                  
D. immitis exposure and/or infection in dogs have been published4 and data on these infections is 
lacking in Morocco. Therefore, the aim of this study was to collect current data on the occurrence of 
Anaplasma spp., Ehrlichia spp., B. burgdorferi and D. immitis exposure in dogs in Morocco using a 
commercial in-clinic ELISA test. 
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Materials and methods 
 
Study population  
 
From January 2014 to May 2015, urban and rural client-owned dogs and military dogs were 
sampled from seven locations of Morocco (Figure 1). Dogs sampled in Benslimane, Tangier, Oujda 
and Sahara were military dogs; those sampled in Sidi Kacem and Marrakech lived in rural areas and 
dogs from Rabat were urban client-owned dogs. Military and rural dogs were considered at high risk 
for acquiring VBPs because of their regular outdoor activities or permanent outdoor living, 
respectively, and their close contact with other domestic or feral animals. Clinical signs compatible 
with a tick-borne disease (TBD) (i.e., fever, inappetence or anorexia, lethargy or lameness without 
orthopedic origin) or heartworm disease (i.e., chronic exercise intolerance, weight loss and coughing) 
were recorded. 
 
The study protocol was approved by the Ethical Committee for Biomedical Research of the 
Mohammed V University of Rabat (n°698; July 10, 2014) and the Ministry of Health of Morocco 
(n°965; June 12, 2014). 
 
 
Figure 1. Map of Morocco showing the seven locations of sampling 
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Blood testing 
 
For each dog, 8 ml of anticoagulated blood was collected and all samples were tested using an 
in-clinic enzyme-linked immunosorbent assay (ELISA) SNAP 4Dx Plus (IDEXX Laboratories, Inc., 
Westbrook, ME), according to the manufacturer‘s directions. The test is registered for the detection of 
D. immitis antigens, and specific antibodies against Anaplasma phagocytophilum/A. platys,            
Ehrlichia canis, Ehrlichia ewingii and B. burgdorferi in canine serum, plasma or anticoagulated whole 
blood. The sensitivity and specificity of the performed test were, respectively, 93.2% and 99.2% for                           
A. phagocytophilum, 89.2% and 99.2% for A. platys, 96.7% and 98.8% for B. burgdorferi sensu lato, 
97.8% and 92.3% for E. canis, and 98.9% and 99.3% for D. immitis, respectively.5 
 
Statistical analysis 
 
The statistical analysis was performed using SAS version 6.4 (SAS Institute Inc., Car, NC, 
USA). The exact logistic regression model was fitted to compare seroreactivity rates between regions, 
between rural, military and urban dogs and between sick and healthy dogs. The tests were performed 
at the 5% significance level. 
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Results and discussion 
 
The dogs sampled included 57 urban, 110 rural and 50 military dogs. Age was available for 137 
dogs and ranged from 3 months to 13 years old (mean age = 4.4 years old). Sex and breed were 
available only for 54 dogs from the western region and included German Shepherds (n = 27), Belgian 
Shepherds (n = 6), Retrievers (n =6), Pointers (n = 4), Mixte breed dogs (n = 5) and one dog each of 
Damatian, Rottweiler, Akita Inu, English Setter and Poodle. In the same group, males were more 
frequently sampled (n = 42) than females (n = 12). The majority of the dogs sampled were apparently 
healthy (n = 163) and 54 displayed clinical signs compatible with a TBD or heartworm disease.  
 
A total of 182 (83.9%) were positive for at least one pathogen. Table 1 summarizes the results of 
Anaplasma spp. and Ehlichia spp. exposure and D. immitis infection in dogs for the seven locations. 
These results are the first describing Anaplasma spp. and Ehrlichia spp. exposure in dogs in Morocco. 
The overall positivity rate to D. immitis antigens found in our study (16.1%) is quite similar to the 
prevalence found in a previous study in Rabat (12.3%).6 However, our positivity rate in Rabat is lower 
probably because our dogs from this city were client-owned urban dogs rather than stray or rural dogs 
as in the previous study, or to differences in D. immitis detection methods. Prevalence rates of canine           
D. immitis infection up to 17.6% have been recorded in other African and Mediterranean countries.7-9 
None of the dogs tested seropositive to B. burgdorferi. Our results contrast with those published in 
Algeria where antibodies against A. phagocytophilum were the most prevalent (47.7%), followed by  
B. burgdorferi (37.6%) and E. canis (30.0%).4 These discrepancies could be due to differences in 
inclusion criteria and in ticks populations and density between countries or between regions within the 
same country. Indeed, B. burgdorferi is transmitted by Ixodes spp. ticks and the main vector in Europe 
is I. ricinus.4 This tick species has been identified in eastern Morocco and more specifically in the 
region of Taza, close to the Algerian boundaries,10-12 but none of the dogs included in our study was 
sampled in this region. Therefore, the negative result for B. burgdorferi antibodies could be due to a 
selection bias. Table 2 summarizes the simultaneous exposure to two and three VBPs. Co-exposure 
was found in 14.3% of dogs and was more frequent in rural dogs (26.4%) (Table 3) especially those 
from the north central region (34.6%) (Table 2). 
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Table 1. Distribution of dogs positive to Anaplasma spp. and Ehrlichia spp. antibodies, D. immitis 
antigens and co-infections according to cities and regions. 
 
Region/city 
 
Anaplasma spp. (%) 
 
Ehrlichia spp. (%) 
 
D. immitis (%) 
 
Co-infections (%) 
 
Positive Negative Positive Negative Positive Negative Positive Negative 
 
Northern region  
(n=9) 
 
1 (11.1) 
 
8 (88.9) 
 
1 (11.1) 
 
8 (88.9) 
 
1 (11.1) 
 
8 (88.9) 
 
1 (11.1) 
 
8 (88.9) 
Tangier (n=4) 1 (25.0) 3 (75.0) 1 (25.0) 3 (75.0) 0 (0.0) 4 (100.0) 1 (25.0) 3 (75.0) 
Oujda (n=5) 0 (0.0) 5 (100.0) 0 (0.0) 5 (100.0) 1 (20.0) 4 (80.0) 0 (0.0) 5 (100.0) 
Central northern 
region (n=78) 
16 (20.5)
a
 62 (79.5) 47 (60.3)
 a
 31 (39.7) 28 (35.9)
 a
 50 (64.1) 27 (34.6) 51 (65.4) 
Sidi Kacem (n=78) 16 (20.5) 62 (79.5) 47 (60.3) 31 (39.7) 28 (35.9) 50 (64.1) 27 (34.6) 51 (65.4) 
Northwestern 
region (n=82) 
16 (19.5)
 a
 66 (80.5) 19 (23.2)
 a
 63 (76.8) 6 (7.3)
 a
 76 (92.7) 8 (9.8) 74 (90.2) 
Rabat (n=57) 10 (17.5) 47 (82.5) 10 (17.5) 47 (82.5) 1 (1.7) 56 (98.2) 4 (7.0) 53 (93.0) 
Benslimane (n=25) 6 (24.0) 19 (76.0) 9 (36.0) 16 (64.0) 5 (20.0) 20 (80.0) 4 (16.0) 21 (84.0) 
Southern region  
(n=48) 
3 (6.2)
b
 45 (93.8) 8 (16.7)
 b
 40 (83.3) 0 (0.0)
 b
 48 (100.0) 0 (0.0) 48 (100.0) 
Marrakech (n=32) 1 (3.1) 31 (96.9) 8 (25.0) 24 (75.0) 0 (0.0) 32 (100.0) 0 (0.0) 32 (100.0) 
Sahara (n=16) 2 (12.5) 14 (87.5) 0 (0.0) 16 (100.0) 0 (0.0) 16 (100.0) 0 (0.0) 16 (100.0) 
Total (n=217) 36 (16.6) 181 
(83.4) 
75 (34.6) 142 (65.4) 35 (16.1) 182 (83.9) 36 (16.6) 181 (83.4) 
Pvalue 0.062  <0.001  <0.001  -  
The Pvalue refers to the diference between regions (excluding Northern regions as only few observatins were 
available). Regions means with different letters differ significantly at the 5% significance level. The bold values 
represent the regions. 
 
Table 2. Distribution of dogs positive to two or three pathogens (i.e., Anaplasma spp.,            
Ehrlichia spp. and D. immitis) according to cities and regions. 
Co-infections 
 
Anaplasma- 
Ehrlichia (%) 
Anaplasma-               
D. immitis (%) 
 
Ehrlichia-                       
D. immitis (%) 
Anaplasma-
Ehrlichia-                
D. immitis (%) 
Northern region (n=9) 1 (11.1) 0 (0.0) 0 (0.0) 0 (0.0) 
Tangier (n=4) 1 (25.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Oujda (n=5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Central northern region 
(n=78) 
6 (7.7) 0 (0.0) 16 (20.5) 5 (6.4) 
Sidi Kacem (n=78) 6 (7.7) 0 (0.0) 16 (20.5) 5 (6.4) 
Northwestern region (n=82) 6 (7.3) 1 (1.2) 1 (1.2) 0 (0.0) 
Rabat (n=57) 4 (7.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Benslimane (n=25) 2 (8.0) 1 (4.0) 1 (4.0) 0 (0.0) 
Southern region (n=48) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Total (n=217) 13 (6.0) 1 (0.5) 17 (7.8) 5 (2.3) 
The bold values represent the regions. 
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Table 3. Distribution of dogs positive to Anaplasma spp. and Ehrlichia spp. antibodies, D. immitis 
antigens and co-infections according to the health status and living conditions (i.e., rural, urban 
or military dogs). 
 
Groups 
 
Anaplasma spp. (%) 
 
Ehrlichia spp. (%) 
 
D. immitis (%) 
 
Co-infections (%) 
  
Healthy dogs (n=163) 25 (15.3) 57 (35.0) 30 (18.4) 29 (17.8) 
Rural dogs (n=106) 17 (16.0) 54 (50.9) 28 (26.4) 28 (26.4) 
Urban dogs (n=32) 5 (15.6) 2 (6.2) 1 (3.1) 0 (0.0) 
Military dogs (n=25) 3 (12.0) 1 (4.0) 1 (4.0) 1 (4.0) 
     
Pvalue 0.93 <0.0001 0.02 - 
     
Sick dogs (n=54) 11 (20.4) 18 (33.3) 5 (9.3) 8 (14.8) 
The Pvalue refers to differences between dog origin within the healthy dogs group. The bold characters are for healthy 
and sick groups. 
 
No significant differences in the positivity rates to Anaplasma spp. (p = 0.5484), Ehrlichia spp.        
(p = 0.3119) and D. immitis (p = 0.2891) was detected according to the age of dogs. The seropositivity 
rates were significantly higher in the north central region for both Ehrlichia spp. and D. immitis in 
comparison to the other regions, but not for Anaplasma spp. (Table 1). Similarly, seropositivity rates 
in rural dogs were significantly higher when compared to military and urban dogs for Ehrlichia spp. 
and D. immitis but not for Anaplasma spp. (Table 3). This difference could be explained by the 
statistically significant difference found between regions with the highest prevalence rates recorded in 
the central northern region where all dogs sampled were rural dogs. Other studies showed higher 
positivity rates for VBPs in stray and rural dogs,4,8,9 probably because outdoor living increases the risk 
of contact with infected vectors. No statistically significant differences were found in the seropositivity 
rates between dogs displaying clinical signs compatible with a TBD or heartworm and those 
apparently healthy for Anaplasma spp. (p = 0.4025), Ehrlichia spp. (p = 0.8702) and D. immitis          
(p = 0.1372). Some reports described significant differences in seropositivity to E. canis according to 
the health status of the dog and found positive correlation between seropositivity to this bacterium and 
the presence of clinical signs4,8 while no correlation with the seropositivity to A. phagocytophilum or 
D. immitis was detected.8 
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Serological-based surveys on Anaplasma spp. and Ehrlichia spp. have two main limitations. The 
first is that a positive result can be indicative of either an ongoing infection or a previous exposure to 
the pathogen.13 The second limitation is the existence of cross-reaction between Ehrlichia species                
(i.e., E. canis, E. ewingii and E. chaffeensis) and between Anaplasma species (i.e., A. phagocytophilum 
and A. platys).5 Ehrlichia chaffeensis and E. ewingii and their respective diseases have been described 
almost exclusively in some regions of the United States where Amblyomma americanum is the only 
proven competent vector.14 Consequently, the positivity rates to Ehrlichia spp. obtained in our study 
are likely due to the presence of E. canis antibodies. Its main vector, Rhipicephalus sanguineus,15 is 
present in Morocco12 and canine exposure to this bacterium has been reported in North African and 
Mediterranean countries with seroprevalence rates up to 46%.4,8,16,17 Similarly, the seropositivity to 
Anaplasma spp. in this study is likely to reflect exposure to A. platys. Indeed, this bacterium is also 
most likely transmitted by Rhipicephalus sanguineus and has been described in African countries with 
prevalence rates up to 80.8%.15,18,19 Additionnaly, B. burgdorferi and A. phagocytophilum seem to be 
transmitted by the same Ixodes spp. ticks,8 hence the lack of detection of B. burgdorferi antibodies 
could indicate that Anaplasma spp-seropositive dogs in this study might have been exposed to            
A. platys. Finally, only a few prevalence surveys on A. phagocytophilum are available from African 
countries with prevalence rates up to 4% in Africa and the Mediterranean area.4,9,16,20-25 
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Conclusions 
 
This study demonstrates the canine exposure to Anaplasma spp., Ehrlichia spp. and D. immitis 
in military, rural and urban dogs in seven Moroccan locations with high prevalence rates. Rural dogs, 
especially from the north central region, were significantly more exposed to Ehrlichia spp. and                
D. immitis. This study also described the occurrence of simultaneous exposure to two and three VBPs 
with Ehlichia spp. and D. immitis co-exposure the mot frequently detected. These findings highlight 
the importance of regular preventive measures against arthropod vectors especially in dogs with free 
access to the outdoors. Veterinarians need to include these diseases in their differential diagnosis and 
to recommend the use of regular and adapted prophylactic measures to prevent disease transmission. 
Finally, this study highights the need for large scale prevalence studies to determine the occurrence of 
these VBPs in all Moroccan regions and associated risk factors. Molecular-based surveys are also 
mandatory to identify the Anaplasma and Ehrlichia species circulating in the canine population in 
Morocco. 
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Summary 
 
Anaplasma phagocytophilum is an emerging tick-borne zoonotic pathogen of increased interest 
worldwide which has been detected in northern Africa. Anaplasma platys is also present in this region 
and could possibly have a zoonotic potential. However, only one recent article reports on the human 
exposure to A. phagocytophilum in Morocco and no data are available on canine exposure to both 
bacteria. Therefore, we conducted a cross-sectional epidemiological study aiming to assess both canine 
and human exposure to Anaplasma spp. in Morocco. A total of 425 dogs (95 urban, 160 rural and 175 
working dogs) and 11 dog owners were sampled from four cities of Morocco. Canine blood samples 
were screened for Anaplasma spp. antibodies by an enzyme-linked immunosorbent assay (ELISA) and 
for A. phagocytophilum and A. platys DNA by a real-time polymerase chain reaction (RT-PCR) 
targeting the msp2 and groEL genes, respectively. Human sera were tested for specific                               
A. phagocytophilum immunoglobulin G (IgG) using a commercial immunofluorescence assay (IFA) 
kit. 
 
Anaplasma spp. antibodies and A. platys DNA were detected in 21.9 and 7.5% of the dogs, 
respectively. Anaplasma phagocytophilum DNA was not amplified. Anaplasma platys DNA was 
significantly more frequently amplified for working dogs. No statistically significant differences in the 
prevalence of Anaplasma spp. antibodies or A. platys DNA detection were observed between sexes, 
age classes or in relation to exposure to ticks. A total of 348 Rhipicephalus sanguineus (sensu lato) 
ticks were removed from 35 urban and working dogs. The majority of dog owners (7/10) were 
seroreactive to A. phagoyctophilum IgG (one sample was excluded because of hemolysis). 
 
This study demonstrates the occurrence of Anaplasma spp. exposure and A. platys infection in 
dogs, and A. phagocytophilum exposure in humans in Morocco.  
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Introduction 
 
Ticks are considered to transmit the widest number of pathogens when compared to other 
arthropod vectors, and several of these pathogens are of veterinary and medical importance.1 Some 
tick-borne pathogens (TBPs) are considered to be emerging because of several factors that play a 
crucial role in ticks multiplication and expansion, increasing the likelihood of ticks feeding on humans 
and animal and transmitting pathogens.2 Among these emerging TBPs of zoonotic relevance,                        
Anaplasma phagocytophilum (formerly Ehrlichia equi, Ehrlichia phagocytophila, and the human 
granulocytic ehrlichiosis agent) is an obligate intracellular gram negative bacterium belonging to the 
family of Anaplasmataceae.3 This bacterium causes a widespread disease called granulocytic 
anaplasmosis and is commonly transmitted by Ixodes tick species.4 In the past decades, both human 
and animal exposure to A. phagocytophilum has continuously increased in the USA, Europe and some 
Asian countries.4-8 The clinical presentation of human granulocytic anaplasmosis is a non-specific flu-
like disease potentially fatal with severe complications, high hospitalization rates and difficult 
diagnosis.7-9 Dogs are mostly recognized as incidental hosts and their role as potential reservoir hosts 
for A. phagocytophilum infection is still controversial.10 However, some authors suggested that dogs 
may be considered as potential reservoir hosts for A. phagocytophilum in some regions, especially in 
urban environments,11-14 or at least as effective sentinels to assess the risk for human infection.15 
 
Anaplasma platys is another species of Anaplasma known to infect dogs, which are considered 
the main reservoir hosts. This bacterium is most likely transmitted by Rhipicephalus sanguineus (s.l.) 
ticks and is responsible for infectious canine cyclic thrombocytopenia.16 Anaplasma platys is not 
considered as zoonotic although infection of other domestic animals17-22 and humans23-27 have been 
reported. Both A. platys and A. phagocytophilum infections remain usually asymptomatic or 
subclinical in dogs. When present, clinical signs are unspecific and include fever, lethargy, anorexia, 
lymphadenopathy, lameness, thrombocytopenia and anemia.15,16 
 
In Morocco, both Ixodes ricinus and R. sanguineus (s.l.) ticks are present.28-30 In addition,               
A. phagocytophilum and A. platys were reported in domestic animals and ticks in North Africa.31-36 
However, only one recent report described human exposure to A. phagocytophilum in Morroco37 and 
no data are available on the canine exposure to both A. phagocytophilum and A. platys. Therefore, the 
aim of this study was to assess the occurrence of Anaplasma spp. infection and/or exposure in different 
groups of dogs and dog owners in Morocco. 
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Material and methods 
 
Dogs 
 
Between December 2013 and May 2015, 425 dogs were sampled from four Moroccan cities 
(Figure 1) and divided in 3 groups. The first group (Group I) included 95 clientowned dogs sampled in 
the Veterinary Teaching Hospital (VTH) of the Institut Agronomique et Vétérinaire Hassan II, Rabat 
(34°01'31"N, 06°50'10"W). These dogs were clustered in two subgroups: Group Ia included 63 dogs 
without clinical signs compatible with tick-borne diseases (TBDs) and brought to the VTH for 
vaccination, surgery or post-surgical follow up, dermatology, cardiology or orthopedic consultations, 
and Group Ib included 32 dogs with clinical signs compatible with TBDs (fever, inappetence or 
anorexia, lethargy and lameness without orthopedic origin). For each dog of the first group, an 
epidemiological questionnaire was completed describing the date of sample collection, age, sex, breed, 
outdoor activities, ectoparasite prophylaxis, exposure to ticks, travel history outside Morocco during 
the previous year, vaccination status, presenting complains and physical examination. The second 
group (Group II) was composed of 160 client-owned dogs from the rural region of Sidi Kacem 
(34°13'00"N, 5°42'00"W). These dogs behave like stray or roaming dogs because of their outdoor 
living, close contact with other domestic of feral animals, and low health and or wellness care (absence 
or irregular vaccination and/or, parasite prevention). Information available on this group included age, 
sex and breed. The third group (Group III) contained 170 military and gendarmerie working dogs 
sampled in the first kennel of the Royal Army Forces of Benslimane (33°36'44"N, 7°07'16"W) and the 
kennel of the Royal Gendarmerie of Temara (33°55'36"N, 6°54'44"W), respectively. Data available on 
these dogs were age, sex and breed. Groups II and III included apparently healthy dogs considered at 
high risk for acquiring TBPs because of their regular outdoor activities or permanent outdoor living 
conditions and irregular ectoparasites prevention. All owners gave their consent for enrollment of their 
dogs. 
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Figure 1. Map of Morocco showing the geographic location of the four cities of sampling 
 
For each dog, 8 ml of non-anticoagulated blood were collected from the cephalic vein. Blood 
was centrifuged at 3,500 rpm for 10 min and serum was separated, aliquoted and frozen at -32°C. In 
addition, 2 ml of whole blood collected on ethylenediaminetetra-acetic acid (EDTA) anticoagulant 
tubes were sampled and frozen at -32°C. The frozen sera and whole blood samples were sent to the 
IDEXX Laboratories (Sacramento, California, USA) to be tested for for anti-Anaplasma spp. 
antibodies and for A. phagocytophilum and A. platys using PCR. 
 
Ticks 
 
A total of 348 ticks were removed manually from the dogs included in this study, identified 
(species, stage, sex)38 and conserved in 70% ethanol at 4 °C until shipment to the IDEXX Laboratories 
(Sacramento, California, USA). 
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Owners 
 
All dog owners of the dogs included in Group I were contacted by phone to be sampled for                       
A. phagocytophilum antibodies testing. Only eleven accepted to be enrolled in this study and signed an 
informed consent forms. An epidemiological report was completed for each owner. Age, city of 
residence, occupational activity, travels outside Morocco during the previous year, outdoor activities, 
tick exposure and potential contact with dogs and other domestic animals (cats, horses and ruminants) 
were recorded. 
 
For each patient, 5 ml of non-anticoagulated blood were collected from the elbow groove vein. 
Blood samples were centrifuged at 3,500 rpm for 10 min and serum was separated, aliquoted and 
stored at -32 °C until shipment to the National Reference Laboratory for A. phagocytophilum in Queen 
Astrid Hospital (Brussels, Belgium). 
 
Laboratory procedures 
 
Serological analysis of canine sera (ELISA) 
 
The Anaplasma spp. antibody ELISA utilizes orthogonal assay protocols to screen and 
subsequently confirm the presence of Anaplasma antibodies in a serum or plasma sample. The 
protocols employ microwells coated with Anaplasma p44 peptide and Anaplasma peptide conjugated 
to Horseradish peroxydase (HRPO).39 Briefly, 50 μl of sample was added to a microtiter plate well, 
followed by 50 μl of conjugate. The plate was incubated for 30 min at room temperature. Wells were 
washed 5 times with a PBS Tween wash solution, followed by adding 100 μl of TMB substrate and a 
15-min incubation step at room temperature. The assay is stopped by adding a stop solution and read at 
650 nm using a plate reader spectrophotometer. Positive and negative controls were run in parallel on 
each plate. 
 
DNA extraction and real-time PCR assays on dogs 
 
EDTA blood samples were used to extract total nucleic acid following a protocol adapted from 
Boom et al.40 Briefly, 180 μl whole blood were resuspended in a lysis solution and incubated for 10 
min. Lysates were extracted using Whatman binding plates (Thermo Fisher Scientific, Whatham, 
Massachusetts, USA) on a Corbett X-Tractor platform (Qiagen, Valencia, CA, USA). Nucleic acids 
were eluted into 150 μl of PCR-grade nuclease-free water (Thermo Fisher Scientific, Whatham, 
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Massachusetts, USA) and 5 μl amplified in subsequent real-time PCR reactions. Analysis was 
performed on a Roche LightCycler 480 (Roche Applied Science, Indianapolis, USA) and raw data 
analyzed using the second derivative maximum method with the ‗high sensitivity‘ setting to generate 
crossing points (CP values). 
 
Whole blood samples for PCR testing were available only for 362 dogs including 59 from Group 
Ia, 32 from Group Ib, 104 from Group II and 167 from Group III. Anaplasma spp. real-time PCR 
assays were used from a commercial source (IDEXX Laboratories, Inc., Westbrook, Maine, USA; test 
code 2824 RealPCRTM test). Real-time PCR tests were designed using a commercially available 
software (PrimerExpress 3.0) according to the published guidelines.41 The test was adapted from 
previous publications42,43 and consisted of a mixture of two strain specific tests including A. 
phagocytophilum (msp2 gene, GenBank accession no. DQ519570) and A. platys (groEL gene, 
AY848753). PCR tests positive for Anaplasma spp. were then screened at the species level using the 
individual strain specific real-time PCR tests. The internal sample control real-time PCR test was 
designed using 18S rRNA (DQ287955). All assays were designed and validated according to industry 
standards (Thermo Fisher Scientific, Whatham, Massachusetts, USA; User Bulletin #3). 
 
Real-time PCR was run with 6 quality controls including (1) PCR positive controls 
(quantitatively); (2) PCR negative controls; (3) negative extraction controls; (4) DNA pre-analytical 
quality control targeting canine 18S rRNA gene complex; (5) environmental contamination monitoring 
control; and (6) spike-in internal positive control. These controls assessed the functionality of the PCR 
test protocols for the (1), absence of contamination in the reagents (2) and laboratory (5), absence of 
crosscontamination during the extraction process (3), quality and integrity of the DNA as a measure of 
sample quality (4), reverse transcription protocol (5 and 6) and absence of PCR inhibitory substances 
as a carryover from the sample matrix (6). 
 
Real-time PCR tests were validated analytically and clinically. For the analytical validation, 
each assay had to pass 6 validation criteria including amplification efficiency, linearity, reproducibility 
intra-run, reproducibility inter-run, r-square value and signal to noise ratio of the fluorescent signal. 
Clinical samples were used to repeat standard curves and to confirm PCR positive results by 
sequencing with outside flanking primers. A total of 4,125 clinical samples were used during the 
clinical validation of this panel and test results were compared to either alternative PCR test systems or 
immunofluorescence assay (IFA) methods. 
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Serological analysis of human sera (IFA) 
 
Human sera were screened for A. phagocytophilum immunoglobulin G (IgG) antibodies by a 
semi-quantitative indirect IFA using a commercial kit (Focus Diagnostics, Cypress, California, USA) 
containing HL60 cells infected with a human isolate of A. phagocytophilum HGE-1 according to the 
manufacturer‘s instructions. Briefly, 5 μl of serum were diluted in 315 μl of phosphate-buffer saline 
(PBS) (0.01 M, pH = 7.2 ± 0.1). The positive IgG control was also diluted in PBS to obtain five 
dilutions 1:2, 1:4, 1:8, 1:16 and 1:32. Then, 25 μl of diluted sera were added in the slides wells (one 
well per sample). The first line of the first slide contained the négative IgG control and the five 
dilutions of the positive IgG control. The slides were incubated in humid chambers between 35.0 and 
36.5 °C for 30 min. After the incubation period, the slides were washed with PBS solution followed by 
distilled water to eliminated non-conjugated serum antibodies. In the second step, 25 μl of conjugate 
containing human IgG combined with fluorescein were added in each well. The slides were incubated 
again then washed in the same formerly described conditions. Finally, the slides were dried, 
coverslipped using mounting medium and observed with ultraviolet light microscopy (×400). The titer 
was defined as the reciprocal of the highest dilutions of serum with the homogeneously stained 
cytoplasmic morulae. A serum titer of ≥ 1:64 was considered as positive for A. phagocytophilum IgG 
according to the manufacturer‘s instructions. Samples that were positive at the first dilution of 1:64 
under ultraviolet light microscopy (×400) were then further diluted to 1:128 and those remaining 
positive at the second dilution were then tittered at 1:256 and 1:512. 
 
Statistical analysis 
 
Statistical analysis was performed using SAS version 6.4 (SAS Institute Inc., Car, NC, USA). 
The exact logistic regression model was fitted to compare seroreactivity and PCR positive rates 
between the different groups, age classes, sex and in relation to the presence of ticks. First, global 
hypothesis tests were performed, comparing all dog groups, based on the likelihood ratio test (LRT). 
With an overall significant test, groups were compared pairwise using Bonferroni‘s multiple 
comparisons technique at a global significance level of 5%. Significant pairwise comparisons were 
summarized in terms of the odds ratio (OR) with a 95% confidence interval (95% CI). Other risk 
factors (sex, tick exposure, age groups) were analysed in the same way. 
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Results 
 
Serological and molecular screening of dogs  
 
Off the 425 dogs, breed, sex and age were available for 299 (70.3%), 398 (93.6%) and 402 
(94.6%) dogs, respectively. Dogs belonged to 23 different breeds with German and Belgian Shepherds 
(n = 122), Retrievers (n = 58), Saluki (n = 36), Cocker and English Spaniel (n = 27), mixed breeds     
(n = 19) and Pointers dogs (n = 10) the most frequently found during sampling. Other breds included 
Poodles (n = 4), Rottweilers (n = 3), Pekingese (n = 3), Aidi (n = 2), Border Collie (n = 2), Pitbull      
(n = 2), Setters dogs (n = 2) and one dog for Drahthar, Saint Hubert, German Mastiff, Argentin dogo, 
Dalmatian, Akita Inu, Husky, Havanese and Chihuahua. The age of dogs ranged from 3 months to 14 
years-old (mean age 3.2 years-old) and males (n = 257) were more frequently sampled than females   
(n = 141). Previous ticks bites were available for 226 dogs (53.2%) from Group I (n = 40) and Group 
III (n = 18). 
 
Table 1 summarises the results of Anaplasma spp. antibodies and A. platys DNA detection in the 
three groups of dogs. There were significant differences between dog groups (χ2 = 10.28, df = 3,         
P = 0.016). Group Ia differed significantly from Group II (OR = 0.32, 95% CI: 0.14-0.75, P = 0.009). 
None of the 362 dogs screened for A. phagocytophilum DNA by PCR was found positive whereas 
7.5% (95% CI: 0.05-0.11) of them were positive to A. platys (Table 1). There were globally significant 
differences between dog groups (χ2 = 9.44, df = 3, P = 0.024). The highest prevalence of A. platys 
DNA detection was found in Group III but none of the pairwise comparisons was significant (Table 1). 
Table 2 summarizes the prevalence of positivity rates to Anaplasma spp. antibodies and A. platys DNA 
detection according to sex, age and exposure to ticks. No statistically significant differences were 
found in seropositivity rates for the sex (χ2 = 2.161, df= 1, P= 0.142), the age groups (χ2 = 1.75, df= 2, 
P = 0.416) and exposure to ticks (χ2 = 0.83, df = 1, P = 0.363). Similarly, no statistically significant 
differences were found in positivity rates to A. platys DNA detection for sex (χ2 = 2.88, df = 1, 
P=0.090), the exposure to ticks and age groups (χ2 = 5.05, df = 2, P = 0.080).  
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Table 1. Number and prevalence (%) of positive and negative dogs to Anaplasma spp. antibodies (by 
ELISA) and A. platys DNA detection (by PCR), and positive to both methods in the different groups. 
 
Groups 
 
Anaplasma spp. antibodies (%) 
(n=425) 
 
A. platys (%) 
(n=362) 
 
Anaplasma spp. 
and A. platys (%) 
(n=362) 
Positive Negative Positive Negative Not available  
Group I  (n=95) 11 (2.6) 84 (19.8) 3 (0.8) 88 (24.3) 4 1 (0.3) 
Group Ia (n=63) 7 (1.6) 56 (13.2) 2 (0.5) 57 (15.7) 4 0 (0.0) 
Group Ib  (n=32) 4 (0.9) 28 (6.6) 1 (0.3) 31 (8.6) 0 1 (0.3) 
Group II (n=160) 45 (10.6) 115 (27.1) 4 (1.1) 100 (27.6) 56 1 (0.3) 
Group III (n=170) 37 (8.7) 133 (31.3) 20 (5.5) 147 (40.7) 3 9 (2.3) 
Total  (n=425) 93 (21.9) 332 (78.1) 27 (7.5) 335 (92.5) 63 11 (3.0) 
Group I: urban client-owned dogs sample in the VTH; group Ia: urban client-owned dogs sample in the VTH without 
clinical signs compatible with a TBD; group Ib : urban client-owned dogs sample in the VTH with clinical signs 
compatible with a TBD;  group II: rural client-owned dogs; group III: military and Gendarmerie working dogs. 
 
Table 2. Number and prevalence (%) of positive and negative dogs to Anaplasma spp. antibodies (by 
ELISA) and A. platys DNA detection (by PCR) according to the sex, the age and the exposure to 
ticks.  
 
Variables 
 
Anaplasma spp. antibodies (%) 
(n=425) 
 
A. platys DNA (%) 
(n=362) 
Positive Negative Not available Positive Negative Not available 
  Sex Male 59 (13.9) 198 (46.6) - 20 (5.5) 187 (51.7) 50 
Female 23 (5.4) 118 (27.8) - 5 (1.4) 123 (34.0) 13 
Age 
(years-old) 
<1 9 (2.1) 52 (12.2) - 3 (0.8) 52 (14.4) 6 
1-5 56 (13.2) 194 (45.6) - 21 (5.8) 183 (50.6) 46 
≥6 13 (3.0) 61 (14.3) - 2 (0.5) 62 (17.1) 10 
Ticks exposure 40 (9.4) 46 (10.8) 9  40 (11.0) 46 (12.7) 9 
 
Identification of ticks 
 
A total of 348 ticks were removed from 35 dogs and all belonged to R. sanguineus (s.l.). Two 
ticks were nymphs, 284 adult females and 63 adult males. The number of ticks removed from one dog 
ranged from 1 to 54 (mean number 9.9) (Figure 2). Among the 35 infested dogs, 15 belonged to Group 
I, 2 to Group II and 18 to Group III. The number of dogs infested by ticks and positive to            
Anaplasma spp. antibodies only, to A. platys DNA only or to both tests were eight, three and one, 
respectively. The only dog infested by ticks and positive for both tests was from Group II. 
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Figure 2. Rhipicephalus sanguineus (s.l.) engorged ticks attached to the ear of a dog from group I. 
 
Serological screening of owners 
 
Among the eleven dog owners sampled, three were women and eight were men. Ages ranged 
from 23 to 66 years, with an average of 51 years. Most lived in Rabat (9/11) and two in surrounding 
cities (Salé and Arjat). Seven mentioned having leisure outdoor activities in forest or rural areas and 
one farmer lived in a rural area (Arjat). Five owners reported to have contact with other domestic 
animals including cats, horses and ruminants. Five owners had additional dogs. Only one owner 
reported previous exposure to ticks and two traveled to foreign countries during the year.    
 
One sample was excluded due to hemolysis that could interfere with the results according to the 
manufacturer‘s instructions. Seven out of the ten remaining sera were positive to A. phagocytophilum 
IgG at the first dilution (1:64) (Figure 3). Among the seropositive owners, three were women and four 
were men. Four reported regular outdoor activities in the forests of Rabat or the vicinity (Maamora 
forest, Khémisset, Bouznika and Benslimane). Four owners mentioned to have contact with domestic 
animals other than dogs. None of the seropositive owners had a travel history outside Morocco during 
the previous year and two mentioned to be regular blood donors. When further diluted, six, two and 
one samples remained positive at 1:128, 1:256 and 1:512, respectively (Figure 3). The only sample 
that remained positive at 1:512 was from a farmer. 
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Figure 3. Photographs of ultraviolet light microscopy (×400) of A. phagocytophilum IgG semi-
quantitative IFA measurement using a commercial kit (Focus Diagnostics, Cypress, California, 
USA) showing a negative control (A), a positive control (B) and four positive dilutions i.e., 1:64 
(C), 1:128 (D); 1:256 (E) and 1:516 (F). The positivity is set on the observation of green morulae 
surrounding the cell‘s cytoplasmic membrane. 
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DISCUSSION 
 
To our knowledge, the results of this cross-sectional study demonstrated for the first time in 
Morocco a prevalence of 21.9 and 7.5% of Anaplasma spp. antibodies and A. platys DNA detection in 
dogs, respectively. It also showed that 7 among 10 dog owners were seroreactive to                             
A. phagocytophilum IgG. Currently the two most important Anaplasma species known to infect dogs 
and humans are A. platys and A. phagocytophilum.27 Infection by both species have already been 
detected in dogs and ticks in North Africa.28,31,33-36 Our study detected A. platys infection in dogs with 
a prevalence similar to what has been published in Algeria (5.4%).36 Although not statistically 
significant, working dogs tested more frequently positive to A. platys DNA than rural dogs. Therefore, 
although considered as a major risk factor for acquiring tick-borne infections,44-46 outdoor access alone 
cannot explain the high prevalence in working dogs. Similarly, a study on Senegalese gendarmerie and 
private kennel living dogs showed a high prevalence of E. canis infection,47 another R. sanguineus 
(s.l.)-transmitted pathogen, probably because this tick species can complete its entire life-cycle either 
indoor (in houses, kennels and veterinary hospitals where it readily colonizes the infrastructure) or in 
outdoor environments (peri-urban and rural).25,47,48 Other factors explaining the higher prevalence in 
working dogs in our study can be the absence of efficient ectoparasite control programs in this group 
or the access to areas with higher burdens of A. platys. 
 
Our study detected both Anaplasma spp. antibodies and A. platys DNA in dogs but failed to 
identify A. phagocytophilum DNA. This discrepancy has also been reported in other African, European 
and American studies.31,49-51 Cross-reactivity between Anaplasma spp. pathogens, especially between   
A. phagocytophilum and A. platys, has been reported to occur. Therefore, in regions where both 
pathogens could co-exist, seropositivity may not enable the distinction at the species level.16 In areas 
where Ixodes spp. ticks are less prevalent or absent, a positive Anaplasma spp. serology could be the 
result of A. platys exposure.52 Consequently, the fact that we detected exclusively R. sanguineus (s.l.) 
ticks infesting dogs can be supportive of the potential predominance of A. platys in Morocco. 
However, Ixodes ricinus ticks are also present in this country28-30 and could have infected these dogs 
previously. On the other hand, infection with A. phagocytophilum in Rhipicephalus spp. has also been 
reported especially in the Mediterranean countries, and these ticks have been suggested as potential 
competent vectors of this bacterium in this part of the world.33,53-56 In a study from Jordan, a high 
prevalence of A. phagocytophilum infection (39.5%) was found in dogs and the most abundant tick 
species removed was R. sanguineus (s.l.) (95.1%) followed by two Haemaphysalis species, whereas no 
I. ricinus was collected from these dogs. The authors suggested that the ticks found in their study 
could be a possible competent vector of the pathogens detected including A. phagocytophilum.57 
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Further studies are necessary to evaluate the ability of Rhipicephalus ticks in transmitting                   
A. phagocytophilum. 
 
In regions where both A. platys and A. phagocytophilum are present, a PCR-based assay is 
required to determine which of the two agents is responsible for positive serological test.16 
Nevertheless, false-negative results are reported to occur with PCR, mainly due to low template 
concentrations,27,58 the short duration of A. phagocytophilum bacteremia in dogs and the variations in 
the levels of circulating bacteria.15,58 In addition, selective amplification of the predominant organism 
can occur in patients coinfected with genetically similar organisms27,59 such as A. phagocytophilum 
and A. platys, which could be the case in our study. As DNA-based diagnostic tool enables the early 
detection of the infection by A. phagocytophilum, the bacteriemia is of short duration and is usually 
present transiently during the acute phase of the infection,15,60,61 negative PCR results might be more 
difficult to interpret in healthy dogs. Therefore, negative PCR results only indicate that the respective 
nucleic acid sequence was not detected in the sample evaluated under the assay conditions used and 
should not be interpreted as evidence of absence of infection.58 In addition, other factors could explain 
the negative results in our study mainly the likely degradation of the DNA due to the transport 
conditions from Morocco to the USA and the selected region of sampling. Indeed, our dogs were 
sampled exclusively from the western part of Morocco but previous studies detected I. ricinus ticks in 
the eastern regions.28,29 In addition, Borrelia burgdorferi (s.l.), that is transmitted by Ixodes spp. ticks, 
was reported in dogs in Algeria,31 a neighbour country of Morocco, and ticks in north-eastern 
Morocco,30 suggesting that these ticks could be more prevalent in eastern regions. 
 
Consistently with our previous report that detected high prevalence rates of A. phagocytophilum 
exposure in humans in northwestern regions of Morocco,37 the majority of dog owners sampled were 
found positive to A. phagocytophilum IgG. In our previous study, the contact with dogs or other 
domestic animals was not a risk factor for the seropositivity,37 suggesting that other factors such as 
outdoor activities might be incriminated. Indeed, outdoor activities especially related to forests, 
meadow habitats and grasslands are considered as a major risk factor for acquiring a tick-borne 
infection due to the increase risk of contact with infected ticks.62 Another study has found no 
significant difference in the seroprevalence of A. phagocytophilum among owners of seropositive pets 
and owners without pets, suggesting that dog ownership may not be a risk factor.63 
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Anaplasma platys was known to infect dogs exclusively, and they are are recognized as the main 
reservoir hosts. However, recent reports described the infection in domestic ruminants, cats and even 
in humans.17-27 In addition, human infestation with R. sanguineus (s.l.) has also been reported,47,57,59 
suggesting that A. platys could be transmitted to humans through the bite of this tick species. 
Moreover, all human cases infected with A. platys had regular contact with dogs and/or reported 
infestation of their dogs with R. sanguineus (s.l.).25-27 In addition, in two human cases, the A. platys 
sequence was identical to the sequence found in their dog.27 This is in contrast to our current and 
previous study that both failed to detect a relationship between contact with dogs and human 
seropositivity to A. phagocytophilum possibly suggesting that humans in Morocco could be more 
likely to exposed to this bacterium than to A. platys. All previously reported cases of human A. platys 
infection were diagnosed by DNA detection or microscopic identification of morulae within 
platelets25-27 and hence, the occurrence of immunological response to this bacterium is unknown. 
Moreover, to the authors‘ knowledge, the possible occurrence of crossreaction between A. platys and 
A. phagocytophilum antibodies has not been evaluated in humans. The IFA based on HL60-cells 
infected with a human isolate of A. phagocytophilum, such as the one used in our study, are considered 
to be both sensitive64 and highly specific for the investigation of seroreactivity to this bacterium9 with 
a specificity of 100%, according to the manufacturer. 
 
Rhipicephalus sanguineus (s.l.) is the most common tick in the Mediterranean region.57 It is 
known to transmit several pathogens including Rickettsia conorii, Babesia canis, Hepatozoon canis 
and E. canis and probably Bartonella spp., Mycoplasma haemocanis and A. platys.46 This tick has the 
particularity to be active during almost all the year and to achieve two or more generations per year. 
Warmer temperature may contribute to increased tick abundance by a more rapid development. 
Although R. sanguineus (s.l.) ticks usually feed on dogs, they can feed on a wide variety of animal 
species including humans.48,65 Therefore, due to its high degree of adaptability, R. sanguineus (s.l.) 
represents a major threat not only to dogs, but also to humans. Furthermore, the report of E. canis and      
A. platys human infections23-27,66,67 emphasizes the importance of R. sanguineus (s.l.) and the zoonotic 
potential of these two infections, and further investigation should be carried out to assess the public 
health implication.48 
 
The major limitations of this study are the restricted area of sampling, the absence of PCR 
performed on the ticks sampled from dogs, and the small number of owners and dogs with clinical 
signs compatible with a TBD. Unfortunately, DNA from the ticks collected was too degraded to 
perform PCR analysis, most probably due to the shipping conditions from Morocco to the USA.  
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Conclusion 
 
This study demonstrates the Anaplasma spp. exposure in humans and dogs in Morocco. To our 
knowledge, it is also the first report on the occurrence of A. platys infection in dogs. Our results 
showed that working dogs living in kennels are at an increased risk for acquiring this infection. These 
findings highlight the importance of regular preventive measures against arthropod vectors especially 
in dogs living in kennels and dogs that have access to outdoor environments. This study also suggets 
that human exposure to A. phagocytophilum is likely to be frequent and emphazises the need for large-
scale serological and clinical surveys to better estimate the prevalence of this bacterium and to 
determine its ability in causing disease in Morocco. Since the human infection by A. platys has been 
reported, Moroccan dogs are frequently infected with this bacterium and dogs are the main reservoir 
hosts, it is important to evaluate if this bacterium can cause human disease in Morocco and if the 
infection is associated with an immunological response. This study should serve as an indicator to 
Moroccan physicians and veterinarians that A. phagocytophilum and A. platys exposure and infection 
are not rare, and it will help raise awareness on the potential occurrence of TBDs more generally in 
this country. Since we reported results in a limited area of the country and on a very limited number of 
humans, larger and more represeantative surveys are recommended 
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Summary 
 
Anaplasma phagocytophilum is an emerging tick-borne zoonotic bacterium with extensive 
increased interest. Epidemiological data are available in several regions of the USA, Europe and Asia in 
contrast to other parts of the world such as North Africa.  
 
Blood samples of 261 healthy individuals divided in two groups i.e., dog handlers and blood 
donors were analyzed. Indirect immunofluorescent assay using a commercial kit was performed to 
detect specific A. phagocytophilum IgG. Two dilutions were used to assess the prevalence of 
seroreactive samples. Demographic variables were assessed as potential risk factors using exact logistic 
regression.  
 
Seropositivity rates reached 37% and 27% in dog handlers and 36% and 22% in blood donors. No 
statistically significant differences were found in the prevalence rates between the two groups. Analysis 
of risk factors such as gender, age groups, outdoor activities, self-reported previous exposure to ticks, or 
contact with domestic animals (dogs, cats, ruminants and horses) did not shown any significant 
difference.  
 
Anaplasma phagocytophilum exposure was common in both high-risk population and blood 
donors in Morocco. 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter V Human exposure to Anaplasma phagocytophilum 
 132 
Introduction 
 
Anaplasma phagocytophilum is an obligate intracellular gram-negative bacterium that infects 
neutrophils. The bacterium causes an emerging zoonotic tick-borne disease (TBD) called granulocytic 
anaplasmosis,1 and is mostly transmitted to humans through the bites of ticks of the Ixodes genus. 
However, other modes of transmission have been described including transplacental transmission, 
percutaneous exposure or inhalation of the contaminated blood of deer, nosocomial infection following 
direct contact with blood and respiratory secretions and through blood transfusions.2,3 
 
Human granulocytic anaplasmosis (HGA) is an unspecific flu-like illness that is typically 
characterized by the acute onset of fever, headache, chills, myalgia, malaise, nausea, and cough. 
Depending on several risk factors, which include advanced age, immunosuppression, co-morbidities and 
delays in the onset of treatment, HGA can be mild or fatal.4,5 Life-threatening complications occur in 
3% of cases. Consequently, half of the HGA cases are hospitalized and up to 17% of patients require 
admission to intensive care units, especially when the diagnosis and treatment are delayed.1,4 Therefore, 
the Infectious Diseases Society of America recommends that antimicrobial therapy be given to every 
person suspected of having HGA on the basis of their clinical presentation, so as not to delay the 
treatment.6 Due to the potentially serious outcome and the difficulty of the diagnosis, epidemiological 
data on the prevalence and distribution of human cases within a country are important to increase 
awareness of physicians and to develop adapted public health strategies to prevent and control this 
disease.7 
 
HGA commonly occurs in the USA and Europe, and it is increasingly diagnosed in some Asian 
countries.6,8 In the USA, at least 15,952 HGA cases were reported since 1995 and a 12-fold increased 
incidence has been observed between 2001 and 2011.4 In China, the exposure to A. phagocytophilum 
has continuously increased from 8.8% to 59.2% in high-risk populations between 2006 and 2009.3 
Despite a moderate to high seroprevalence in several countries, HGA is still unrecognized and rarely 
diagnosed due to several factors including limited epidemiological information, difficult diagnosis, 
asymptomatic or subclinical infections and the lack of awareness among physicians and the public.2,3,6 
Moreover, the occurrence of HGA is unknown in many regions of the world such as Oceania, South 
America, Africa, and in large regions of Asia. To the author‘s knowledge, no data are available in North 
Africa on either the occurrence of HGA or the prevalence of human exposure to A. phagocytophilum. 
However, ticks are abundant in this region and might represent a hazard for both animal and human 
public health.9 Therefore, we carried out a cross-sectional epidemiological serologic survey to 
investigate the potential human exposure to A. phagocytophilum in Morocco. 
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Materials and Methods 
 
Study population  
 
Between June and September 2015, 261 healthy individuals from two groups were sampled from 
three cities of Morocco (Figure 1). The first group included 144 military and police dog handlers from 
the first kennel of the Royal Forces Army of Benslimane and the kennel of the Royal Gendarmerie of 
Temara. This group was considered to be at a high risk for TBDs because of their regular contact with 
dogs and outdoor occupational activities. The data collected on this group included age and exposure to 
ticks. The second group included 117 blood donors from the Regional Transfusion Centre of Rabat. All 
of the blood donors were informed on the purpose of the survey and signed informed consent forms 
before enrollment. An epidemiological report was completed for each blood donor containing data on 
the age, city of residence (Figure 1), occupation, travels outside Morocco during the previous year, 
outdoor activities, tick exposure and potential contact with dogs and other domestic animals (i.e., cats, 
horses and ruminants).  
 
 
Figure 1. Map of Morocco showing the cities of sampling (in bold) and the cities of residence and 
of outdoor activities of the blood donors. 
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The study protocol was approved by the Ethical Committee for Biomedical Research of the 
Mohammed V University of Rabat (n°698; July 10, 2014) and the Ministry of Health of Morocco 
(n°965; June 12, 2014). 
 
Blood sampling 
 
For each person included in the study, 5 ml of non-anticoagulated blood was collected from the 
elbow groove veins. Blood samples were centrifuged at 3500 rpm during 10 min at 15°C and sera were 
aliquoted and stored at -32°C until shipment to the National Reference Laboratory for                                  
A. phagocytophilum in Belgium. 
 
Serological tests 
 
Immunoglobulin G (IgG) antibodies were detected against A. phagocytophilum by a semi-
quantitative indirect immunofluorescent assay (IFA) using a commercial kit (Focus Diagnostics, 
Cypress, California, USA) containing HL60 cells infected with a human isolate of A. phagocytophilum 
HGE-1 according to the manufacturer‘s instructions. Briefly, 5 μL of serum were diluted in 315 μL of 
phosphate-buffer saline (PBS) (0.01 M, pH = 7.2±0.1). The positive IgG control was also diluted into 
the following five dilutions: 1:2, 1:4, 1:8, 1:16 and 1:32. Then, 25 μL of diluted sera were added in the 
wells of each slide. The first line of the first slide contained the negative IgG control and the five 
dilutions of the positive IgG control. The slides were incubated in humid chambers between 35 and 
36.5°C for 30 min, then they were washed with the PBS solution followed by distilled water to 
eliminated non-conjugated serum antibodies. Next, 25 μL of the conjugate containing human IgG and 
fluorescein were added to each well. The slides were incubated again and washed as described above. 
Finally, the slides were dried and coverslipped using a mounting medium and were examined under 
ultraviolet light microscopy (×400). The titer was defined as the reciprocal of the highest dilutions of 
serum with the homogeneously stained cytoplasmic morulae (Figure 2). A serum titer of ≥ 1:64 was 
considered as positive for A. phagocytophilum IgG, according to the instructions provided by the 
manufacturer. Samples that were positive at the first dilution of 1:64 were then further diluted to 1:128 
and those remaining positive at the second dilution were then tittered at 1:256 and 1:512. Ten samples 
were reassessed by a blinded technician from the laboratory at a dilution of 1:64 and the results were 
confirmed in all cases. 
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Statistical analysis 
 
A statistical analysis was performed using SAS version 6.4 (SAS Institute Inc., Car, NC, USA). 
The exact logistic regression model was fitted to compare seroreactivity rates between both dog handler 
and blood donor groups and between gender, the presence or absence of outdoor activities, exposure to 
ticks, dogs or other domestic animals inside the blood donor group. The statistical significance was set 
at 5%. The results were summarized in terms of the odds ratio with a 95% confidence interval. 
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Results 
 
Eight samples were excluded due to hemolysis that could interfere with the results according to 
the manufacturer instructions. A total of 138 dog handlers (54.5%) and 115 blood donors (45.4%) were 
included in the study. The majority of blood donors (105/115) lived in Rabat or the surrounding cities 
whereas nine blood donors were from other cities (Table 1).  
 
The city of origin was unavailable for one blood donor. All dog handlers were men between 21 
and 51 years of age (average age: 33 years). The blood donors group included 63 men (54.8%) and 52 
women (42.2%), and their ages ranged from 18 to 61 years (average age: 39 years). The distribution 
according to the epidemiological variables in the two groups is summarized in Table 2.  
 
Outdoor activities in the forest or rural areas were either occupational or for leisure (picnic, 
hiking, jogging, walking or hunting). More than half of the blood donors (47/86) reported their outdoor 
activities in the region of Rabat-Salé-Kenitra region and 20.9% (18/86) reported their activities in other 
Moroccan regions including Moulay Bousselham, Gharb region, Tangier, Ouazzane, Rif mountain, 
Ifrane, Azrou, Khouribga, Oued Zem, Nador, Taza, Oujda, El Jadida, Safi, Essaouira, Agadir, Tiznit, 
Dakkhla, Beni Mellal, Azilal, Marrakech, Ait Baha, Zagora, Taroudant and the High Atlas mountains 
(Figure 1). The remaining 21 blood donors (24.4%) reported their outdoor activities in both Rabat-Salé-
Kenitra and other regions. Previous exposure to ticks was recorded in 1.4 (2/138) and 6.1% (7/117) of 
dog handlers and blood donors, respectively. Travel outside of Morocco was recorded in 15.6% 
(18/115) of blood donors and ten traveled to two or more countries. 
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Figure 2. Photographs of ultraviolet light microscopy (×400) of A. phagocytophilum IgG semi-
quantitative IFA measurement using a commercial kit (Focus Diagnostics, Cypress, California, 
USA) showing a negative control (A), a positive control (B) and four positive dilutions i.e., 1:64 
(C), 1:128 (D), 1:256 (E) and 1:516 (F) from the same patient. The positivity is set on the observation 
of green morulae surrounding the cell‘s cytoplasmic membrane. 
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Table 1. Distribution of the number of blood donors and of positive samples for both dilutions 
according to city. 
 
Administrative 
region 
 
City 
 
Distance to 
Rabat (km) 
 
Number of 
blood donors 
 
Number of 
positive IgG 1:64 
 
Number of 
positive IgG 1:128 
 
 
 
Rabat-Salé-Kénitra 
 
Rabat  55 19 10 
Salé 5.2 32 11 6 
Temara 8.0 13 5 2 
Ain El Aouda 30.0 1 1 1 
Sidi Allal El 
Bahraoui 
37.7 1 0 0 
Kenitra 55.0 1 0 0 
 
Casablanca-Settat 
 
Bouznika 39.6 1 1 1 
Benslimane 60.0 1 0 0 
 
Béni Mellal-
Khénifra 
Khenifra 237.4 1 1 1 
Beni Mellal 233.1 1 1 1 
Tanger-Tétouan-Al 
Hoceima 
Tangier 250.0 1 1 1 
 
Souss-Massa-Drâa 
 
Tinghir 477.0 1 0 0 
Agadir 547.0 3 1 1 
Tizi n'Tichka  1 0 0 
Guelmim-Oued 
Noun 
Sidi Ifni 686.0 1 0 0 
   Abbreviations: IgG, immunoglobulin G. 
 
The seropositivity rates for A. phagocytophilum IgG at the first dilution reached 37.0% (51/138) 
and 35.7% (41/115) in dog handlers and blood donors, respectively (Table 3 and Figure 3). At the 
second dilution, 27.5% (38/138) and 21.7% (25/115) of sera were still reactive in the dog handlers and 
the blood donors groups, respectively (Table 3 and Figure 3). Most seropositive blood donors for both 
dilutions (i.e., 1:64 and 1:128) were from the region of Rabat-Salé-Kénitra (Figure 4). 
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 Table 2. Distribution of age, sex, exposure to ticks, contact with dogs or other domestic animals 
and travel history outside Morocco in both dog handlers (n = 138) and blood donors (n = 115) 
groups.  
Variables 
 
Dog handlers (%) Blood donors (%) 
 
Sex 
Men 138 (100) 63 (54.8) 
Women 0  (0.0) 52 (45.2) 
 
Age 
(years-
old) 
 
 
≤20 1 (0.7) 7 (6.1) 
21-30 78 (56.5) 26 (22.6) 
31-40 47 (34.1) 27 (23.5) 
41-50 10 (7.2) 36 (31.3) 
>50 1 (0.7) 19 (16.5) 
Exposure to ticks 2 (1.4) 7 (6.1) 
Outdoor activities 138 (100) 86 (74.8) 
Contact with dogs 138 (100) 11 (9.6) 
Contact with other 
domestic animals 
- 17 (14.8) 
Travel 0 (0.0) 18 (15.7) 
 
Table 3. Number of seropositive samples in both dog handlers (n=138) and blood donors (n=115) 
groups at the four different dilutions. 
Variables Dog handlers (%) Blood donors (%) OR 95%CI P value 
IgG 1:64 51 (37.0) 41 (35.7) 1.05 0.61-1.83 0.90 
IgG 1:128 38 (27.5) 25 (21.7) 1.37 0.74-2.56 0.31 
IgG 1:256 11 (8.0) 2(1.7) - - - 
IgG 1:512 7 (5.1) 2 (1.7) - - - 
Abbreviations: IgG, immunoglobulin G; OR, odd ratio; 95%CI, 95% confidence interval. 
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No statistically significant differences were found between the two groups considering the 
seroreactivity rates at both dilutions (Table 3). Similarly, no statistically significant differences were 
found in the blood donor group when comparing between gender, age groups, the presence of outdoor 
activities, exposure to ticks, and contact with dogs or other domestic animals at both dilutions (Table 2). 
In the dog handlers group, 11 (8.0%) and 7 (5.1%) of the sera were still positive when further diluted to 
1:256 and 1:512, respectively (Table 3 and Figure 3). Only two of the samples remained positive at both 
1:256 and 1:512 in the blood donors group (Table 3 and Figure 3). 
 
 
Figure 3. Distribution of positivity rates for the four A. phagocytophilum IgG dilutions (i.e, 1:64, 
1:128, 1:256 and 1:516) in both dog handlers (A) and blood donors (B) groups.  
 
                     
Figure 4. Distribution of A. phagocytophilum IgG positivity rates in blood donors according to the 
region of living in Rabat-Salé-Kénitra (RSK), Casablanca-Settat (CS), Tangier-Tétouane-Al 
Hoceima (TTAlH) and Souss-Massa-Drâa (SMD) regions and for both 1:64 (A) and 1:128 (B) 
dilutions. 
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Discussion 
 
To the author‘s knowledge, this is the first report investigating human exposure to                           
A. phagocytophilum in Africa. In Europe, the USA and Asia, several reports have investigated the 
prevalence of human exposure in blood donors10-19 and in high-risk populations including people living 
in forest areas and forestry workers,10,12,16,20-25 people living in rural areas and farmers,3,8,19,26-28 
hunters,8,11 national parks rangers,29-30 military personnel,31 people in close contact with domestic 
animals,7,21 and people at high risk of exposure or previously exposed to ticks.7,32,33 The prevalences 
recorded in high-risk populations or in endemic areas were up to 32%, 35.6%, and 33.7% in Europe,23 
the USA,34 and China,35 respectively. However, several serological methods and cutoffs were used, 
which made the comparison between these studies difficult.31 When comparing the results of military 
dog handlers obtained in this study at the threshold of 1:64, i.e., 37%, with other Chinese24,35 and 
European12,21,23,25,28,32,36 reports using the same method and the same cutoff, it appears that the 
prevalence in Morocco is higher. The highest prevalences recorded in both China and Europe were 
20%7 and 9.6%,25 respectively. One study from Cyprus reported a prevalence of 32% with a cutoff of 
1:128,23 which is slightly higher than the results found in Morocco at the same cut off (27.5%). When 
comparing the results of this study with high-risk populations from other European Mediterranean 
countries such as Italy (8.8%),22 Portugal (5.4%),17 and Spain (1.4%),21 the prevalence found in 
Moroccan dog handlers is higher at both the first and second dilutions.  
 
Moreover, the prevalence in Moroccan dog handlers is even higher than the prevalence found in 
patients with clinical signs and history of tick bites in Belgium.5 Because high-risk populations were 
shown to have a significantly higher prevalence of A. phagocytophilum exposure,3,16,31 they may not 
reflect the true exposure of the general population of the same country.7 Therefore, a more 
representative sample including blood donors with more diverse social and intellectual levels, 
occupational and leisure activities would be a better sample to estimate the prevalence of                          
A. phagocytophilum exposure in Morocco. In addition, the high seroprevalence rates in blood donors of 
some geographic locations, the potential asymptomatic or subclinical evolution of the disease, the 
survival of A. phagocytophilum in refrigerated blood products and documented transfusion-transmitted 
HGA cases, provide further reasons to screen blood donors in Morocco. Although only a few cases of 
transfusion-transmitted anaplasmosis have been reported, A. phagocytophilum infection is among the 
TBDs that are considered to represent a potential risk for transmission by blood transfusion. In addition, 
because sharing blood products between different areas is growing, such an acute illness after blood 
transfusion should be included in the differential diagnosis even in nonendemic areas.2,37 Our results 
showed that even in the blood donor group, high prevalences of 35.7% and 21.7% at both the 1:64 and 
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1:128 dilutions, respectively, were recorded. When compared to European prevalences in blood donors 
using the same method and the same cutoffs, these results are higher than those published in Poland 
(2%),12 and Austria (9%),15 but they are similar to those from Greece (21.4%).18 Without taking into 
account the method and the cutoffs, the results from Moroccan blood donors are even higher than those 
from several US13,14 and European reports.10,11,16,17,19,33,38 In several reports that compared the 
seroreactivity rates of blood donors to those of high-risk populations, significant differences were 
found;10,16,17 these findings are in contrast to our report. These differences could be due to the relatively 
high proportion of the blood donors that report outdoor activities, which could then increase the possible 
exposure to ticks and thus predispose them to A. phagocytophilum infection. 
 
No risk factors were identified in this survey in either group. Similarly, some reports failed to 
identify specific demographic variables as potential risk factors.12,17,23,25,28 In contrast, other reports 
demonstrated that seropositivity rates were significantly higher in men,3,23,30 in age groups from 20 to 
403,23 and 40 to 65 years of age32 and the rates increased with age.29 Seropositivity rates among 
Moroccan blood donors were higher in men especially for the dilution of 1:128 and lower in the age 
group ≤20 year-old, although this was not statistically significant. No statistically significant 
associations between seroreactivity rates and the contact with animals or outdoor activities were found 
in this study. However, the chance of coming into contact with infected ticks depends on several 
epidemiological and ecological factors, such as the environment, the presence of appropriate hosts and 
reservoirs. Consequently, outdoor activities that are especially related to wooded areas, meadow habitats 
and grasslands are considered to be some of the major risk factors for acquiring TBDs.39 Moreover, a 
large number of participants to a study from Germany mentioned contracting their most recent tick bite 
in their gardens and half of the participants with past exposure to A. phagocytophilum listed gardening 
as a regular leisure activity; despite a comparatively low risk of exposure associated with this activity. 
Therefore, public health measures to increase awareness for TBDs should also target the large portion of 
the population who are involved in comparatively low risk outdoor activities such as gardening, cycling 
or walking.32 Although not statistically significant, a high proportion (74.8%) of the blood donors 
mentioned participating in outdoor activities. Consequently, the obvious popularity of outdoor activities 
may predispose a large number of people to the risk of infection by A. phagocytophilum. Only a small 
portion (3.6%) of the tested population had a history of tick exposure without any significant difference 
between both groups. Similarly, several surveys did not find any association between selfreported 
exposure to ticks and the seroreactivity rates of A. phagocytophilum.3,10,12,25,28,40 Moreover, a range of 
studies demonstrated seropositivity among the blood donors and the control populations without a 
specific history of a tick bite.32 Another report described the highest seropositivity among persons who 
denied having tick bites.25 A study investigating the risk of acquiring a tick-borne pathogen after a tick 
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bite failed to identify a significant difference between the group of persons bitten by ticks infected with 
A. phagocytophilum and the group bitten by uninfected ticks.40 The possible explanations for this 
oversight could be that the stage of feeding ticks as nymphs and larvae may not be detectable because of 
their small size or that the capacity of ticks to modulate host immune and inflammatory responses may 
also decrease the chance of detection.12,28 Further, several persons from the blood donor group that were 
questioned about previous contact with ticks were not familiar with these parasites. Therefore,                  
A. phagocytophilum infection should not be ruled out in the absence of self-reported previous tick 
exposure.4 
 
Most of the epidemiological surveys about A. phagocytophilum have used only the indirect IFA or 
the enzyme linked immunosorbent assay (ELISA). Either technique used alone with the standard cutoffs 
may overestimate the prevalence of antibodies.28,40 The World Health Organization guidelines set the 
cutoff at the 98th percentile i.e., at 1:128, to fulfil the requirements for seroepidemiological studies. This 
cutoff should reduce the overestimation of the seroprevalence and therefore provide reliable information 
with regard to previous infections.15,18 The overestimation of the seroreactivity with IFA testing might 
be due to false-positive results secondary to potential cross-reactions.40 These results can be observed 
with several other vector-borne pathogens including tick-borne encephalitis virus (6.7%),             
Rickettsia conorii (8%), Coxiella burnetii (10%), Borrelia burgdorferi (16.7%) and Bartonella quintana 
(70%).5 The Epstein-Barr virus infection, autoimmune disorders and Ehrlichia species may also induce 
cross-reactivity.3,15,33,40 However, two studies have failed to demonstrate an increased reactivity to                    
A. phagocytophilum in samples that were seropositive to Epstein-Barr virus, cytomegalovirus, 
parvovirus B19, Toxoplasma gondii, Borrelia burgdorferi sensu lato, Coxiella burnettii,               
Rickettsia conorii and E. chaffeensis.15,21 Moreover, IFA based on HL60-cells infected with a human 
isolate of A. phagocytophilum are considered to be both sensitive15 and highly specific for the 
investigation of seroreactivity.5 According to the manufacturer, the specificity of this test reaches 100%, 
and the sensitivity depends on the period between the moment of sampling and the beginning of the 
clinical signs, which ranges from 66.7% to 100%. 
 
Clinical data were not recorded in our study; thus it is unknown whether the subjects who were 
seropositive to A. phagocytophilum experienced any clinical signs before the date of sampling. Although 
one previous report has found a positive association between fever in the last two years and a high 
seroprevalence of A. phagocytophilum,3 all or almost all seropositive persons denied any clinical 
symptoms of HGA in several epidemiological surveys especially in Europe,18,25 suggesting that a high 
proportion of the infections could be subclinical.31 Other possible reasons for the discrepancy between a 
high seroprevalence and a low incidence of the disease include underdiagnosis or misdiagnosis due to 
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the unawareness of physicians, the circulation of variants that are non-pathogenic for humans, which 
may cause only transient infections without the relevant clinical signs and the potential serologic cross-
reactivity with other bacteria.32,40 Despite a low incidence rate and because the severity of the disease is 
closely linked to delayed diagnosis and treatment, some authors have emphasized the importance of 
clinicians awareness to promptly diagnose this infection especially in high-risk areas and even in 
persons without a self-reported history of a tick bite.28 At least, A. phagocytophilum should be 
considered in the differential diagnosis of flu-like syndromes, febrile patients especially from high-risk 
areas, febrile illness of unknown etiology or in those who are not responding to beta-lactam antibiotics 
or macrolides.16,20,21 Only one serum sample was performed for each participant; samples were not 
paired and IgM were not measured. Therefore, it was not possible to estimate the incidence of 
seroconversion and evaluate a potential acute exposure.28 IgM antibodies are detectable during the first 
40 days after infection and IgG seroconversion occurs approximately 20-40 days after the onset of 
symptoms and persists for several months to years post infection. Therefore, with a single positive IgG 
titer, it is not possible to distinguish between current and past exposure to A. phagocytophilum.35 In 
addition, serological testing close to the onset of symptoms is usually negative.4,6,32 However, IgM 
testing is reported to be less sensitive than IgG detection, even during early stages of infection.4 
Sampling took place only in two cities of Morocco and subjects‘ deployment histories were unavailable 
in the dog handler group. Therefore, no valuable data were available on human exposure in other 
regions of the country or the distribution or the presence of specific foci within some regions. A more 
comprehensive and representative study should be conducted to better estimate the prevalence of this 
bacterium in Morocco. 
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Conclusion 
 
To the author‘s knowledge, this study is the first evidence of human exposure to                             
A. phagocytophilum or to an antigenically similar bacterium in Morocco. The very high prevalence rate 
found in both high-risk populations and blood donors indicated the necessity for large-scale serologic 
surveys to better estimate the prevalence of this bacterium in Morocco. We hope that this study can 
serve as an indicator to Moroccan physicians that A. phagocytophilum infection is present and that this 
will help raise awareness of the potential occurrence of TBDs. Further studies especially those based on 
the isolation of the causative agent from patients with clinical signs compatible with HGA are warranted 
to clearly confirm the presence of the bacterium and to assess its role in causing disease in Morocco. 
Investigations of the epidemiology and the ecology of the bacterium in Morocco are also needed. 
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1. Prevalence of vector-borne pathogens exposure in dogs in Morocco 
 
Our study demonstrates that dogs in Morocco are frequently exposed to Anaplasma spp. (21.9%), 
Ehrlichia spp. (34.6%) and D. immitis (16.1%). In addition, this study reported A. platys infection in 
dogs for the first time in Morocco with a prevalence of 7.5%. Before this survey, only a few and sparse 
data were available on VBPs in dogs in Morocco, other than Leishmania spp., and none on TBPs. Only 
one previous report described canine infection with D. immitis in a small number of stray and rural dogs 
from the region of Rabat1 and all previous studies on Anaplasmataceae tick-borne pathogens were 
conducted mainly on ticks.2-4 Although a few studies demonstrated the occurrence of                                      
A. phagocytophilum, A. platys, B. burgdorferi, and E. canis in African countries close to Morocco,5-8 
VBPs often have geographical variations in their ecology and prevalence due to differences in host and 
vector distribution, and to biotic and abiotic influences on the ecology.9 Although differences in 
diagnostic methods and studied populations might have an impact on differences found between our 
study and the results in Algerian dogs,7 geographical variation in ecological factors are also important to 
consider. These variations can also influence the spatial distribution and prevalence between regions 
within a given country.9,10 Indeed, we demonstrated that rural dogs, especially from the central northern 
region of Morocco are exposed more frequently to Ehrlichia spp. and D. immitis while working dogs 
living in kennels from Benslimane and Témara were infected more frequently with A. platys. In addition 
to these geographic variations other important factors such as living conditions of dogs influence the 
prevalence of canine VBPs. Outdoor living has been considered the major risk factor for acquiring a 
vector-borne infection in dogs11-13 and several studies showed that rural, stray, hunting, shelter and 
working dogs are more exposed to these infections.7,10-12,14-23 In addition, kennel dogs can be more 
frequently exposed to some TBPs such as E. canis and B. canis,6,12 probably due to the particular life 
cycle of its tick vector tick R. sanguineus, also strongly suspected to transmit A. platys.24 Finally, when 
dogs live in close contact to humans, there is an increased risk of transmission of some zoonotic 
pathogens. The occurrence of occult infections and coinfections with zoonotic organisms in clinically 
healthy dogs and humans might result in a complex disease expression in sick dogs and humans.25-27 
 
In addition to the occurrence of single exposure to several VBPs, our study demonstrates the 
existence of frequent co-exposure (16.6%) among the canine populations studied. Dogs can be 
simultaneously or sequentially infected with a large number of VBPs depending on the presence and 
abundance of arthropod vectors.28 Co-infection by multiple VBPs appears to be more frequent in dogs 
living in endemic areas and particularly in environments in which the vector population density is 
high.28-30 Exposure to multiple VBPs has been detected in several serological surveys worldwide with 
prevalence rates of co-exposure up to 61%.5,7,12,31-35 In the Mediterranean region including North Africa, 
Chapter VI General discussion 
 151 
other VBPs than those detected in our study have been reported to infect dogs including             
Leishmania spp., Bartonella spp., Rickettsia spp., Babesia spp. and Hepatozoon canis. Co-infection with 
these VBPs and Anaplasma spp., Ehrichia spp. or D. immitis have also been described.14,15,32,33,36-40 
Considering that co-infections complicate the pathophysiology, clinical manifestations, outcome, 
diagnosis and management of VBDs,41,42 the identification of the pathogens circulating in a canine 
population within a specific area is necessary. In addition, specific diagnostic tools are necessary to help 
veterinarians in the achievement of an accurate diagnosis and to adapt the management of these 
diseases. Furthermore, long-term antibody persistence of some select VBPs detected in our study 
(Anaplasama spp., Ehrlichia spp.) contributes to the challenges of co-exposure interpretation.33,35 
Moreover, the complex interactions occurring between the host immune system and single pathogens 
can be modified by simultaneous or sequential infections with multiple pathogens, which may influence 
the serological and parasitological diagnosis. Indeed, experimental infection with A. platys and E. canis 
can alter the anticipated serological response in dogs that were co-infected or sequentially infected 
compared to that of those infected with a single organism.43 In light of the detrimental clinical impact 
associated with VBD co-infections, further characterization of co-exposure epidemiology would benefit 
both animals and humans.35  
 
The frequency of exposure to single and multiple VBPs in Moroccan dogs highlight the 
importance of adapted diagnostic tools to identify the organism(s) involved in these infections. In 
Morocco, no laboratory is currently interested in the preparation of diagnostic tests for these pathogens 
and serological and molecular diagnostic tools for Anaplasma spp., Ehrlichia spp. and D. immitis are 
lacking. The only available diagnostic tools in some veterinary practices are the cytological diagnosis 
based on blood smear evaluation and in-clinic serological tests. Consequently, empirical treatments are 
frequently given to dogs clinically suspected to have Anaplasma spp. or Ehrlichia spp. infections in 
Morocco, without considering the possibility of co-infections with other VBPs such as D. immitis. 
Noteworthy, the most frequent co-exposure detected in our study is between Ehrlichia spp. and               
D. immtis (7.8%). It has been suggested that the high tick infestation and the subsequent high prevalence 
of E. canis,44 prompt local veterinary practitioners the indiscriminate use of tetracycline to treat the 
suspected Ehrlichia infection. However, tetracycline therapy may contribute to the reduction of adult 
worms and its reproduction capability by destroying a filarial endosymbiont Wolbachia spp., which 
could lead to false negative serological results using the SNAP 4DX Plus.45,46 The diagnosis of canine 
VBDs is challenging for veterinarians because clinical signs induced by various VBPs may be similar, 
asymptomatic or subclinical infections are frequent and because co-infections may lead to overlapping 
or atypical clinical signs.25-27,47,48 Moreover, direct visualization of A. platys, A. phagocytophilum, and 
E. canis on blood smears examination of acutely infected dogs might be time-consuming, technically 
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challenging, and diagnostically insensitive due to the low-level and transient parasitemia27 and its 
sensitivity is lower than molecular-based diagnostic tools.33,49 Serological tests can be very easy to 
perform due to the development of in-clinic devices. However, they have two main limitations, i.e, the 
cross-reactions between closely related bacteria such as Anaplasma species and Ehrlichia species, and 
the inability to discriminate active infection from prior exposure especially in endemic areas.27,33,50,51 
For D. immitis, blood sample examination for the presence of microfilariae and identification based on 
morphology is considered definitive proof of infection. However, this method is based on the training of 
the persons examining the blood smear to differentiate D. immitis microfilariae from other species 
(Dirofilaria repens, Acanthocheilonema spp.). Also, up to 30% of infected dogs do not have circulating 
microfilariae even though they harbor adult worm. Therefore, the sensitivity of testing for microfilariae 
is not sufficient to rule out infection in the case of a negative result.52 The in-clinic tests designed to 
detect adult heartworm antigens based on ELISA and immunochromatography/lateral flow staining 
techniques are considered highly specific, but since these tests allow for detection of antigens produced 
only by female worms, false negative results may occur in infections of less than 5 months duration or 
very light infections or when only male worms are present.52 Consequently, the diagnostic confirmation 
of canine VBDs should take into consideration the historical exposure to arthropod vectors, compatible 
clinical signs and physical examination findings, biochemistry and hematological abnormalities, and the 
combination of multiple diagnostic modalities including cytological, serological, and molecular 
tests.27,33,41,52 Considering the very limited diagnostic tools available in Morocco, the risk of 
misdiagnosis might be increased and probably leads to an overuse of tetracycline in dogs clinically 
suspected to have a VBD, which can impact the serological diagnosis of D. immitis infection in dogs. 
Therefore, negative serological results to D. immitis should be interpreted with caution and possible 
underestimation of the true prevalence of D. immitis can occur.  
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2. Prevalence of Anaplasma spp. in dogs in Morocco 
 
Although seroprevalence of Anaplasma spp. antibodies in dogs was high (21.9%), only 7.5% of 
dogs tested positive to A. platys by PCR and none tested positive to A. phagocytophilum. The 
discrepancy between the high seroprevalence and the moderate A. platys DNA detection could be due to 
several factors including the cyclic bacteremia associated with this bacterium or DNA degradation in 
some samples due to transport conditions. Indeed, in experimental A. platys infections, morulae appear 
8-17 days after inoculation with maximal parasitemia occurring during the initial parasitemic episode 
about 4 days after the first appearance of morulae and then becoming cyclic at approximately 10-14 day 
intervals.53-56 The percentage of platelets containing morulae decreases to as low as 1% or less with 
subsequent parasitemic episodes, making detection of morulae more difficult.53,57 Finally, the cyclic 
nature of the parasitemias diminishes with time, resulting in mild, slowly resolving thrombocytopenia in 
association with sporadically occurring organisms in blood platelets. Therefore, although appropriately 
performed PCR-based assays are the most sensitive assays available to diagnose A. platys infection, 
false-negative test results can occur even in acute infections due to the evolution of A. platys 
bacteremia.24,58 It is hence possible that some dogs sampled in our study had A. platys infection below 
the detection limits of the method used or were in a phase without bacteremia. Another explanation is a 
resolved infection with only persisting antibodies as a result of previous exposures. 
 
The discrepancy between the high seroprevalence and the moderate A. platys infection could also 
be explained by the circulation of other Anaplasma spp. such as A. phagocytophilum in the sampled 
dogs which has not been detected by PCR but could be responsible of an immunological response. This 
hypothesis could be supported by the fact that other studies form the Mediterranean area found very 
high prevalence rates up to 57.7% of A. platys DNA in dogs.39 Anaplasma platys was thought to be the 
main Anaplasma species in some regions such as South America and Africa. However, studies detected 
A. phagocytophilum DNA in Mediterranean, African and South American countries.5,17,59-67 Moreover, 
the geographic distributions of both bacteria can overlap in some regions of the world since a few  
reports evaluated the occurrence of both bacteria in the same country and detected their DNA.5,59,63-65 
The PCR method used in our study based on the detection of A. phagocytophilum msp2 gene using a 
real-time quantitative PCR (TaqMan-PCR) is reported to be highly specific and sensitive68 and 
succeeded in detecting A. phagocytophilum DNA in regions where other protocols (mainly based on 
conventional PCR targeting the 16S rRNA gene) failed to detect it.61,62,69-70 The use of the msp2 gene 
target improves the specificity because it is not present in some more distantly related bacteria such as 
Ehrlichia spp. or Bartonella spp., and due to a lower risk of contamination.69,71,72 The greater analytical 
sensitivity of the msp2 assay occurred because of TaqMan‘s more efficient amplification chemistry.     
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In addition, this method was designed to amplify the msp2 gene over a wide variety of                           
A. phagocytophilum strains from varying locations.68 However, although the PCR protocol used in our 
study is reported to be highly sensitive, false-negative results are reported to occur with molecular-based 
diagnosis of A. phagocytophilum due to the low template concentrations,50,73 the short duration of 
bacteremia in dogs and the variation in levels of circulating bacteria.50,74 Therefore, even when using 
assays with well-documented sensitivity, clinical specimens from known positive dogs may test 
negative, particularly when collected at a single time point.50 Moreover, several studies demonstrated a 
higher prevalence of A. phagocytophilum DNA in clinically ill dogs than in apparently healthy 
ones,30,59,75-77 suggesting an association between positive PCR results and clinical illness.74 Since DNA-
based diagnostic tool enables the early detection of the infection by A. phagocytophilum, the bacteremia 
is of short duration and is usually present transiently during the acute phase of the infection,74,78,79 
negative PCR results might be more difficult to interpret in healthy dogs which is probably the case in 
our study. On the other hand, selective amplification of the predominant organism can occur in patients 
co-infected with genetically similar organisms73,80 such as A. phagocytophilum and A. platys, which 
could be the case in our study. A recent study on Anaplasmataceae experimental infection in dogs 
demonstrated that under the same experimental conditions and using the same PCR protocol, A. platys 
was more frequently detected on blood by PCR (92%) than was A. phagocytophilum (50%).56 Therefore, 
negative PCR results only indicate that the respective nucleic acid sequence was not detected in the 
sample evaluated under the assay conditions used and should not be interpreted as evidence of absence 
of infection.50 Other factors could also explain the negative A. phagocytophilum-PCR result mainly the 
likely degradation of the DNA due to the transport conditions from Morocco to the USA, the circulation 
of A. phagocytophilum strains not detected by the protocol used and the selected region of sampling. 
The dogs included in our study were sampled exclusively from the western part of Morocco but 
previous studies detected I. ricinu ticks, the main vector of both A. phagocytophilum and B. burdgorferi 
in Europe,81 in the eastern regions of Morocco.2-4 In addition, Borrelia burgdorferi, that is transmitted 
by Ixodes spp. ticks, was reported in dogs in Algeria7 and ticks in Northeastern Morocco,2 suggesting 
that these ticks could be more prevalent in eastern regions of the country.  
 
Although a higher prevalence of A. platys infection was recorded in working dogs living in 
kennels, no risk factor associated with this infection in dogs was identified. Other studies on A. platys 
infection in dogs demonstrated an association with ticks infestation, especially with R. sanguineus.36,48,82 
It has been suggested that the prevalence of A. platys could be influenced by the structure of the tick 
community and especially by the abundance of R. sanguineus probably because of the short duration of 
the bacteremia.43 In a recent study, low prevalence of R. sanguineus was associated with the detection of 
A. platys in other Rhipicephalus spp. in Kenyan islands.82 We also did not found any significant 
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difference between dogs with clinical signs compatible with TBDs and those apparently healthy. In 
another study, A. platys-positive dogs were mostly apparently healthy and displayed only occasional 
laboratory abnormalities.83 It has been suggested that more pathogenic strains than those found in the 
USA are circulating in the Mediterranean region, responsible of more severe clinical signs including 
lethargy, fever, anorexia, lymphadenomegaly, splenomegaly, abdominal pain, bleeding disorders, 
purulent nasal discharges more frequent mortality and possible decreased response to doxycycline 
therapy. Co-infections with other VBPs or intrinsic factors specific to each dogs (age, physical 
condition, immune status, or stress) may contribute to a more severe expression of the disease.40,84-93 
However, a recent study on naturally infected dogs in the Mediterranean region did not find any 
significant differences regarding the clinical expression of A. platys between mono- and co-infected 
dogs suggesting that strains virulence and/or other factors (concurrent diseases, genetic factors, immune 
status, physical condition, stress) could be involved in the more sever clinical expression. Putative 
immune-mediated processes such as immune-mediated hemolytic anemia or thrombocytopenia might 
explain the severity of some cases, especially the dogs that died or did not improve despite appropriate 
medication.40 Therefore, ICCT should be considered in the differential diagnosis of dogs displaying 
clinical signs compatible with those aforementioned in Morocco, and co-infections as well as immune-
mediated processes should be suspected in treatment cases. 
 
3. Rhipicephalus sanguineus ticks and their epidemiological significance 
 
Rhipicephalus sanguineus, commonly called the brown dog tick or kennel tick, is probably the 
most widely distributed tick species. It is also the most common tick found in the Mediterranean 
region.94,95 This tick has been introduced from the Afrotropical Region to many countries in the world, 
probably by the importation of infested domestic dogs, its preferred host.96,97 For dogs, the brown dog 
tick can produce debilitating effects due to both blood loss and the transmission of infectious agents.96 
More recently, a report described suspected paralysis associated with these tick bites in dogs.98                
Rhipicephalus sanguineus is known as a competent vector of several pathogens including            
Rickettsia spp., Babesia canis, Hepatozoon canis and E. canis, is suspected to transmit Bartonella spp., 
Mycoplasma haemocanis and A. platys42,98 and could be implicated in the epidemiology of canine 
visceral leishmaniasis.99-102 In addition, several other TBPs known to be transmitted by Ixodes spp. ticks 
where detected in R. sanguineus including A. phagocytophilum and Borrelia spp.62,95,103-105 Several 
Rhipicephalus species including R. sanguineus were infected by A. phagocytophilum and were 
suggested as potential competent vectors of this bacterium in the Mediterranean area.106-111 A report 
from Jordan detected high prevalence of A. phagocytophilum infection in stray dogs and R. sanguineus 
was the most abundant species parasitizing these dogs (95.1%) whereas no Ixodes spp. were detected.17 
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Although A. phagocytophilum DNA is increasingly reported from R. sanguineus ticks, it remains to 
establish if they play a role in the transmission of this pathogen to humans and other animals.104 
Morphological and molecular data indicated that R. sanguineus represents a complex of species and at 
least four different taxa have been identified under the name R. sanguineus.112-117 Therefore, the 
potential genetic diversity among R. sanguineus species could also influence its vectorial competence in 
some geographic regions, but more studies are needed to elucidate this issue.116 
 
 In tropical and subtropical regions, R. sanguineus ticks have the particularity to be active 
throughout the year and to achieve two or more generations per year. Warm temperature may contribute 
to increased tick abundance by a more rapid development.118,119 R. sanguineus is a nidiculous tick that 
can complete its entire life cycle either indoor (in houses, kennels and veterinary hospitals where it 
readily colonizes the infrastructure) or in outdoor environments (peri-urban and rural).6,96,120,121 
Rhipicephalus sanguineus populations can reach very high numbers in sheltered environments, because 
the blood supply necessary for their development is guaranteed by the presence of hosts in close 
proximity. In dogs without appropriate protection, parasitic loads can reach hundreds of ticks per 
animal, with ticks in all developmental stages.122 Although R. sanguineus ticks usually feed on dogs, 
they can also feed in a wide variety of animals including humans.94-96,121 Due to the close relationship 
between dogs and humans, some ectoparasites of domestic dogs may parasitize people. This parasitism, 
though unusual, might be responsible for a simple skin lesion or for the transmission of infectious 
agents.96,123 However, several reports described human parasitism with R. sanguineus ticks, suggesting 
that it is more unfrequently reported than unusual and human infestation might be associated with a high 
level of environmental infestation.95,96,123-135 Surveys investigating tick infestation in human from 
southern Europe and southern America found that R. sanguineus was amongst the most frequently 
retrieved tick species,95,123,133,134 especially in urban areas.134 One report describing four cases of human 
parasitism with R. sanguineus found several ticks in the house of the patients mainly on the sofa and the 
wall.96 Therefore, people living or in daily contact with highly parasitized dogs might be included in the 
group at risk for parasitism by R. sanguineus. Veterinarians and veterinary employee are also included 
in this group, because of close contact with infested dogs.96,118 TBDs are recognized as an emerging 
public health problem in many countries and R. sanguineus has been linked to some of these diseases, 
such as boutonneuse fever caused by Rickettsia conorii.94,96,136 In Europe and the USA, most cases of 
boutonneuse fever are registered during summer, when R. sanguineus ticks are highly active.136 
Similarly, human parasitism by R. sanguineus ticks in the USA has been reported to occur 
predominantly during the summer and fall126,127 In Morocco, cases of R. conorii infection have been 
reported.137-139 It has been found that the human affinity of R. sanguineus was increased in warmer 
temperatures, and that there is a warming-mediated increase in the aggressiveness of R. sanguineus, 
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leading to increased human attacks, and more pathogens transmitted by the brown dog tick may emerge 
in the future as a result of globalization and global warming.140 This could explain the report of E. canis 
and A. platys human infections,73,120,141-145 and emphasizes the importance of R. sanguineus. Therefore, 
due to its high degree of adaptability, R. sanguineus represents a major threat not only to dogs, but also 
to humans. Consequently, as R. sanguineus infestation in dogs was frequent in our study, further 
investigation should be carried out to better understand the ecology and biology of R. sanguineus in 
Morocco and to assess its public health importance and its ability in transmitting TBPs. 
 
4. Prevalence of Anaplasma phagocytophilum exposure in healthy humans in Morocco 
 
This survey is the first to report human exposure to A. phagocytophilum in Morocco and in Africa 
more generally. Our study detected relatively high prevalence rates in both the high risk population 
composed by military and gendarmerie dog handlers and in blood donors with 27.5% and 21.7% of 
seropositivity, respectively at the dilution recommended by the WHO (1:128).146 Our results are quite 
similar to those found in endemic areas of the USA and Europe.147-149 In addition, 6 out of 10 dog 
owners were also seropositive to A. phagocytophilum IgG at the same dilution. In Morocco, sparse 
published surveys are available on TBPs mainly on ticks and domestic animals.2-4,150-157 Although the 
tick population is abundant in Morocco and several TBPs of medical importance have been detected, 
only very few studies on human cases or human exposure are currently available. Meskini et al., 
reported in 1995 the prevalence of Rickettsi conorii, R. typhy and Coxiella burnetti in two cities of 
Morocco with rates of 5.6% to 7%, 1.7% to 4% and 1% to 18.3%, respectively; but they failed to detect 
Ehrlichia chaffeensis.158 Another survey found that 20.5% of patient displaying fever of unknown 
etiology in northwestern Morocco had tick-borne relapsing fever caused by Borrelia hispanica 
confirmed by PCR.159 Cases of human rickettsiosis caused by R. conorii or R. aeschlimannii have also 
been reported from Moroccan people living in Morocco or in Europe after a stay in Morocco.137-139,160 
The incidence of zoonotic TBDs (anaplasmosis, borreliosis, babesiosis, rickettsiosis) is increasing 
worldwide. These infections may be associated with both domestic and wild animals with a high risk of 
acquiring infections for humans frequenting tick-infested areas such as forests, meadow habitats and 
grassland.95,161-163 Indeed, the distributions of ticks and thus the risk of pathogen transmission to humans 
is closely related to the type of environment, often depending on local tick feeding habits and the 
distribution and density of small-mammal species that act as competent pathogen reservoirs.28,94,95 Some 
TBPs such as A. phagocytophilum, are more likely related to wild animals as this bacterium is mostly 
maintained in enzootic cycles involving ticks and wildlife fauna.164 Dogs and humans are mostly 
considered as incidental hosts and become infected with A. phagocytophilum when they come in contact 
with the vector in host reservoir habitat.165 Ixodes ricinus the main competent vector of this bacterium in 
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Europe is an hygrophilous tick species adapted to cool weather that has a high affiliation with wooded 
areas and pastures.81,94,133,166 In our study, no Ixodes spp. ticks were found infesting dogs in contact with 
seropositive humans and dogs were exclusively parasitized by R. sanguineus. Discrepancies between 
distributions of Ixodes tick species and the pathogens they transmit are reported to occur and are not 
well understood but may be related to habitat needs, feeding behavior and host-reservoir dynamics.28 
Although dogs were mostly infested by R. sanguineus ticks, patients included in this survey could have 
been previously in contact with other tick species during their outdoor occupational or leisure activities 
since a high proportion of the blood donors (74.8%) and dog owners (7/10) mentioned having outdoor 
activities, and dogs handlers are regularly involved in outdoor working. Therefore, the obvious 
popularity of outdoor activities in the sampled population may have increased the risk of exposure to           
A. phagocytophilum. It has been reported that the kind of activity especially related to outdoor is a 
conditioning factor for human parasitism by ticks.123 Indeed, people working or living in rural 
environments and in forest areas, hunters, national parks rangers and military personnel167-174 are 
considered high-risk populations for acquiring A. phagocytophilum infection. However, staying indoor 
is not a warranty of absence of risk for tick infestation.96,123 A large number of participants to a study 
from Germany mentioned contracting their most recent tick bite in their gardens and half of the 
participants with past exposure to A. phagocytophilum listed gardening as a regular leisure activity; 
despite a comparatively low risk of exposure associated with this activity. Additionnally, only a small 
portion (3.6%) of the tested population had a history of tick exposure. Similarly, several surveys did not 
find any association between self-reported exposure to ticks and the seroreactivity rates of                     
A. phagocytophilum phagocytophilum175-180 and others demonstrated seropositivity to                            
A. phagocytophilum without a history of tick bite.174 Another report described the highest seropositivity 
rate to A. phagocytophilum among persons who denied having tick bites while the lowest rate was 
observed in persons who were frequently bitten, probably because the latter are used to checking their 
body for attached ticks, which may reduce the risk of A. phagocytophilum transmission.178 Several 
factors can explain this oversight including the stage of feeding ticks and the capacity of ticks to 
modulate host immune and inflammatory responses, thats may also decrease the chance of detection. 
Indeed, nymphs and larvae may not be detectable because of their small size.130,176,177,181 In some studies, 
nymphal stages of ticks were the predominant stage parasitizing humans, complicating their detection 
and increasing the risk of pathogens transmission.95,130,182 The site of attachment on the body can also 
make the tick detection difficult.96,181 Furthermore, several persons from the blood donor group that 
were questioned about previous contact with ticks were not familiar with these parasites and were not 
able to identify a tick. Ticks can also be confounded with other arthropod parasites such as lice.123  
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Our results showed that even in the blood donor group, high prevalences of 35.7% and 21.7% at 
the 1:64 and 1:128 dilutions were recorded, respectively. When compared to European prevalences in 
blood donors using the same method and the same cutoffs, these results are higher than those published 
in Poland (2%),177 and Austria (9%),146 but they are similar to those from Greece (21.4%).183 Without 
taking into account the method and the cutoffs, the results from Moroccan blood donors are even higher 
than those from US and European reports.167,168,175,184-189 In several reports that compared the 
seroreactivity rates of blood donors to those of high-risk populations, significant differences were 
found;175,186,187 these findings are in contrast to our report. Therefore, our report highlights the potential 
importance of A. phagocytophilum infection in blood donors in Morocco. This infection can be 
subclinical or asymptomatic especially in endemic areas,190,191 increasing the risk of sampling infected 
blood donors. Indeed, it has been suggested that people at high risk for a tick bite have a higher 
proportion of asymptomatic anaplasmosis.192 In addition, A. phagocytophilum is able to survive in 
refrigerated blood products up to 18 days.193 Since this bacterium infects neutrophils, leukoreduction 
was thought to be able to avoid the risk of transmission through blood transfusion.194 However, this 
method did not successfully prevent the transmission of this bacterium in several cases suggesting that it 
is not efficient in eliminating the risk.191,195-198 Although transfusion-transmitted A. phagocytophilum 
infection seems to be rare, it is likely to be more severe than the infection acquired after a tick bite196 
probably due to the immune status of these patients and to the administration of immunosuppressive 
therapy.190,191 Considering the discrepancy between the seroprevalence and the reported cases in 
endemic areas, it has been hypothesized that transfusion-transmitted A. phagocytophilum infection 
might be unrecognized in the majority of cases owing to the low bacterial virulence that can be 
enhanced by immunosuppressive therapy.190,191,195 Because of the rarity of transfusion-associated cases 
reported even in endemic areas of the USA, concerns regarding the specificity of available tests, and the 
economic costs associated with implementation, the blood supply in the USA is not routinely screened 
for tick-borne disease using laboratory methods.190 Indeed, in endemic areas of the USA where 
seroprevalence is high, the chance of accepting a donor with subclinical infection is a less hazardous 
alternative than using serologic screening with a resultant dramatic reduction in blood supply. In 
addition, PCR testing of donors would be cost prohibitive and likely low yield. Deferring potential 
donors in disease-endemic areas during peak tick activity (April-September) would severely limit the 
blood supply with little potential gain.195 Furthermore, tick bite–specific screening questions have not 
proved useful, as donors usually do not remember a tick bite. Donors who do find a tick typically do so 
within the first 24 to 48 hours, before infective transmission is likely to have taken place; excluding 
these donors may limit donation by up to 9% in the USA endemic regions.190,199,200 Similarly, the report 
of outdoor activities in wooded habitat in an anaplasmosis endemic area is poorly predictive for possible 
infection.190 Therefore, in the absence of effective screening tools to identify infected donors or products 
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and since the incidence of anaplasmosis increases, physicians should suspect A. phagocytophilum 
infection when febrile illness associated with leukopenia or thrombocytopenia develops in a patient after 
transfusion. Such signs should lead to rapid assessment for rickettsial agents especially                          
A. phagocytophilum and empiric treatment with doxycycline.196,199  
  
5. Future perspectives 
 
This study demonstrates that Moroccan dogs are frequently exposed to Anaplasma spp.,  
Ehrlichia spp. and D. immtis and detected co-exposures. It has also shown that rural dogs with outdoor 
living and working dogs living in kennels are more exposed to Ehrlichia spp. and D. immitis, and 
infected by A. platys, respectively. In addition to the importance of adapted diagnostic tools lacking in 
Morocco, our study highlights the need for adapted ectoparasites and heartworm preventive programs in 
all dogs and especially in those with frequent access to outdoor or living in kennels. Several reports 
demonstrated that ectoparasites prevention is a protective factor against tick-borne infections such as     
E. canis and A. phagocytophilum6,12,14,37,201 or that tick infestation is a risk factor associated with higher 
prevalence rates.10,49,62,82,202 Therefore, veterinarians should pay attention to the living conditions of dogs 
to prescribe the more adapted preventive treatment. Such as the lack of some important diagnostic 
modalities in Morocco, only a very few ectoparasites preventive treatments are available. Finally, 
because VBPs can have serious outcome for both canine and human health, dogs can serve as effective 
sentinels and fluctuations in geographic distribution of vectors and reservoir hosts occur frequently, 
annual testing of dogs for VBPs exposure and identifying risk factors associated with these infection are 
crucial.203 Improved understanding of the geographic distribution, prevalence and risk factors of VBPs 
and co-exposure in Morocco can facilitate prompt disease diagnosis and effective animal and public 
health interventions.34,35,204 
 
Our study has shown that dogs are infected by A. platys but failed to detect A. phagocytophilum.  
The discrepancy between the high seroprevalence to Anaplasma spp. and the A. platys-positive results 
by PCR and the lack of specificity of serological tests at the species level could suggest that some of the 
dogs sampled in this study were exposed to other Anaplasma spp. such as A. phagocytophilum. Further 
studies are therefore necessary to evaluate the presence of the later in Morocco. As I. ricinus, the most 
common vector of A. phagocytophilum in Europe has been detected in the northeastern of Morocco,2-4 
future surveys must include dogs from this part of the country. Our study was limited to four cities of 
northwestern Morocco. However, ecological variations between regions of a country can impact the tick 
populations and thus the associated pathogens that can be transmitted.9,10 Therefore, large-scale 
epidemiological surveys are needed to assess the risk for dogs of acquiring A. phagocytophilum and     
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A. platys in each region of the country. Since serological tests cannot discriminate between past 
exposure and present infection, are unable to identify the Anaplasma pathogen at the species level and 
false negative results can occur with PCR,50,74,78,79 the combination of both methods is necessary.   
 
The dogs sampled were exclusively parasitized by R. sanguineus. This tick species is also known 
as competent vector of E. canis another Anaplasmataceae pathogen widely distributed and responsible 
for canine monocytic ehrlichiosis. The disease is unspecific and associated with life threatening 
complications such as glomerulonephritis, meningitis and potential cardiac injury.204-208 The SNAP 4DX 
Plus used to detect anti-Ehrlichia antibodies does not discriminate between E. canis, E. ewingii and      
E. chaffeensis.51 Ehrlichia chaffeensis and E. ewingii are the causative agents of two tick-borne zoonosis 
called human monocytis and granulocytic ehrlichiosis, respectively.209,210 In Africa, these two bacteria 
are poorly investigated but their DNA has been detected in some tick species including R. sanguineus 
and canine exposure has been reported.3,211-213 However, these two pathogens and their respective 
diseases have been described almost exclusively in some regions of the USA where              
Amblyomma americanum is the only proven competent vector.209,210,212 Therefore, the positivity rates 
obtained in our study are likely due to the presence of E. canis antibodies in the samples tested, 
especially because this bacterium is prevalent in Africa and the Mediterranean area5-7,12,19 and that        
R. sanguineus is its main vector. However, since both E. chaffeensis and E. ewingii are zoonotic and 
their DNA has been detected in R. sanguineus and dogs in Africa, molecular-based epidemiological 
surveys are needed to clarify which species are circulating in the canine population in Morocco. 
Rhipicephalus sanguineus ticks are competent vectors of other pathogens that can cause serious illness 
in dogs such as Babesia canis and Hepatozoon canis and others zoonotic ones such as R. conorii and 
Bartonella spp.33,42,94,98,124,214 In addition, one tick can be infected by and is able to transmit more than 
one pathogen to a host 28,215 and co-infections are reported to complicate both the diagnosis and the 
management of the disease.41,42 Therefore, prevalence data on these infections and co-infections are 
diagnostically and epidemiologically important for veterinarians and to evaluate the risk of exposure of 
humans in Morocco, respectively. Future studies should evaluate the occurrence and prevalence of all                     
R. sanguineus-transmitted pathogens in dogs in Morocco.      
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This study is the first to report human exposure to A. phagocytophilum in Africa with a high 
prevalence in dog handlers, owners and blood donors. Although we did not find any risk factor for the 
seropositivity, blood donors and dog owners frequently reported having outdoor activities. In addition, 
the occupational activity of dog handlers is frequently associated with outdoor working in divers 
environments. Anaplasma phagocytophilum infection has been frequently associated with outdoor 
activities especially related to wooded areas.94,124,162,163 Therefore, studies investigating the occurrence 
and the prevalence of this bacterium DNA in ticks in parks and forests of Morocco are important to 
evaluate the risk of exposure and to evaluate the potential vector range. Since our survey detected a high 
seroprevalence rate in blood donors without difference with the high risk population and higher than the 
seroprevalence recorded in blood donor in endemic areas of the USA,195 a large scale study of the 
prevalence of both exposure and infection with A. phagocytophilum in blood donors should be carried in 
Morocco to better assess the risk of transmission through blood transfusion. In the USA, human 
granulocytic anaplasmosis in known since several years and is a nationally notifiable disease suggesting 
that physician are more concerned about this disease.216,217 In contrast, Moroccan physicians are 
probably not familiar with this infection and its potential transmission through blood transfusion and 
hence, adapted screening tools to evaluate the contamination of blood supply are likely to be necessary. 
In addition, increasing physician awareness to promptly diagnose and treat cases of transfusion-
transmitted A. phagocytophilum is crucial. This study has been designed to evaluate the occurrence of 
human exposure in two cities of Morocco and a large-scale survey is needed to evaluate the occurrence 
and the prevalence of exposure at the national level. In addition, this study was based on the serological 
screening and thus is only indicative of previous exposure to A. phagocytophilum. Future surveys should 
associate the documentation of seroconversion or a four-fold increase in antibody titer and PCR 
screening to diagnose an active infection.149,176 Molecular-based analysis is also important to determine 
the strain (s) circulating in Morocco since not all are pathogenic for humans.164,218-221  
 
The dogs sampled in our study lived in close contact with dog handlers and owners also enrolled. 
Therefore, due to the close contact and the frequent infestation of these dogs by R. sanguineus, dog 
handlers and owners were at high risk of being infested by this tick species and thus of acquiring a         
R. sanguineus-transmitted pathogen such as R. conorii.96,118,140 Cases of R. conorii infection have 
already been reported in Morocco137-139 and might be underestimated. In addition although not 
considered zoonotic, E. canis and A. platys can also infect human.73,120,141,144,145 Hence, it is important to 
determine which pathogens infect R. sanguineus ticks in Morocco with a special emphasis on those that 
are zoonotic or able to infect both dogs and humans. Both the occurrence of R. sanguineus infested dogs 
and A. phagocytophilum exposure in humans suggests that people in this study have been exposed to at 
least two tick species, since A. phagocytophilum is mostly transmitted by Ixodes spp. ticks.28,81,205 
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Several studies on human parasitism by ticks have shown that the actual diversity of ticks potentially 
infesting humans is greater than previously believed and any case of human infestation by ticks should 
be regarded as of clinical significance.124 Therefore, surveys evaluating human parasitism by ticks and 
identifying the species and the associated pathogens are warranted. It could also be that R. sanguineus 
plays a role in the transmission of this bacterium in Morocco since the DNA of A. phagocytophilum has 
been detected in this tick species and that some authors suggested that this tick could be a competent 
vector in the Mediterranean area.106-111 However, the contact with dogs was not a risk factor                  
A. phagocytophilum seropositivity, which is not in favor of this hypothesis. Studies investigating the 
prevalence of A. phagocytophilum DNA using molecular tools in questing ticks and ticks feeding on 
dogs and humans are mandatory.  
 
Anaplasma platys was known to infect dogs exclusively, but recent reports described human 
infection.73,120,144 Since R. sanguineus is the most probable competent vector and our dogs were 
frequently infested by these ticks, we can therefore wonder if the persons included in our study can be 
infected by this bacterium? Indeed, all human cases of A. platys infection reported regular contact with 
dogs and/or infestation of their dogs with R. sanguineus.73,120,144  In addition, A. platys DNA sequencing 
in two human cases was identical to the sequence found in their dog.73 All published cases of A. platys 
infection in humans were diagnosed by DNA detection or microscopic identification of morulae within 
platelets.73,120,144 In addition, a previous report describing intra-platelet inclusions in humans failed to 
detect anti-A. platys antibodies.143 Therefore, the occurrence of an immunological response to this 
bacterium in humans is unknown. Moreover, to our knowledge, the possible occurrence of cross-
reactions between A. platys and A. phagocytophilum antibodies has not been evaluated in humans. The 
IFA based on HL60-cells infected with a human isolate of A. phagocytophilum, such as the one used in 
our study, are considered to be both sensitive146 and highly specific for the investigation of 
seroreactivity to this bacterium222 with a specificity of 100%, according to the manufacturer. In addition, 
the absence of relationship between the seropositivity to A. phagocytophilum and dogs in our study 
might be less in favor of an A. platys infection. A cross-reaction between antibodies against these two 
bacteria seems unlikely but we cannot exclude that some of the persons enrolled in our study have had 
an A. platys infection. Consequently, future studies should also investigate the occurrence of A. platys 
infection in humans in Morocco using molecular-based assays.  
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Our research work implicated the close collaboration between veterinarians, physicians, public 
health institutions and both humans and veterinary laboratories. Therefore, it is an application of the 
―One Health‖ approach. The ―One Health‖ approach as been defined by the American Veterinary 
Medicine Association as ―the collaborative effort of multiple disciplines working locally, nationally and 
globally to attain the optimal health for people, animals and environment‖.223 The ―One Health‖ 
movement has emerged in the mid of the 20th century due to the increased awareness of zoonotic 
diseases and embraces a cross-disciplinary, collaborative approach between veterinary and human 
medicine with clinicians, researchers, agencies and governments working together for the benefit of 
domestic and wild animal and human health and the global environment to address diseases of 
importance to both scientific communities. Such interactions may take place at many levels - from 
management of zoonotic infectious disease outbreaks in the field, to joint research programmes to 
integrated policy making and funding decisions.224,225,226,227 It was however, not until the past five years, 
that the One Health concept has truly gathered international momentum. More recently, the role of 
companion animals and the VBDs they share with humans have been conceptualized with a One Health 
approach.124,224,228 
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6. Conclusion of the thesis 
 
In this thesis, we investigated for the first time the exposure of dogs to selected vector-borne 
pathogens of veterinary and medical significance in Morocco. This first investigation enables us to 
demonstrate that dogs were frequently exposed to Anaplasma spp., Ehrlichia spp. and infected by           
D. immitis, with rural dogs at higher risk for Ehrlichia spp. and D. immitis exposure. This first 
investigation detected antibodies against Anaplasma and Ehrlichia genera without discrimination at the 
species level. Since A. phagocytophilum is an emerging zoonotic tick-borne pathogen increasingly 
recognized worldwide, with potential severe complications, transmitted through blood transfusion and 
detected in the Mediterranean area and some African countries, we focused on the genus Anaplasma.  
 
In the second part of this thesis, we investigated both the exposure to Anaplasma spp. and the 
infections with A. phagocytophilum and A. platys in a higher number of dogs sampled from three cities 
of northwestern Morocco. We confirmed that dogs are frequently seropositive to Anaplasma spp. 
without difference according to the living conditions. This study also demonstrates that dogs are 
infected by A. platys but failed to detect A. phagocytophilum DNA by PCR. In addition, the only tick 
species detected on these dogs was R. sanguineus, which is considered the most probable vector of          
A. platys. Although A. phagocytophilum DNA was not detected, this study cannot exclude the 
circulation of this bacterium in canine population and further investigations are warranted. In addition, 
dogs were sampled exclusively in the northwestern part of Morocco but I. ricinus ticks have been 
reported to occur in the northeastern regions. Future surveys should include dogs from the eastern part 
of the country. 
 
Considering the zoonotic aspect of A. phagocytophilum we also evaluated the human exposure to 
this bacterium in Morocco in the final part of this study. This investigation demonstrated a high 
seroprevalence in both the high-risk group of dog handlers and the blood donor group without 
significant difference between both groups. In addition, dog owners were also frequently exposed to this 
bacterium. Although this study failed to identify risk factors for human exposure to A. phagocytophilum 
in Morocco, a high proportion of the persons sampled reported regular outdoor occupational or leisure 
activities, which could have increased the risk of exposure to ticks. The seroprevalence rates obtained 
were similar than those from endemic areas of the USA and Europe. This study is the first to 
demonstrate human exposure to A. phagocytophilum in Africa and highlight its importance in Morocco 
due to its high seroprevalence.  
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This thesis investigated canine and human exposure to vector-borne pathogens focusing on             
A. phagocytophilum and A. platys. Although it has failed to detect the DNA of A. phagocytophilum in 
dogs, the discrepancy between the high seroprevalence to Anaplasma spp. antibodies and the moderate 
prevalence of A. platys DNA in those dogs suggests the possible exposure to other Anaplasma species. 
In addition, the high seroprevalence in humans supports the likely circulation of this bacterium in 
Morocco and should encourage investigation to better understand the epidemiology of this bacterium 
and its medical significance.  
 
Above all, this thesis highlights the importance of tick-borne infections in Morocco and the need 
for further surveys to identify the pathogens circulating in this country, and their veterinary and public 
health significance.   
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Zoonotic vector-borne diseases (VBDs) are of increasing interest because they constitute an 
important emerging threat to both canine and human health. Dogs can play an important 
epidemiological role in some zoonotic vector-borne pathogens (VBPs) as competent reservoir hosts, 
carriers of infected vectors in close contact to humans or effective sentinels to assess the risk for human 
infection. Due to the complexity of VBDs diagnosis and control, as well as the possibility of subclinical 
infection in dogs that increases the risk of disease transmission, epidemiological data aiming at 
improving knowledge within a region is fundamental. Anaplasma phagocytophilum, A. platys,    
Borrelia burgdorferi, Ehrlichia canis and Dirofilaria immitis are important canine VBPs; some of them 
are recognized as zoonotic while others are able to infect humans. Among all vectors, ticks are 
considered to transmit the widest number of pathogens when compared to other arthropod vectors. Some 
tick-borne pathogens (TBPs) are considered to be emerging because of several factors that play a crucial 
role in ticks multiplication and expansion, increasing the likelihood of humans and animal tick biting 
and pathogens transmission. Among these emerging TBPs of zoonotic relevance,                           
Anaplasma phagocytophilum is responsible of a widespread disease called granulocytic anaplasmosis. 
In the past decades, both human and animal exposure has continuously increased in the USA, Europe 
and some Asian countries. The disease in humans is potentially fatal with severe complications, high 
hospitalization rates and difficult diagnosis. Anaplasma phagocytophilum has been detected in Africa 
and the Mediterranean region. In these regions, A. platys is another Anaplasma species causing disease 
in dogs and able to infect humans. In Africa, only a few studies on A. phagocytophilum, A. platys,        
B. burgdorferi, E. canis and D. immitis exposure and/or infection in dogs are available and data on these 
infections is lacking in Morocco. Similarly, only very few studies on tick-borne diseases (TBDs) in 
humans in Morocco have been published and no data are currently available on human exposure to       
A. phagocytophilum.  
 
Chapter I explains the importance of VBDs worldwide and emphasizes on the factors that 
contribute to their expansion and increasing interest. This chapter focusses on TBDs and especially on 
A. phagocytophilum. This section also summarizes the most important epidemiological features of        
A. phagocytophilum and A. platys including transmission modes, host reservoir range, life cycle, genetic 
diversity, zoonotic potential, worldwide distribution and discusses the epidemiological roles of dogs. 
We conclude that due to the worldwide distribution of A. phagocytophilum and A. platys, these two 
bacteria might be present in the canine population in Morocco and humans could be exposed to            
A. phagocytophilum. This led us to the objective of this thesis stated in Chapter II: the evaluation of the 
occurrence of A. phagocytophilum in both dogs and humans and A. platys in dogs in Morocco.  
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At the start of this thesis, no data on canine exposure to Anaplasma spp., Ehrlichia spp. and 
Borrrelia burgdorferi in Morocco were available and only one published study reported     
Dirofilaria immitis infection in a small number of dogs. In Chapter III, we investigated the 
exposure to the four aforementioned VBPs in 217 dogs from seven Moroccan locations using a 
commercial in-clinic ELISA test. Of these dogs, 83.9% were positive for at least one pathogen and 
co-exposures were detected in up to 14.3% of the dogs. None of the dog tested seropositive to           
B. burgdorferi. In contrast, antibodies against Anaplasma spp. and Ehrlichia spp. and D. immitis 
antigens were frequently detected. Statistically significant differences in seropositivity rates were 
found for Ehrlichia spp. and D. immitis in rural dogs but not for Anaplasma spp. This first part of the 
thesis demonstrated that Moroccan dogs are at high risk of acquiring a vector-borne infection and 
detected Anaplasma spp. antibodies in the dogs sampled. Since the ELISA test used is not able to 
discriminate between A. phagocytophilum and A. platys, we decided to assess the canine infection 
with these two bacteria. 
 
In Chapter IV, we investigated the exposure to Anaplasma spp. and infection with                 
A. phagocytophilum and A. platys in a higher number of dogs (n = 425) from three cities of 
northwestern Morocco. Canine blood samples were screened for Anaplasma spp. antibodies by 
enzyme-linked immunosorbent assay (ELISA) and for A. phagocytophilum and A. platys DNA by a 
quantitative real-time polymerase chain reaction (RT-PCR) targeting the msp2 gene. The results 
confirmed that Anaplasma spp. antibodies were frequently detected in dogs. The DNA of A. platys 
was also amplified while no dog tested positive to A. phagocytophilum by PCR. Although the PCR 
protocol used is highly sensitive, false-negative results are reported to occur with                              
A. phagocytophilum PCR mainly due to the short duration of bacteremia and the variation in levels of 
circulating bacteria. Therefore, the negative A. phagocytophilum-PCR results only indicate that the 
respective nucleic acid sequence was not detected in the sample evaluated under the assay conditions 
used in our study and should not be interpreted as evidence of absence of infection in dogs in 
Morocco. Moreover, the discrepancy between the high seroprevalence to Anaplasma spp. antibodies 
and the moderate prevalence of A. platys DNA could suggest that the dogs sampled were potentially 
exposed to other Anaplasma species. Noteworthy, we collected ticks from some of the dogs included 
in this study. All ticks were identified as Rhipicephalus sanguineus, the most probable vector of      
A. platys. Unfortunately, screening of these ticks for A. phagocytophilum and A. platys DNA was not 
possible due to the degradation of the DNA. 
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Currently, no data are available on the occurrence of human exposure to A. phagocytophilum in 
Africa. In Chapter V, we evaluated the seropositivity to this bacterium in 271 healthy dog handlers, 
owners and blood donors from two cities of northwestern Morocco. Indirect immunofluorescent 
assay using a commercial kit was performed to detect specific A. phagocytophilum immunoglobulin 
G. Two dilutions were used to assess the prevalence of seroreactive samples. Seropositivity rates 
reached 37% and 27% in dog handlers and 36% and 22% in blood donors, without significant 
difference between both groups. In addition, 7 and 6 out of 10 owners were also seropositive at the 
first and second dilutions, respectively. No risk factor was identified but a high proportion of blood 
donors and dog owners reported regular outdoor activities and dog handlers were frequently involved 
in outdoor occupational activities. This investigation demonstrates that A. phagocytophilum exposure 
is common in both the high-risk group of dog handlers and blood donors in Morocco, and therefore 
emphasizes its public health importance.  
 
This study provides important knowledge on canine exposure to Anaplasma spp. and  
Ehrlichia spp., and on infection with A. platys and D. immitis in Morocco. In addition, it provides the 
first demonstration of human exposure to A. phagocytophilum in Morocco and Africa more 
generally. Our results showed that both dogs and humans in Morocco are frequently exposed to TBPs 
and emphasize the public health importance of these agents. Our study was designed to evaluate the 
occurrence of A. phagocytophilum and A. platys  in both dogs and humans in limited regions of the 
country. Large scale surveys are mandatory to evaluate the risk of exposure in all Moroccan regions. 
Future studies should evaluate the epidemiological aspects of A. phagocytophilum infection (i.e., 
vectors, reservoir hosts, genetic variability), the risk factors associated with this infection, the public 
health importance of transfusion-transmitted anaplasmosis and the ability of this bacterium in 
causing diseases in both dogs and humans in Morocco.    
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Er bestaat een toenemende belangstelling voor zoönotische vector overdraagbare ziekten omdat ze 
een belangrijke opkomende bedreiging vormen voor de gezondheid van zowel honden als mensen. 
Honden kunnen een belangrijke epidemiologische rol spelen bij sommige zoönotische vector 
overdraagbare ziekten als competente reservoir gastheren, dragers van geïnfecteerde vectoren dichtbij 
mensen of als effectieve schildwachten om het risico voor humane infecties in te schatten. Omwille van 
de complexiteit van de diagnose en controle van vector overdraagbare ziekten, en mede door de 
mogelijkheid dat subklinische infecties bij honden het risico op overdracht van deze ziekten kan doen 
verhogen, is het bekomen van epidemiologische data om de kennis binnen een streek te verhogen van 
fundamenteel belang. Anaplasma phagocytophilum, A. platys, Borrelia burgdorferi, Ehrlichia canis en 
Dirofilaria immitis zijn belangrijke vector overdraagbare pathogenen bij de hond; sommige van deze 
pathogenen zijn erkend als zoönosen, terwijl andere de mogelijkheid hebben om mensen te infecteren. 
Vergeleken met andere geleedpotige vectoren, kunnen teken de meeste pathogenen overdragen. 
Sommige teken overdraagbare pathogenen worden als opkomend beschouwd omwille van verschillende 
factoren die een cruciale rol spelen bij de vermenigvuldiging en uitbreiding van de tekenpopulatie, 
leidend tot een toename van de kans op overdracht van pathogenen naar mensen en dieren na een 
tekenbeet. Bij deze opkomende teken overdraagbare pathogenen van zoönotisch belang, is      
Anaplasma phagocytophilum verantwoordelijk voor een wijd verspreide ziekte genaamd granulocytaire 
anaplasmose. In de laatste decennia is de blootstelling aan deze infectieziekte bij mens en dier 
toegenomen in de Verenigde Staten van Amerika, Europa en sommige Aziatische landen. De ziekte is 
bij mensen mogelijk fataal met ernstige complicaties, een hoge graad van hospitalisatie en een moeilijke 
diagnose. Anaplasma phagocytophilum werd reeds gedetecteerd in Afrika en in het Middellandse 
Zeegebied. In deze regio‘s vormt A. platys een andere Anaplasma species die ziekte veroorzaakt bij 
honden en ook mensen kan infecteren. In Afrika zijn slechts enkele studies beschikbaar die de 
blootstelling aan en/of de infectie van honden met A. phagocytophilum, A. platys, B. burgdorferi,         
E. canis en D. immitis beschrijven. Informatie over deze infecties zijn afwezig in Marokko. Evenzeer 
zijn er slechts enkele studies over teken overdraagbare ziekten bij mensen in Marokko gepubliceerd, en 
is er momenteel geen informatie beschikbaar over humane blootstelling aan A. phagocytophilum.  
 
Hoofdstuk I handelt over het wereldwijde belang van vector overdraagbare ziekten en legt de 
nadruk op factoren die bijdragen aan hun uitbreiding en toenemend belang. Dit hoofdstuk spitst zich toe 
op teken overdraagbare ziekten en meer specifiek vooral op A. phagocytophilum. In dit hoofdstuk wordt 
ook een samenvatting gemaakt van de meest belangrijke epidemiologische kenmerken van                    
A. phagocytophilum en A. platys, onder andere de wijzen van overdracht, de mogelijke reservoir 
gastheren, de levenscyclus, de genetische diversiteit, het zoönotische potentieel, de wereldwijde 
distributie en wordt de epidemiologische rol van honden hierbij besproken. We concluderen dat, door de 
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wereldwijde distributie van A. phagocytophilum en A. platys, deze twee bacteriën mogelijk aanwezig 
zijn in de hondenpopulatie van Marokko, en dat mensen mogelijk blootgesteld worden aan                    
A. phagocytophilum. Dit leidde ons tot de doelstelling van deze thesis in Hoofdstuk II: de evaluatie van 
het voorkomen van A. phagocytophilum bij honden en mensen en van A. platys bij honden in Marokko. 
 
Bij de start van deze thesis was er geen informatie gekend over de blootstelling aan       
Anaplasma spp., Ehrlichia spp. en Borrrelia burgdorferi bij honden in Marokko, en slechts één 
gepubliceerde studie beschreef een infectie met Dirofilaria immitis bij een kleine groep van honden. In 
Hoofdstuk III onderzoeken we de blootstelling aan de vier hierboven genoemde vector overdraagbare 
pathogenen bij 217 honden op zeven verschillende locaties in Marokko met behulp van een 
commercieel beschikbare in-huis ELISA test. Van deze honden waren 83.9% positief voor minstens één 
pathogeen en werden meerdere blootstellingen tegelijk vastgesteld bij 14.3% van de honden. Geen 
enkele hond testte seropositief voor B. burgdorferi. Antistoffen tegenover Anaplasma spp. En   
Ehrlichia spp. en D. immitis antigenen werden daarentegen frequent gedetecteerd. Voor Ehrlichia spp. 
en D. immitis, maar niet voor Anaplasma spp., werden statistisch significante verschillen gevonden wat 
betreft de mate van seropositiviteit bij honden op het platteland. Dit eerste deel van de thesis toont aan 
dat Marokkaanse honden een hoog risico hebben om een vector overdraagbare infectie op te lopen, en 
ook werden antistoffen tegenover Anaplasma spp. gedetecteerd bij honden. Aangezien de gebruikte 
ELISA test geen onderscheid kan maken tussen A. phagocytophilum en A. platys, besloten we om de 
infectie met deze twee bacteriën bij honden verder te onderzoeken.  
 
In Hoofdstuk IV onderzoeken we de blootstelling aan Anaplasma spp. en de infectie met A. 
phagocytophilum en A. platys bij een groter aantal honden (n = 425) afkomstig uit drie steden in 
noordwestelijk Marokko. Bloedstalen van honden werden gescreend voor Anaplasma spp. antistoffen 
door middel van een enzyme-linked immunosorbent assay (ELISA), en voor A. phagocytophilum en A. 
platys DNA door middel van een real-time polymerase chain reaction (RT-PCR) van het msp2 gen. De 
resultaten bevestigen dat Anaplasma spp. antistoffen frequent gevonden worden bij honden. Het DNA 
van A. platys werd ook geamplificeerd, terwijl geen enkele hond positief testte voor A. phagocytophilum 
door middel van PCR. Hoewel het gebruikte PCR protocol zeer sensitief is, wordt beschreven dat vals 
negatieve resultaten bij A. phagocytophilum PCR kunnen optreden voornamelijk ten gevolge van de 
korte duur van de bacteriëmie en door de variatie in aantal circulerende bacteriën. Daarom tonen de 
negatieve A. phagocytophilum-PCR resultaten enkel aan dat de respectievelijke nucleïnezuursequentie 
niet gedetecteerd werd in de geëvalueerde stalen onder de omstandigheden van de assay in onze studie, 
en bijgevolg dat deze resultaten niet geïnterpreteerd mogen worden als bewijs van afwezigheid van 
infectie bij honden in Marokko. De discrepantie tussen de hoge seroprevalentie van Anaplasma spp. 
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antistoffen en de matige prevalentie van A. platys DNA zou kunnen suggereren dat deze honden 
mogelijk blootgesteld werden aan andere Anaplasma species. We verzamelden ook teken van sommige 
honden die geïncludeerd werden in deze studie. Alle teken werden geïdentificeerd als Rhipicephalus 
sanguineus, de meest waarschijnlijke vector van A. platys. Het was helaas niet mogelijk om deze teken 
te screenen voor A. phagocytophilum en A. platys DNA omwille van degradatie van het DNA. 
 
Momenteel zijn er geen data beschikbaar over het voorkomen van humane blootstelling aan        
A. phagocytophilum in Afrika. In Hoofdstuk V evalueren we de seropositiviteit tegenover deze bacterie 
bij 271 gezonde hondenverzorgers, hondeneigenaars en bloeddonoren afkomstig uit twee steden in 
noordwestelijk Marokko. Een indirecte immunofluorescentietest van een commercieel beschikbare kit 
werd gebruikt om specifiek immunoglobuline G van A. phagocytophilum te detecteren. Twee 
verdunningen werden gebruikt om de prevalentie van seroreactieve stalen te evalueren. Seropositiviteit 
bereikte 37% en 27% bij hondenverzorgers en 36% en 22% bij bloeddonoren, zonder een significant 
verschil tussen beide groepen. Daarnaast waren 7 en 6 van de 10 hondeneigenaars ook seropositief bij 
respectievelijk de eerste en tweede verdunning. Risicofactoren werden niet geïdentificeerd, maar een 
hoge proportie van de bloeddonoren en hondeneigenaars vermeldden wel regelmatige activiteiten 
buitenshuis en de hondenverzorgers waren frequent betrokken bij beroepsmatige activiteiten 
buitenshuis. Dit onderzoek toont aan dat blootstelling aan A. phagocytophilum vaak voorkomt in 
Marokko, zowel bij de hoog risicogroep van de hondenverzorgers als bij de bloeddonoren. Deze 
resultaten benadrukken bijgevolg het belang van A. phagocytophilum voor de volksgezondheid.  
 
Deze studie levert ons belangrijke kennis over de blootstelling aan Anaplasma spp. en      
Ehrlichia spp., en over infecties met A. platys en D. immitis bij honden in Marokko. Daarnaast heeft 
deze studie voor het eerst de blootstelling aan A. phagocytophilum aangetoond bij mensen in Marokko 
en meer algemeen in Afrika. Onze resultaten toonden aan dat zowel honden als mensen in Marokko 
frequent worden blootgesteld aan teken overdraagbare pathogenen en benadrukken onze resultaten het 
belang van deze ziekten voor de volksgezondheid. Onze studie werd opgesteld om het voorkomen van 
A. phagocytophilum en A. platys bij honden en mensen in beperkte regio‘s van het land te evalueren. 
Grootschalige onderzoeken zijn noodzakelijk om het risico op blootstelling in alle Marokkaanse regio‘s 
te evalueren. Toekomstige studies zouden de epidemiologische aspecten van A. phagocytophilum 
infecties (i.e., vectoren, reservoir gastheren, genetische variabiliteit), de risicofactoren geassocieerd met 
deze infectie, het belang voor de volksgezondheid van anaplasmosis overgedragen door transfusie en de 
mogelijkheid van deze bacterie om ziekte te veroorzaken bij zowel honden als mensen in Marokko, 
kunnen onderzoeken. 
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Les zoonoses vectorielles présentent un intérêt croissant car elles constituent une menace 
émergente pour la santé publique et animale. Les chiens peuvent jouer un rôle épidémiologique dans de 
nombreuses zoonoses vectorielles en tant que réservoirs d‘agents pathogènes, transporteurs de vecteurs 
infectés au contact de l‘Homme ou sentinelle dans l‘évaluation du risque d‘infection pour l‘Homme. 
Etant donné la complexité du diagnostic et du contrôle des maladies vectorielles ainsi que l‘existence 
d‘infection asymptomatiques chez le chien augmentant le risque de transmission des pathogènes aux 
vecteurs, les données épidémiologiques au sein d‘une région sont fondamentales.                    
Anaplasma phagocytophilum, A. platys, Borrelia burgdorferi, Ehrlichia canis et Dirofilaria immitis sont 
d‘importants agents pathogènes à transmission vectorielle reconnus comme zoonotiques pour certains 
ou ayant la capacité d‘infecter l‘Homme pour d‘autres. Les tiques sont considérées comme les vecteurs 
transmettant le plus grand nombre d‘agents pathogènes en comparaison avec les autres arthropodes 
vecteurs. Certaines maladies transmises par les tiques sont considérées comme émergentes du fait de la 
contribution de différents facteurs jouant un rôle crucial dans la multiplication et l‘expansion territoriale 
des tiques et par conséquent, augmentant le risque d‘infestation par les tiques et de transmission 
d‘agents pathogènes à l‘Homme et à l‘animal. Parmi les agents pathogènes transmis par les tiques 
émergents et zoonotiques, A. phagocytophilum est responsable d‘une maladie de distribution mondiale 
nommée « anaplasmose granulocytaire ». Durant les dernières décennies, le nombre d‘exposition 
humaine et animale à A. phagocytophilum a continuellement augmenté aux Etats Unis d‘Amérique, en 
Europe et dans certains pays d‘Asie. L‘infection chez l‘Homme est potentiellement mortelle, de 
diagnostic difficile et peut entraîner de sévères complications associées à des taux d‘hospitalisation 
élevés. A. phagocytophilum a été détectée dans des pays d‘Afrique du nord et du bassin méditerranéen. 
Dans ces régions, une autres espèce d‘Anaplasma, A. platys, pathogène pour le chien et capable 
d‘infecter l‘Homme est également présente. En Afrique, très peu d‘études on été menées sur 
l‘exposition et/ou l‘infection canine par A. phagocytophilum, A. platys, B. burgdorferi, E. canis and D. 
immitis et ces données sont manquantes au Maroc. De même, très peu d‘études sur les maladies 
transmises par les tiques chez l‘Homme sont disponibles au Maroc et aucune donnée concernant 
l‘exposition humaine à A. phagocytophilum n‘est actuellement publiée.  
 
Le Chapitre I explique l‘importance des maladies vectorielles dans le monde et met en relief les 
facteurs contribuant à leur expansion et l‘intérêt croissant suscité par ces maladies, en insistant sur celles 
transmises par les tiques et plus particulièrement sur A. phagocytophilum. Ce chapitre résume également 
les plus importantes caractéristiques épidémiologiques d‘A. phagocytophilum et d‘A. platys comprenant 
les modalités de transmission, les hôtes réservoirs, les cycles de transmissions, la diversité génétique, le 
potentiel zoonotique, la distribution mondiale et discute le rôle épidémiologique du chien dans ces deux 
infections. Du fait de la distribution mondiale d‘A. phagocytophilum et d‘A. platys, ces deux bactéries
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devraient être présentes et circuler au sein de la population canine au Maroc et l‘Homme pourrait être 
exposé à A. phagocytophilum étant donné son caractère zoonotique. Par conséquent, l‘objectif de ce 
travail de thèse exposé dans le Chapitre II est l‘évaluation de la possible circulation                                            
d‘A. phagocytophilum chez le chien et l‘Homme, et d‘A. platys chez le chien au Maroc.  
 
Au commencement de ce travail de thèse, aucune donnée concernant l‘exposition canine à 
Anaplasma spp., Ehrlichia spp. et Borrrelia burgdorferi au Maroc n‘était publiée et seul un précédent 
article a décrit l‘infection par D. immitis chez un petit nombre de chiens. Dans le Chapitre III, 
l‘exposition à ces quatre agents vectoriels a été étudiée chez 217 chiens prélevés dans sept villes 
marocaines en utilisant un kit ELISA rapide. Parmi les chiens prélevés, 83.9% ont présenté des résultats 
positifs pour au moins un agent pathogène. L‘exposition simultanée à au moins deux agents pathogènes 
a été observée chez 14 .3% des chiens. Aucun chien séropositif pour B. burgdorferi n‘a été détecté. A 
l‘inverse, les anticorps anti-Anplasma spp. et Ehrlichia spp. ainsi que les antigènes de D. immitis ont été 
fréquemment détectés. Une différence significative dans la prévalence à Ehrlichia spp. et D. immitis a 
été notée  pour le groupe de chiens ruraux mais pas pour Anaplasma spp. Cette première partie de notre 
étude a démontré que les chiens au Maroc présentent un risque important d‘infection par des agents 
vectoriels et a détecté les anticorps anti-Anaplasma spp. dans la population de chien prélevés. Etant 
donné que le test ELISA utilisé ne permet pas de différencier entre une exposition à A. phagocytophilum 
ou à A. platys, nous avons décidé d‘évaluer la présence de l‘infection par ces deux bactéries chez le 
chien.  
 
Dans le Chapitre IV, nous avons étudié simultanément l‘exposition à Anaplasma spp. et 
l‘infection par A. phagocytophilum et A. platys dans un effectif canin plus important (n = 425) prélevés 
dans trois villes du nord-ouest du Maroc. Les anticorps anti-Anaplasma spp. ont été recherchés par une 
méthode immuno-enzymatique ELISA et l‘ADN d‘A. phagocytophilum et d‘A. platys par une technique 
de réaction de polymérase en chaine quantitative en temps réel (RT-PCR) ciblant le gène msp2. Les 
résultats obtenus confirment ceux de la précédente étude démontrant encore une fois que les anticorps 
anti-Anaplasma spp. sont fréquemment détectés chez les chiens prélevés. L‘ADN d‘A. platys a 
également été amplifiée tandis qu‘aucun chien n‘a été positif à l‘ADN d‘A. phagocytophilum. Malgré la 
sensibilité du protocole de PCR utilisé, des résultats faussement négatifs peuvent exister principalement 
dus à la courte durée de la bactériémie et aux variations du nombre de bactéries circulantes. Par 
conséquent, un résultat négatif lors de la recherche de l‘ADN d‘A. phagocytophilum par PCR signifie 
uniquement que la l‘acide nucléique recherché n‘a pas été détecté dans l‘échantillon examiné sous les 
conditions du protocole utilisé et ne devrait en aucun cas être interprété comme une absence de cette 
bactérie chez le chien au Maroc. De plus, la disproportion entre une forte séroprévalence à      
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Anaplasma spp. et une prévalence modérée de détection d’A. platys pourrait suggérer que les chiens 
prélevés ont potentiellement été exposés à d‘autres espèces du genre Anaplasma. Il est par ailleurs 
important de noter que les tiques prélevées sur ces chiens ont été exclusivement identifiées comme 
appartenant à l‘espèce Rhipicephalus sanguineus, le vecteur présumé d‘A. platys. Malheureusement, la 
recherche de l‘ADN d‘A. phagocytophilum et d‘A. platys dans les tiques prélevées n‘a pas pu être 
réalisée à cause de la dégradation de l‘ADN.  
 
Actuellement aucune donnée sur la présence de l‘exposition humaine à A. phagocytophilum en 
Afrique n‘est disponible. Dans les Chapitres IV et V, nous avons évalué la séropositivité à cette 
bactérie chez 271 patients cliniquement sains et subdivisés en trois groupes: les maîtres-chiens, les 
propriétaires de chiens et les donneurs de sang prélevés dans deux villes du nord-ouest du Maroc. Un kit 
commercial d‘immunofluorescence a été utilisé pour détecter les immunoglobulines G spécifiques à     
A. phagocytophilum. Deux dilutions ont été réalisées pour évaluer la réactivité des échantillons. La 
proportion de patients séropositifs a été de 37% et 27% chez les maitres-chiens et de 36% et 22% chez 
les donneurs de sang, sans différence significative entre les deux groupes. De plus, les anticorps dirigés 
contre A. phagocytophilum ont été détectés chez 7 et 6 parmi 10 propriétaires de chiens à la première et 
deuxième dilution, respectivement. Aucun facteur de risque associé à la séropositivité n‘a été identifié. 
Cependant, un nombre important de donneurs de sang et de propriétaires ont reporté avoir fréquemment 
des activités en plein air. Cette étude a démontré que l‘exposition à A. phagocytophilum est fréquente à 
la fois dans la population à risque et chez les donneurs de sang au Maroc et souligne son importance en 
terme de santé publique.  
 
Cette étude fournit des données de base sur l‘exposition à Anaplasma spp., Ehrlichia spp. et 
l‘infection par A. platys et D. immitis au Maroc. Elle fournit également la première démonstration de 
l‘exposition humaine à A. phagocytophilum au Maroc et en Afrique plus généralement. Les résultats 
obtenus ont montré que les chiens et l‘Homme sont fréquemment exposés aux agents pathogènes 
transmis par les tiques et soulignent leur importance en termes de santé publique. Cette étude a été 
conçue afin d‘évaluer la présence d‘A. phagocytophilum et d‘A. platys chez le chien et l‘Homme dans 
un nombre limité de villes marocaines. Des études à l‘échelle nationale sont nécessaires afin d‘évaluer 
le risque d‘exposition à ces bactéries dans toutes les régions du Maroc. Les prochains travaux devraient 
également étudier les différents aspects épidémiologiques de l‘infection à A. phagocytophilum (les 
différentes espèces de tiques potentiellement vectrices, les hôtes réservoirs, la diversité génétique), 
évaluer les facteurs de risque associés à cette infection, l‘importance en terme de santé publique de la 
transmission de cette infection par transfusion sanguine et la pathogénicité de cette bactérie chez le 
chien et l‘Homme au Maroc.  
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 اٌح١ٛأبد طحخ ػٍٝ وج١ش خطش ِٓ رشىٍٗ ٌّب ِزضا٠ذا ا٘زّبِب إٌّشأ اٌح١ٛأ١خ الأِشاع رؼشف
 ػٍٝ أ٠ؼب لبدسح أٔٙب وّب إٌّشأ اٌح١ٛأ١خ الأِشاع ِٓ اٌؼذ٠ذ فٟ ٚ٠بئٟ دٚس ٌؼت ػٍٝ لبدسح فبٌىلاة ٚاٌؼَّٛ،
 ثبلارظبي عٛاء الإٔغبْ إطبثخ ثئِىبٔٙب ٚاٌزٟ اٌّظبثخ ٌٍؼٛاًِ ٚإٌبلً ٌٍّشع اٌّغججخ اٌؼٛاًِ ِخضْدٚس ٌؼت
 ٚرزجغ رشخ١ض ٌظؼٛثخ ٔظشا ٠ض٠ذ إٌبللاد ٌذٜ الأِشاع ِغججبد أزمبي خطش. ٌٍجشش ػذٜٚ ثزمذ٠ُ أٚ اٌّجبشش
 اٌّؼط١بد أْ وّب اٌىلاة، ٌذٜ الأػشاع ػذ٠ّخ ػذٜٚ ٚجٛد ػٓ فؼلا اٌحششاد، ػجش إٌّمٌٛخ الأِشاع
 .أعبع١ب أِشا رؼزجش إٌّطمخ فٟ اٌٛثبء حٛي ٚاٌؼشٚس٠خ اٌلاصِخ
 ٟ٘   sitimmi airaliforiD te sinac aihcilrhE ,irefrodgrub ailerroB ,sytalp .A ,mulihpotycogahp .A   
 اٌمذسح ٌٙب اٌزٟ أٚ اٌجؼغ ٌذٜ إٌّشأ وبٌح١ٛأ١خ ِؼٍِٛخ ٔبللاد ػجش رٕزمً اٌزٟ ٌٍّشع اٌّغججخ اٌؼٛاًِ أُ٘
 ػذد لأوجش اٌحبًِ إٌبلً اٌمشاد ٠ؼذ الأخشٜ اٌّفظٍ١خ ثبٌٕبللاد ِمبسٔخ. ا٢خش اٌجؼغ ٌذٜ الإٔغبْ إطبثخ ػٍٝ
 اٌّخزٍفخ اٌؼٛاًِ ِغبّ٘خ ٔز١جخ فجبئ١خ أٚ ٔبشئخ رؼزجش اٌمشاد ػجش إٌّزمٍخ الأِشاع ثؼغ .اٌّشع ِغججبد ِٓ
 اٌّغججخ اٌؼٛاًِ ٚأزمبي اٌمشاد ػجش الإطبثخ خطش ص٠بدح ٚثبٌزبٌٟ اٌمشاد ٚرىبصش ّٔٛ فٟ حبعّب دٚسا رٍؼت ٚاٌزٟ
  ٔجذ إٌّشأ ٌح١ٛأٟٚا إٌبشئ اٌمشاد ػجش اٌّزٕبلٍخ ٌٍّشع اٌّغججخ اٌؼٛاًِ ث١ٓ ِٓٚ. ٚاٌح١ٛاْ ٌلإٔغبْ ٌٍّشع
  .» eriatycolunarg esomsalpana« اٌّغّٝ ٌٍّشع اٌؼبٌّٟ اٌزٛص٠غ ػٓ اٌّغؤٚي mulihpotycogahp .A
 ثشىً mulihpotycogahp .A ٔز١جخ ٚاٌح١ٛاْ الإٔغبْ ٌذٜ الإطبثبد ػذد اصداد الأخ١شح اٌؼمٛد خلاي
 .الأع١ٛ٠خ اٌذٚي ٚثؼغ ٚأٚسٚثب الأِش٠ى١خ اٌّزحذح اٌٛلا٠بد فٟ ِٕمطغ غ١ش ِغزّش
 راد خط١شح ِؼبػفبد رغجت أٔٙب وّب اٌزشخ١ض ٚطؼجخ لبرٍخ رىْٛ ِب غبٌجب الإٔغبْ ٌذٜ الإطبثخ إْ
فٟ ثٍذاْ شّبي أفش٠م١ب ٚاٌجحش الأث١غ  mulihpotycogahp .A ػٓ اٌىشف رُ ٚلذ. ػبٌ١خ اعزشفبئ١خ ِؼذلاد
 ثبٌٕغجخ ٌٍّشع ِغججب رشىً اٌزٟ ٚ  sytalp .A ,amsalpanA‘d ِٓ أخش ٔٛع إٌّبؽك ٘زٖ فٟ أْ ح١ش. اٌّزٛعؾ
 .الإٔغبْ إطبثخ ػٍٝ أ٠ؼب لبدسح ٚ ٌٍىلاة
  ةاٌىلا ػذٜٚ أٚ رؼشع ػٓ أجش٠ذ زٟاٌ ٟ٘ لٍ١ٍخ دساعبد إفش٠م١ب، فٟ
 ، sitimmi .D ,sinac .E ,irefrodgrub .B ,sytalp .A ,mulihpotycogahp .A :ة
 اٌّزٕبلٍخ الإِشاع حٛي أجش٠ذ اٌزٟ اٌذساعبد أْ وّب .اٌّغشة فٟ ِٕؼذِخ ٚ ِفمٛدح اٌّؼط١بد ٘زٖ أْ ػٍّب
 ػجش ٌٍّشع الإٔغبْ رؼشع حٛي اٌّؼط١بد ف١ّب ثبٌّغشة جذا لٍ١ٍخ الإٔغبْ ٌذٜ اٌمشاد ػجش
 .ِٕٙب أٞ رٕشش ٌُ mulihpotycogahp.A
 اٌؼٛء ٠غٍؾ وّب ،اٌؼبٌُ فٟ اٌحششاد ػجش إٌّمٌٛخ الأِشاع أّ٘١خ ،اٌجحش ٘زا ِٓ الأٚي اٌفظً ٠ؤوذ
 خبطخ اٌمشاد ػجش رزٕبلً اٌزٟ رٍه ػٍٝ ِؤوذا ثٙب، اٌّزضا٠ذ الا٘زّبَٚ أزشبس٘ب فٟ اٌّغبّ٘خ ٌؼٛاًِا ػٍٝ
 mulihpotycogahp .A ي اٌٛثبئ١خ اٌخظبئض وزٌه، اٌفظً ٘زا ٠ٍخضٚ. mulihpotycogahp .A 
 اٌظٙٛس إِىبٔ١خ اٌٛساصٟ، اٌزٕٛع الأزمبي، دٚساد اٌّؼ١فخ، اٌخضأبد ،الأزمبي ؽشق إٌٝ إػبفخ sytalp .A ٚ 
 اٌؼبٌّٟ اٌزٛص٠غ ٚٔز١جخ ،الإطبثز١ٓ ولا فٟ ٌٍىٍت اٌٛثبئٟ اٌذٚس ٠ٕبلش أٔٗ وّب اٌؼبٌّٟ، اٌزٛص٠غ اٌح١ٛأٟ،
 ملخص
 
 891 
 فٟ اٌىلاة ٌذٜ ِزذاٌٚخٚ حبػشح رىْٛ أْ اٌّؤوذ ِٓ اٌجىز١ش٠ب ٖ٘ز فئْ  sytalp .A ٚ mulihpotycogahp .A ي
 . اٌح١ٛأ١خ ٌٚخظبئظٗ mulihpotycogahp .A ي اٌزؼشع ٌلإٔغبْ ٠ّىٓ ح١ش ،اٌّغشة
  ِحزًّ رذفك إِىبٔ١خ رم١١ُ ٘ٛ اٌجحش، ِٓ اٌضبٟٔ اٌفظً فٟ اٌّمذَ الأؽشٚحخ ٘زٖ ِٓ اٌٙذف فئْ ٌزٌهٚ
 .اٌّغشة فٟ اٌىلاة ٌذٜ sytalp .A ٚ اٌح١ٛاْ ٚ الإٔغبْ ٌذٜ mulihpotycogahp .A ي
  ،الأؽشٚحخ ٘زٖ ثذا٠خ لجً اٌّغشة فٟ اٌّٛػٛع فٟ ثحش أٞ ٕ٘بن ٠ىٓ ٌُ أٔٗ ثبٌزوش ٚاٌجذ٠ش
 اٌىلاة رؼشع حٛي ثلادٔب فٟ ِؼط١بد أٞ ٔشش ٠زُ ٌُ وّب
  irefrodgrub ailerrroB  ،aihcilrhE ,pps amsalpanA pps ي
 .sitimmi .D  ؽش٠ك ػٓ ٌلإطبثخ اٌىلاة ِٓ لٍ١ً ػذد رؼشع رٕبٚي ، فمؾ ٚاحذ ِمبي ُوزت فٍمذ
 عجغ ِٓ وٍجب 217 ٌذٜ الأسثغ اٌؼٛاًِ ٘زٖ ٔز١جخ اٌزؼشع دساعخ رّذ اٌجحش ٘زا ِٓ اٌضبٌش اٌفظً فٟ
 حٛي إ٠جبث١خ ٔزبئج لذِذ اٌّذسٚعخ اٌىلاة ػ١ٕبد ِٓ %8..9. اٌغش٠ؼخ  ASILE ػذح ثبعزؼّبي ِغشث١خ ِذْ
 ػٍٝ ٌٍّشع ٌّغجج١ٓ اٌٛلذ ٔفظ فٟ رؼشػذ اٌىلاة ِٓ % ...1 أْ وّب. الألً ػٍٝ ٌٍّشع ٚاحذ ِغجت
 ِؼبداد غشاس ػٍٝ irefrodgrub .B ي إٌّبػخ ٔمض ف١شٚط ِٓ ٠ؼبٟٔ وٍت أٞ سطذ ٠زُ ٌُ ح١ٓ فٟ.  الألً
 . وض١شا سطذ٘ب رُ اٌزٟ sitimmi .D ِؼبداد ٌِٛذاد ٚوزٌه itna-pps aihcilrhE الأجغبَ
 اٌىلاة ِٓ ِجّٛػخ ٌذٜ رغج١ٍٗ رُ sitimmi .D ٚ  aihcilrhE pps  يالأزشبس فٟ ٘بَ فشق ٕ٘بن أْ وّب
 .amsalpanA  pps ػىظ ػٍٝ اٌمشٚ٠خ
 اٌؼٛاًِ ٘زٖ ػجش ٌلإطبثخ ثبٌٕغجخ خطشا رشىً اٌّغشة فٟ اٌىلاة أْ دساعزٕب ِٓ الأٚي اٌجضء أظٙش ٌمذ
  .اٌّذسٚعخ اٌىلاة ػ١ٕبد ٌذٜ itna-amsalpanA ppsو الأجغبَ ِؼبداد سطذد أٔٙب وّب إٌبلٍخ
 لشسٔب ، sytalp .A ي أٚ mulihpotycogahp .A ي اٌزؼشع ث١ٓ اٌزّ١١ض ِٓ ٠ّىٕٕب ٌُ  ASILE اخزجبس وْٛ ٚ
 .اٌىٍت ٌذٜ اٌجىز١ش٠ب ٘زٖ ؽش٠ك ػٓ اٌؼذٜٚ ٚجٛد رم١١ُ
  الإطبثخٚ amsalpanA ppsي اٌزؼشع ثذساعخ اٌٛلذ، ٔفظ فٟ لّٕب فٍمذ ،اٌشاثغ اٌفظً فٟ أِب
 ِذْ صلاس ِٓ ِأخٛرح ،فشدا 47. رؼُ اٌىلاة ِٓ ِّٙخ ػ١ٕخ ٌذٜ sytalp .A  ٚ  mulihpotycogahp .A ة
-ِٕؼبر١خ ؽش٠مخ ثٛاعطخ amsalpanA-itna pps الأجغبَ ِؼبداد ػٓ اٌجحش رُ وّب .اٌّغشة غشة شّبي
   mulihpotycogahp .A ي إٌٛٚٞ ٚاٌحّغ  ASILE ػٓ ٕ٘ب اٌحذ٠شٚ أٔض٠ّ١خ،
 ح١ش ،2psm اٌج١ٕبد ِغزٙذفخ )RCP-TR( اٌضِٓ ػجش وّٟ ثزغٍغً اٌجٍّشح رفبػً رمٕ١خ ؽش٠ك ػٓ sytalp .A  ٚ
  الأجغبَ ِؼبداد أْ ػٍٝ جذ٠ذ ِٓ ِجشٕ٘خ ،اٌغبثمخ اٌذساعخ ٔزبئج إٌزبئج ٘زٖ رؤوذ
 حّغ رؼخ١ُ رُ وّب .اٌّذسٚعخ اٌىلاة ػ١ٕبد ٌذٜ وض١شا سطذ٘ب رُ لذ pps amsalpanA-itna 
 حّغ ثخظٛص إ٠جبث١ب وٍت أٞ ٠ىٓ ٌُ ح١ٓ فٟ إٌٛٚٞ sytalp .A 
  .إٌٛٚٞ mulihpotycogahp .A 
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ٚ٠شجغ رٌه أعبعب إٌٝ لظش ِذح  ،وبرثخ، فمذ رحذس ٔزبئج عٍج١خ RCPٚػٍٝ اٌشغُ ِٓ حغبع١خ ثشٚرٛوٛي 
 حّغ ػٓ اٌجحش ػٕذ ٚاحذح عٍج١خ ٔز١جخ فئْ ٌزٌه رجشصُ اٌذَ ٚاٌزغ١شاد فٟ ػذد ِٓ اٌجىز١ش٠ب إٌّزششح.
 فٟ سطذٖ ٠زُ ٌُ ػٕٗ اٌّجحٛس إٌٛٚٞ اٌحّغ أْ فمؾ رؼٕٟ ، RCP ثطش٠مخ إٌٛٚٞ mulihpotycogahp .A 
 ٚجٛد ثؼذَ رفغش أْ ،الأحٛاي ِٓ حبي أٞ فٟ ٠ٕجغٟ لا ٚ ،ثٗ اٌّؼّٛي اٌجشٚرٛوٛي لأحىبَ ٚفمب اٌّفحٛطخ اٌؼ١ٕخ
  اٌّظٍٟ الأزشبس اسرفبع ث١ٓ اٌزٕبعت ػذَ فئْ ،رٌه إٌٝ ػبفخثبلإ. ثبٌّغشة اٌىلاة ٌذٜ اٌجىز١ش٠ب ٘زٖ
  أخشٜ أٔٛاع إٌٝ اٌىلاة رؼشع إٌٝ ٠ش١ش أْ ٠ّىٓ sytalp .A سطذ أزشبس اػزذايٚ amsalpanA pps ي
 اٌىلاة ػ١ٕبد ِٓ اٌّأخٛر اٌمشاد أْ ٔلاحع أْ أ٠ؼب اٌُّٙ ِٚٓ. الأزشبس اٌّظٍٟ amsalpanA pps ِٓ
 ٌُ ٌٚلأعف. sytalp .A ي اٌّشٙٛس إٌبلً sulahpecipihR sueniugnas ٌٍٕٛع ٠ٕزّٟ أٗ ػٍٝ رحذ٠ذٖ رُ اٌّذسٚعخ
 ٌزذ٘ٛس ٔظشا اٌمشاد ِٓ إٌٛع ٘زا ٌذٜ إٌٛٚٞ sytalp .A ٚ mulihpotycogahp .A حّغ ػٓ اٌجحش رطج١ك ٠زُ
  .إٌٛٚٞ اٌحّغ
 .حبٌ١ب إفش٠م١ب فٟ ِزٛفشح غ١ش mulihpotycogahp .A ي الإٔغبْ رؼشع حٛي اٌّؼط١بد أْ إٌٝ الإشبسح رجذس
 رُٚ اٌغش٠ش٠١ٓ اٌّشػٝ ِٓ 217 ٌذٜ باٌجىز١ش٠ ٘زٖ حبٌخ ثزم١١ُ لّٕب ٚاٌخبِظ اٌشاثغ اٌفظٍ١ٓ فٟٚ
 غشة شّبي ِذ٠ٕز١ٓ فٟ ثبٌذَ اٌّزجشػْٛٚ اٌىلاة أطحبة اٌىلاة، ِذسثٟ :ِجّٛػبد صلاس إٌٝ رمغ١ُّٙ
  اٌخبطخ G senilubolgonummi ػٓ ٌٍىشف رجبس٠خ ِٕؼبر١خ ػذح اعزخذاَ رُ لذٚ. اٌّغشة
 اٌّظبث١ٓ اٌّشػٝ ٔغجخ ثٍغذ ٚ أجش٠ذ اصٕ١ٓ ِٓ اٌزخف١فبد ٌزم١١ُ رفبػً اٌؼ١ٕبد وّب .mulihpotycogahp .A ة
 ث١ٓ ُِٙ فشق أٞ دْٚ ثبٌذَ ٌٍّزجشػ١ٓ ثبٌٕغجخ  %22 ٚ  %66 ٚ ،اٌىلاة ٌّذسثٟ ثبٌٕغجخ  %27 ٚ % 2.
   mulihpotycogahp .A-itnaاٌّؼبدح الأجغبَ وشف رُ أٗ إٌٝ إػبفخ. اٌّجّٛػز١ٓ
أٞ ػٛاًِ اٌخطش  ٌُٚ رحذد  .اٌزٛاٌٟ ػٍٝ اٌضبٟٔ ٚ الأٚي اٌزخف١ف ػٕذ اٌىلاة ِشث١ٟ ػششح ِٓ 6 ٚ 2 ٌذٜ
 أْ اٌّشرجطخ ثف١شٚط ٔمض إٌّبػخ اٌجشش٠خ. ِٚغ رٌه، فمذ أفبد ػذد وج١ش ِٓ اٌّزجشػ١ٓ ثبٌذَ ٚأطحبة اٌىلاة
٘ٛشبئغ  mulihpotycogahp .Aيٚأظٙشد ٘زٖ اٌذساعخ أْ اٌزؼشع . اٌطٍك اٌٙٛاء فٟ رىْٛ ِب غبٌجب أٔشطزُٙ
 .ِؤوذح أّ٘١زٗ فٟ ِجبي اٌظحخ اٌؼِّٛ١خ ،ٌذَ فٟ اٌّغشةٌذٜ وً ِٓ اٌغىبْ اٌّؼشػ١ٓ ٌٍخطش ٚاٌّزجشػ١ٓ ثب
 وزاٚ   aihcilrhE ,pps amsalpanA pps ي اٌزؼشع حٛي أعبع١خٚ ِّٙخ ِؼط١بد اٌذساعخ ٘زٖ رمذَ
  الإٔغبْ رؼشع حٛي ٚدٌ١ً رؼٍ١ً أٚي أ٠ؼب رٛفش وّب. ثبٌّغشة sitimmi .D  ٚ  sytalp .A ة الإطبثخ
 .ػِّٛب ٚإفش٠م١ب اٌّغشة فٟ mulihpotycogahp .A ي
أْ اٌىلاة ٚالإٔغبْ غبٌجب ِب ٠زؼشع ٌّغججبد الأِشاع اٌزٟ رٕزمً ػٓ  اٌجحش، ٘زا ٚلذ أظٙشد ٔزبئج
 حؼٛس ٌزم١١ُ اٌذساعخ ٘زٖ طّّذ لذ وّب ػٍٝ أّ٘١زٙب فٟ ِجبي اٌظحخ اٌؼِّٛ١خ. ِؤوذح ،ؽش٠ك اٌمشاد
إٌٝ  إػبفخ.  اٌّغشث١خ اٌّذْ ِٓ ِحذٚد ػذد فٟ ٚالإٔغبْ اٌىلاة ٌذٜ sytalp .A’dو  mulihpotycogahp .A 
. اٌّغشةاٌٛؽٕٟ ٌزم١١ُ ِخبؽش اٌزؼشع ٌٙزٖ اٌجىز١ش٠ب فٟ جّ١غ ِٕبؽك  اٌظؼ١ذ اٌّبعخ ٌذساعبد ػٍٝ اٌحبجخ
 ٠جت اٌؼًّ فٟ اٌّغزمجً ػٍٝ دساعخ ِخزٍف اٌجٛأت اٌٛثبئ١خ ٌؼذٜٚٚ
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 ػٛاًِ رم١١ُٚ اٌّؼ١ف، ٚاٌزٕٛع اٌج١ٕٟ) ِٕٙب، اٌخضاْ إٌبلٍخ خبطخ اٌمشاد (أٔٛاع. mulihpotycogahp .Aاي  
 ٌذٜ اٌجىز١ش٠ب ٘زٖ ػ١خِشٚ اٌذَ ٔمً ػجش اٌّشع أزمبي ّ١خأ٘ رم١١ُ إٌٝ ثبلإػبفخ ،اٌّشع ثٙزا اٌّشرجطخ اٌخطش
 .اٌؼِّٛ١خ اٌظحخ ع١بعخ ع١بق ٚفك ،اٌّغشة فٟ اٌىلاةٚ الإٔغبْ
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